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ABSTRACT 
 
The LytTR domain is a DNA-binding domain that is present in 5% of all DNA-binding 
transcription factors (TFs). The LytTR family of DNA-binding TFs is poorly characterised 
but crucially important as LytTR domain-containing TFs (LDCTFs) are disproportionately 
associated with virulence genes regulation. Although some members of the family have been 
extensively studied, how LDCTFs activate transcription remains to be determined.  
The accessory gene regulator A (AgrA) in Staphylococcus aureus (S. aureus) is the master 
TF responsible for the activation of transcription at the agr operon, a key regulatory locus 
involved in the switch between early colonisation and the spread of infection. AgrA is an 
LDCTF and the only one for which the crystal structure of the LytTR domain in complex 
with DNA is available. 
Here an experimental system was developed to study AgrA activity in vivo in order to try to 
unravel the mechanism of transcription activation by LDCTFs using AgrA as a model.  
A systematic alanine scanning mutagenesis of the LytTR domain of AgrA was performed and 
the mutants were characterised in vivo and in vitro. 
Overall, the results identify amino acid (aa) residues in the LytTR domain of AgrA that are 
important for DNA-binding and transcription activation and provide novel molecular and 
mechanistic insights on how AgrA and other LDCTFs activate transcription. More 
specifically, a key residue for transcription activation by AgrA, Y229, was identified. This 
residue is important for transcription activation but is not involved in the ability to bend 
DNA. These findings challenge the current assumption that the DNA bending activity of 
AgrA is responsible for its ability to activate transcription. We therefore propose a new 
model for transcription activation by AgrA based on our findings. 
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E. coli Escherichia coli 
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EMSA Electophoretic mobility shift assay 
Eσ RNAp holoenzyme 
g Gram 
G Guanine 
GFP Green fluorescent protein 
GFP-Fluo GFP fluorescence units 
h Hour(s) 
HK Histidine protein kinase 
HTH Helix-turn-helix 
kb Kilobase 
 kDa  Kilodalton 
LDCTF LytTR domain-containing transcription factor 
M Molar 
Mab Monoclonal antibody 
MD Molecular dynamics 
mg Milligram 
min Minute(s) 
ml Millilitres 
mM Millimolar 
MRSA Methycilin resistant S. aureus 
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n Nano, 10-9  
ng Nanogram 
nm Nanometre 
NTP Nucleoside triphosphate 
OD Optical density 
P Promoter 
p Pico,10-12 
REC Receiver 
RNA Ribonucleic acid 
RNAp DNA-dependent RNA-polymerase(s) 
RPc Closed promoter complex(es) 
rpm Revolutions per minute 
RPo Open promoter complex(es) 
RR Response regulator 
RT Room temperature 
S. aureus Staphylococcus aureus 
SD 
 
Shine-Dalgarno sequence 
SDS Sodium dodecyl sulphate 
sec Seconds 
spp. Species 
T Thymine 
TAD Transcription activation deficient 
TBS Tris-buffered saline 
TCS Two-component systems 
TEMED N’,N’,N',N'-Tetramethylethylenediamine 
TF Transcription factor 
Tm Melting temperature 
Tris Tris(hydroxymethyl)aminomethane 
U Uridine 
v/v Volume:Volume 
VISA Vancomycin resistant S. aureus 
VRSA Vancomycin intermediate S. aureus 
w/v Weight:Volume 
WT Wild-type 
x g Relative centrifugal force 
α RNAp alpha subunit  
β RNAp beta subunit  
β’  RNAp beta prime subunit  
δ RNAp delta subunit 
σ Sigma factor 
ω RNAp omega subunit 
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CHAPTER ONE 
1. Introduction 
1.1. Transcription 
The immense diversity of bacterial life is probably not the result of differences in DNA 
sequences of genes as those are mostly conserved among bacteria. Therefore these 
differences must stem from differences in the amount and the timing of the expression of 
these genes, their transcription (Haugen et al, 2008). Transcription is the first step of gene 
expression, the first opportunity for regulation and is mediated by the RNA polymerase 
(RNAp). The RNAp is a large multi-subunit enzyme responsible for gene transcription in all 
organisms from bacteria to eukaryotes. Transcription is the synthesis of an RNA copy 
complementary to the DNA template by the RNAp using nucleoside tri-phosphates (NTP(s)) 
and consists of three main steps: initiation, elongation and termination (See Figure 1) 
(Borukhov & Nudler, 2008). Regulation can take place at every step of the transcription cycle 
but transcription initiation is widely accepted as being the most frequently regulated step 
(Haugen et al, 2008). 
 
Figure 1: The bacterial transcription cycle. 
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The core RNAp is coloured in grey, the σ factor in orange, the DNA in green and the RNA in red. The 
transcription cycle starts with the association of the core RNAp with the σ factor to form the holoenzyme. 
Then the holoenzyme locates and binds to the promoter DNA to form the closed complex (RPc). The complex 
goes through a series of intermediate states until it reaches the open complex (RPo) conformation where the 
DNA is melted open. The initiation starts with the binding of the first NTP at the +1 site and thus the start of 
the synthesis of the complementary RNA. Then the holoenzyme escapes the promoter and the σ factor 
dissociates from the core RNAp, leading to the formation of the elongation complex. The RNA synthesis is 
continued until the transcriptional stop site is reached and transcription is stopped. Upon transcription 
termination, the newly synthesised RNA molecule and the DNA are released and the core RNAp is free to start 
a new transcription cycle. For more details, refer to the main text. Figure by Ellen James, adapted from 
(Haugen et al, 2008). 
An entire thesis could be written about the transcription cycle in order to describe the 
molecular mechanisms taking place at each stage in detail. Here I will give a brief description 
of the events happening, focusing on transcription initiation as it is the step the most relevant 
to this thesis. The different stages are depicted in Figure 1. 
Transcription initiation starts with the association of the core RNAp consisting of 2α 
subunits, the β subunit, the β’ subunit and the ω subunit with the σ factor to create the 
holoenzyme. The σ factor is required for the recognition of the promoter DNA. 
Then the holoenzyme locates the promoter DNA sequence and specifically binds to it, in a 
conformation referred to as closed complex (RPc) because the DNA is still double stranded, 
hence closed.  
The complex then isomerises and goes through a series of intermediate states until it reaches 
the open complex (RPo) conformation where the DNA is melted open from positions -11 to 
+2 (See section 1.1.1) and is therefore accessible to serve as template for the synthesis of the 
RNA molecule.  
During the isomerisation, a series of conformational changes take places in the DNA and the 
RNAp: the down-stream DNA moves into the main channel and unwinds, the template strand 
(T) is placed in the active site of the RNAp with the +1 in position for base pairing with the 
first NTP and σ region 1.1 is displaced from the main channel by the incoming DNA (See 
sections 1.1.3 and 1.1.4).  
The initiation phase of transcription starts with the binding of the first NTP at the +1 site and 
continues with the binding of the second NTP and the formation of a phosphodiester bond 
between the two NTPs in the active site. The first transcripts synthesised are usually short and 
abortive and happen while the RNAp is still firmly anchored to the promoter sequence and 
pulls the downstream DNA into itself, a mechanism called scrunching that generates free 
energy. After a few rounds of abortive initiation, the free energy accumulated is enough to 
overcome the strength of promoter binding and the RNAp therefore escapes the promoter 
which leads to the dissociation of the σ factor from the core and the formation of the 
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elongation complex. Elongation consists of the repetitive formation of phosphodiester bonds 
as the RNA-DNA hybrid moves across the catalytic cleft in the RNAp due to the 
translocation of the RNAp along the DNA, one base pair (bp) forward at a time. 
 Upon termination, the synthesised RNA strand dissociates from the RNA-DNA hybrid and 
the RNAp in response to specific signals and the RNAp is free to start a new cycle of 
transcription. (Borukhov & Nudler, 2008; Haugen et al, 2008; Imashimizu et al, 2014; 
Saecker et al, 2011).  
1.1.1. The promoter 
The promoter is the DNA sequence located upstream of a gene responsible for the regulation 
of the expression of this gene. It is also the sequence that is recognised by the RNAp and 
brings the RNAp towards the gene to drive its expression. The promoter consists of several 
specific conserved motifs that interact with specific subunits of the RNAp, mainly the σ 
factor. Therefore, there are two main types of promoters, the σ70 promoters and the σ54 
promoters that present a different organisation (See section 1.1.4). This section will focus on 
σ
70 promoters (Haugen et al, 2008). 
The first promoter elements to have been identified are the -10 (5’-TATAAT-3’, from -12 to-7) 
and -35 (5’-TTGACA-3’, from -35 to -30) (See Figure 2) (Maniatis et al, 1975; Pribnow, 1975). 
The names of these elements stem from their position on the DNA in respect to the 
transcriptional start site. The transcriptional start site corresponds to position +1 and the base 
immediately upstream to position -1 and so forth. The -10 and -35 promoter elements are 
separated by a spacer. The optimal size for that spacer is 17 bp and promoters having a 
smaller or bigger spacer have reduced activity (Aoyama et al, 1983; Siebenlist, 1979). The -
35 and -10 promoter elements are conserved amongst bacterial promoters but some positions 
within these elements can vary without affecting the efficiency of the promoter too much 
whilst others cannot. At the -10 promoter element, the TAA motif from position -10 to -8 is 
variable whereas the T at position -12, the A at position -11 and the T at position -7 are very 
well conserved. Any mutation at the three later positions results in a dramatically reduced 
promoter activity. Positions -11 and -7 are the most highly conserved positions of the -10 
element (See Figure 2) (Moyle et al, 1991; Siebenlist et al, 1980). Recently, the reason for 
this high level of conservation was identified. Upon recognition of the -10 promoter element 
by region 2 of the σ factor, the DNA is melted open and the A at position -11 and the T at 
position -7 are flipped out from the DNA base stack and buried into protein pockets on the σ 
factor. The A at position -11 is buried in a hydrophobic pocket which can perfectly 
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accommodate the shape of an A but not a different base. Similarly, the T at position -7 is 
buried in a hydrophilic pocket. Although this pocket is bigger, it can only accommodate a 
pyrimidine base (T or C) and not a purine base (A or G) (Feklistov & Darst, 2011; Zhang et 
al, 2012).  
At the -35 promoter element, the only position that can vary without affecting the promoter 
activity too much and that is less conserved is the A at position -30. Any mutation at any of 
the other positions reduces the activity of the promoter (See Figure 2) (Moyle et al, 1991; 
Siebenlist et al, 1980).  
 
Figure 2: DNA sequence of -10 and -35 promoter elements.  
-35 refers to the -35 element (5’-TTGACA-3’) and -10 refers to the -10 element (5’-TATAAT-3’). The red 
numbers above the sequence correspond to the position of each base with regards to the transcriptional start 
site. The nucleotides that can vary from the consensus sequence without affecting promoter activity drastically 
and are thus less conserved are underlined in black. 
However, some promoters have a very poorly conserved -35 promoter element but retain a 
high activity. This is due to another promoter element, called the extended -10. The extended 
-10 consists of two bases, a T at position -15 and a G at position -14. Not all promoters have 
an extended -10 promoter but those that do have a greater activity. The presence of an 
extended -10 at a promoter can compensate for a poorly conserved -35 promoter element and 
even abolish the need for it. In a similar fashion, the presence of an extended -10 promoter 
element can compensate for a suboptimal spacer length (Burr et al, 2000; Keilty & 
Rosenberg, 1987; Mitchell et al, 2003). 
The last promoter element to be identified was the discriminator region. The optimal 
discriminator consists of three Gs at position -6, -5 and -4 and is required for binding of the 
RNAp to the promoter. It also helps the RNAp to recognise the promoter in the absence of 
the -35 promoter element (Feklistov et al, 2006; Haugen et al, 2006).  
All of the promoter elements listed above are involved in the interaction with the σ factor 
(See Figure 3). However, the σ factor is not the only subunit of the RNAp involved in the 
interaction with the promoter DNA. The UP element consist of an extremely A+T rich 
region, alternating As and Ts, stretching from position -59 to -38 that interact with the C-
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terminal domain of the α subunits of the RNAp. When present, the UP element leads to an 
increase in transcriptional activity (See Figure 3) (Gourse et al, 2000; Ross et al, 1993). 
 
Figure 3: DNA element contributing to the promoter recognition by the RNAp. 
The UP element are the binding site for α-CTD (α-C-terminal domain) at the promoter and consist of a very AT 
rich stretch of DNA from position -59 to -38. -35 refers to the -35 element (5’-TTGACA-3’) recognised by the σ 
factor. Ext refers to the extended -10 element, T at -15 and G at -14 recognised by the σ factor. -10 refers to 
the -10 element (5’-TATAAT-3’) recognised by the σ factor. Dis refers to the discriminator region, three Gs from 
-6 to -4 recognised by the σ factor. +1 refers to the transcriptional start site.  
1.1.2. RNAp 
RNA polymerases are separated into two main families: the single subunit and the multi-
subunit RNAp. Single subunit RNAp are utilised by bacteriophages, mitochondria and 
chloroplasts. The most studied single subunit RNAp is probably the T7 RNAp. Although the 
structure of single subunit RNAp is very different from the multi-subunit ones and resembles 
that of a DNA polymerase, their biochemical properties are similar. Therefore, the small size 
of single subunit RNAp (~100 kDa) has made them attractive for biochemical and structural 
studies (Cheetham & Steitz, 2000; Cramer, 2002a). 
Multi-subunit RNAp share a conserved core of 5 subunits and many regions that diverge in 
term of sequence but are structurally conserved (See Figure 4). The bacterial RNAp consists 
of the 5 core subunits: β’ (~150 kDa), β (~150 kDa), two α (40 kDa) and ω (10 kDa) for a 
total mass of about 400 kDa (See Figure 5). Bacteria also possess a σ factor and some have an 
additional subunit, the δ subunit (~20 kDa) that is found in Gram positive bacteria that have a 
low-G+C content. Eukaryotes possess three RNAp, eRNAp I, II and III that contain 10 
common subunits and 4, 2 and 5 additional subunits, respectively. Archaea contain only one 
RNAp which is composed of 12 subunits, 11 of which are similar to the subunits of eRNAp II 
(Cramer, 2002b; Lane & Darst, 2010). 
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Figure 4: Composition of the RNAp in the three domains of life.  
The subunits are organised according to their function and homologous subunits are colour coded. The 
direction of the arrow indicates the increase in complexity. The asterisks mark the subunits that are conserved 
in all three eRNAP (Werner, 2007). 
1.1.3. The bacterial RNAp 
The active site of the RNAp is formed by the β and β’ subunits and drives the ability to bind 
to the template DNA and the RNA product during transcription (Korzheva et al, 2000). The α 
subunits consist of two independent domains connected by a flexible linker. The N-terminal 
part of α (αNTD) dimerises and is involved in the assembly of the β and β’ subunits (Ebright 
& Busby, 1995). The C-terminal part (αCTD) has a DNA-binding ability and is important for 
promoter recognition by recognizing the UP element (See section 1.1.1) (Blatter et al, 1994; 
Ross et al, 1993). The αCTD interacts with region 4 of the σ factor in addition (Chen et al, 
2003; Ross et al, 2003). The ω subunit is a chaperone and helps the folding of the β’ subunit 
(Minakhin et al, 2001) (See Figure 5). The δ subunit is involved in promoter recognition in 
Staphylococcus aureus (S. aureus) and drives the RNAp towards strongly expressed 
promoters, mainly the key virulence genes (Weiss et al, 2014).  
The RNAp binding to the promoter region involves firstly the binding of the αCTD to the UP 
element and the binding of σ to the -35 promoter element, the extended -10 promoter element 
and the discriminator region (Barne et al, 1997; Feklistov et al, 2006; Gardella et al, 1989; 
Haugen et al, 2006; Ross et al, 1993). The interaction between the -10 promoter element and 
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the σ factor takes place at a later stage, upon strand separation. Moreover, the fact that the 
bases at positions -11 and -7 are inserted into pockets on the σ factor (See section 1.1.1) 
enables to use binding energy to drive DNA unwinding and accounts for the ability of the σ 
factor to facilitate promoter unwinding (Feklistov & Darst, 2011; Zhang et al, 2012). 
 
Figure 5: Crystal structure of the Escherichia coli (E. coli) RNAp.  
Ribbon representation of the E. coli RNAp. The α1 subunit is coloured in green, the α2 subunit is coloured in 
yellow, the β subunit is coloured in cyan, the β’ subunit is coloured in magenta, the ω subunit is coloured in 
grey and the σ factor in orange. All the subunits are labelled in black. Pymol, PDB 4LK0. 
1.1.4. The sigma factors (σ) 
σ factors are responsible for the ability of the holoenzyme to locate and bind to promoter 
sequences and are thus an essential component of the transcription machinery.  
The σ factors are separated into two classes: the σ70 class containing the majority of σ factors 
that are mostly structurally related to the housekeeping σ70 factor from E. coli and the σ54 
class. σ54 is the only member of this class and has a different structure. σ54 is involved in the 
regulation of genes involved in various functions (nitrogen metabolism, carbon metabolism, 
phage and heat shock, etc…) and recognises different promoter elements than the other 
family. σ54 recognises promoters that have conserved -24 and -12 promoter elements. These 
promoters are unable to transition from RPc to RPo without the help of an activator ATPase 
that hydrolyses ATP (Buck et al, 2000; Studholme & Buck, 2000; Wigneshweraraj et al, 
2008).  
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The σ70 family can be divided into 4 groups, based on phylogenetic similarities: the essential 
primary σ factors (σ70), the closely related σ factors that are not essential for growth, the σ 
factors responding to specific signals and the extracytoplasmic function (ECF) σ factors that 
are highly divergent from σ70 and represent the largest group (Gruber & Gross, 2003). 
The σ70 family recognise the conserved -35 and -10 promoter elements, the extended -10 and 
the discriminator region. The σ70 factor consists of 4 domains: σ1, σ2, σ3 and σ4 that are 
subdivided into smaller sub-domains. Region 1.2 is responsible for binding to the 
discriminator region, regions 2.3 and 2.4 for binding to the -10 promoter element, region 3.0 
for binding to the extended -10 and region 4.2 for binding to the -35 promoter element (See 
Figure 6 and section 1.1.1) (Barne et al, 1997; Feklistov et al, 2006; Gardella et al, 1989; 
Gruber & Gross, 2003; Haugen et al, 2006; Siegele et al, 1989). 
 
Figure 6: Domain organisation of σ
70
 and its promoter recognition regions.  
The top figure represents the domain organisation of σ
70
. NCR means non-coding region. The subdomains are 
colour coded. The middle figure is a cartoon representation of σ
70
. The bottom figure is a cartoon 
representation the promoter elements and the σ
70
 subdomains that recognise them. The σ
70
 subdomains are 
colour coded. The UP element are the binding site for α-CTD (α-C-terminal domain) at the promoter and 
consist of a very AT rich stretch of DNA from position -59 to -38. -35 refers to the -35 element (5’-TTGACA-3’) 
recognised by the σ factor. Ext refers to the extended -10 element, T at -15 and G at -14 recognised by the σ 
factor. -10 refers to the -10 element (5’-TATAAT-3’) recognised by the σ factor. Dis refers to the discriminator 
region, three Gs from -6 to -4 recognised by the σ factor. +1 refers to the transcriptional start site. Adapted 
from (Haugen et al, 2008). 
S. aureus contains 4 different sigma factors: the equivalent of σ70, called σA regulating 
housekeeping genes that is essential (Deora & Misra, 1996), σB involved in the 
environmental stress response (Chan et al, 1998), σS an apparent ECF σ factor involved in 
stress responses (starvation, growth under elevated temperature and lysis) (Shaw et al, 2008) 
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and σH that is only activated under certain conditions and enables S. aureus to become 
naturally competent for transformation by DNA (Morikawa et al, 2012). 
1.2. Transcription activation at σ70 promoters 
Transcription activation is an additional step that allows a tighter regulation. Some promoters 
are not optimal by design. They either have weak conservation of their characteristics -10 and 
-35 promoter elements or a spacer length longer or shorter than the optimal 17 nt. 
Transcription from such promoters will be weak unless other factors come into place to help 
them achieve a higher level of transcription. These factors will mainly act to help the 
recruitment of the RNAp, stabilise the RPc or help the transition towards the RPo. They are 
called transcription factors (TFs) and act at to regulate transcription either by activating it or 
repressing it, in response to an environmental signal. They act either at the RNAp in which 
case they do not necessarily have a DNA-binding ability, or are DNA-binding TFs and bind 
to the promoter region of the gene they regulate. Some of the DNA-binding TFs are response 
regulators (RRs) (See section 1.3.2), like the S. aureus AgrA that regulates transcription in 
response to quorum sensing (See section 1.5.5.3). Transcription activation has been 
extensively characterised in E. coli and backed-up by crystal structures of promoter DNA/ TF 
complexes (Lee et al, 2012). This led to the definition of major mechanisms of activation that 
will be listed here. 
1.2.1. Activation by promoter remodelling 
DNA-binding TFs can bind to the promoter DNA and alter its conformation to render it more 
attractive for the RNAp and thus increase the transcription efficiency. They can bind between 
the -10 and -35 promoter elements and rectify a non-optimal spacer by twisting the DNA. A 
non-optimal spacer length results in the σ factor region 2.4 being misaligned in respected to 
the -10 promoter element after binding to the -35 and UP promoter elements and thus 
defective transcription (See section 1.1.1). The bend induced by the TF will act to align σ 
region 2.4 with the -10 promoter element and thereby activate transcription (See Figure 7). 
Examples of such TFs include the MerR family of transcriptional regulators (E. coli MerR, E. 
coli SoxR, Streptomyces TipA, Bacillus subtilis BltR, Bacillus subtilis BmrR) and the cII 
protein from the bacteriophage λ (Brown et al, 2003; Heldwein & Brennan, 2001; Jain et al, 
2005; Lee et al, 2012).  
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Figure 7: Activation by promoter remodelling. 
The TF dimer binds between the -10 and -35 promoter elements and induces a conformational change that 
allows the RNAp to interact with the promoter better. The RNAp subunits are colour coded and labelled in 
black.-35 refers to the -35 element (5’-TTGACA-3’) and -10 to the -10 element (5’-TATAAT-3’). αCTD refers to 
the α-C-terminal domain and αNTD to the α-N-terminal domain. Adapted from (Lee et al, 2012).  
1.2.2. Activation by contacting the RNAp 
In cases where the -10 or -35 promoter elements have a weak conservation compared to the 
consensus sequence, TFs can bind to the promoter DNA upstream or overlapping the -35 
promoter element and directly contact the RNAp when it binds to the promoter region. In 
such cases the interaction between the TF and the RNAp will strengthen the defective 
interaction between the RNAp and the promoter. Thus the final RPo will be similar to that of 
an independent promoter. It appears that such TFs act either by helping recruiting the RNAp 
to the promoter site or by stabilising the contacts between the RNAp and the promoter DNA 
to allow optimal transcription. In this case, TFs can interact with different subunits of the 
RNAp depending on where the TF binds in regard to the -35 promoter element. TFs that bind 
far upstream of the -35 promoter element will be able to interact with the α-CTD subunit. 
Because the α-CTD is connected to the α-NTD by a flexible linker, it has a considerable 
freedom of movement. Therefore, even though the α-CTD usually interacts with TFs with 
binding site located at -61.5, it has been shown to interact with TFs located at -72.5, -82.5 or 
even -93.5. TFs that have a binding site overlapping the -35 promoter element will be able to 
interact with region 4 of the σ factor (not all of them do), the α-CTD and the α-NTD. These 
types of activation have been separated into classes, according to the number of contacting 
regions between the TF and the RNAp (Lee et al, 2012). 
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1.2.2.1. Class I activation 
Class I is used to describe the promoters were the TF binding site or sites, in the case of a 
dimeric TF, are located upstream of the -35 promoter element. In this case, the TFs will be 
able to interact each with the α-CTD. One α-CTD will bind upstream of the TF biding site 
and contact the TF further upstream and the other α-CTD will maintain its interaction with 
region 4 of the σ factor and interact with the downstream TF on the other face (See Figure 8). 
Examples of such TFs in E. coli include the catabolite activator protein (CAP) and the 
fumarate and nitrate reductase regulatory protein (FNR) (Lawson et al, 2004; Lee et al, 2012; 
Wing et al, 1995). 
 
Figure 8: Class I activation.  
The TF dimer binds upstream of the RNAp and contacts the two α-C-terminal domains (αCTD).The RNAp 
subunits are colour coded and labelled in black.-35 refers to the -35 element (5’-TTGACA-3’) and -10 to the -10 
element (5’-TATAAT-3’). αNTD refers to the α-N-terminal domain. Adapted from (Lee et al, 2012).  
1.2.2.2. Class II activation 
Class II refers to promoters where the TF binding site overlaps the -35 promoter element. In 
this case, the localisation of the TF enables it to make contacts with three different subunits 
of the RNAp. Because the TF binds to the upstream part of -35 promoter element the 
interaction between region 4 of the σ factor and α-CTD is prevented and the α-CTD subunits 
will bind further upstream. The TF will be able to contact region 4 of the σ factor, the α-CTD 
subunit and the α-NTD subunit (See Figure 9). Examples of such TFs in the E. coli include 
the CAP and FNR TFs (Belyaeva et al, 1996; Busby & Ebright, 1997; Lee et al, 2012; Niu et 
al, 1996; Wing et al, 2000). 
 
Figure 9: Class II activation.  
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The TF dimer binds close to the RNAp and can interact with three subunits of the RNAP: one α-C-terminal 
domain (αCTD), the α-N-terminal domain (αNTD) and region 4 of the σ factor. The RNAp subunits are colour 
coded and labelled in black.-35 refers to the -35 element (5’-TTGACA-3’) and -10 to the -10 element (5’-
TATAAT-3’). Adapted from (Lee et al, 2012).  
1.2.2.3. Class III activation 
Class III is used to describe the cases where two TF dimers make contact with the RNAp. In 
this situation, if one of the TF binding site overlaps the -35 promoter element and the other 
binding site is further upstream, the situation will be similar to a Class II activation but with 
additional contacts. Because the first TF dimer binds to the upstream part of -35 promoter 
element the interaction between region 4 of the σ factor and α-CTP is prevented and the α-
CTP subunits will bind further upstream. The downstream TF dimer will be able to contact 
region 4 of the σ factor, the α-CTP subunit and the α-NTP subunit and the upstream TF dimer 
will contact the other the α-CTP subunit (See Figure 10). The CAP protein from E. coli is an 
example of such TFs (Belyaeva et al, 1998; Joung et al, 1993; Lee et al, 2012; Murakami et 
al, 1997). 
 
Figure 10: Class III activation Class II-like.  
One TF dimer binds close to the RNAp and can interact with three subunits of the RNAP: one α-C-terminal 
domain (αCTD), the α-N-terminal domain (αNTD) and region 4 of the σ factor. The other TF dimer binds 
upstream of the αCTD and can interact with the most upstream αCTD. The RNAp subunits are colour coded 
and labelled in black.-35 refers to the -35 element (5’-TTGACA-3’) and -10 to the -10 element (5’-TATAAT-3’). 
Adapted from (Lee et al, 2012).  
 
If both TFs binding sites are upstream of the -35 promoter element the situation will be 
similar to a Class I activation. The TF dimers will be able to interact each with an α-CTD. 
One α-CTD will bind in between both TFs biding site and contact the TF dimer further 
upstream and the other α-CTD will maintain its interaction with region 4 of the σ factor and 
interact with the downstream TF dimer on the other face (See Figure 11). The CAP protein 
from E. coli is an example of such TFs (Beatty et al, 2003; Joung et al, 1993; Lee et al, 2012; 
Tebbutt et al, 2002). 
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Figure 11: Class III activation Class I-like.  
One TF dimer binds upstream of the RNAp and can interact with the most upstream α-C-terminal domain 
(αCTD). The other TF dimer binds in-between both αCTD and interacts with the downstream αCTD. The α-N-
terminal domain (αNTD). The RNAp subunits are colour coded and labelled in black.-35 refers to the -35 
element (5’-TTGACA-3’) and -10 to the -10 element (5’-TATAAT-3’). αNTD refers to the α-N-terminal domain. 
Adapted from (Lee et al, 2012).  
 
1.2.2.4. Activation by pre-recruitment 
Some TFs contact the RNAp before it has reached the promoter and act to change its 
promoter preferences in order to drive it to the promoter they activate. This is called pre-
recruitment and modifies the competition between promoters. The TF binds to the RNAp and 
then guides it to the promoter it regulates by binding to its binding site upstream of the -35 
promoter element (See Figure 12). Examples of such TFs in E. coli include MarA and SoxS. 
The binding sites for MarA and SoxS are far more frequent than the proteins themselves. 
Therefore the action of binding to the RNAp first extends the recognition sequence and 
directs MarA and SoxS towards the binding sites located upstream of a promoter (Griffith et 
al, 2002; Griffith & Wolf, 2004; Lee et al, 2012; Martin et al, 2002).  
 
Figure 12: Activation by pre-recruitment.  
The TF dimer binds to the RNAp before it is bound to the promoter DNA and directs it towards a specific 
promoter. The RNAp subunits are colour coded and labelled in black.-35 refers to the -35 element (5’-TTGACA-
3’) and -10 to the -10 element (5’-TATAAT-3’). αCTD refers to the α-C-terminal domain and αNTD to the α-N-
terminal domain. Adapted from (Lee et al, 2012). 
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1.3. Two-component systems (TCS) 
Two-component systems (TCS) are often the mediators of the ability of bacteria to adapt 
efficiently to changes in their environment and are involved in most aspects of bacterial 
regulation. TCS act at all the levels of adaptation used by bacteria: at the level of individual 
genes and proteins, at the level of global regulons, at the whole-cell level and at the 
population level. TCS could therefore be considered as essential prerequisites for the 
pathogenicity of bacteria. TCS have also been identified in eukaryotic organisms (plant, 
fungi, yeast, protozoa) but are much less wide-spread in these organisms than they are in 
bacteria. They are not present in animals, which makes them good targets for antibacterial 
development. The number of TCS identified keeps increasing as more and more new 
bacterial genomes are being sequenced. There seems to be a correlation between the number 
of TCS present in a genome and the size of that said genome. Bacteria that live in a very 
versatile environment and encounter a variety of different conditions will typically encode 
more TCS than bacteria living in a uniform habitat. Thus, bacteria that have adapted to a 
specific niche such as obligate intracellular bacteria or extracellular pathogens will have a 
very small number of TCS with the extreme examples of Mycoplasma spp. that have none 
and Myxococcus xantus that contains over a hundred (Beier & Gross, 2006; Gao et al, 2007; 
Kiil et al, 2005). However, most bacteria encode over a dozen of TCS that are involved in the 
regulation of a wide variety of mechanisms. These mechanisms range from the fundamental 
processes that are metabolism and motility to much more complex behaviours such as 
virulence and development (Galperin, 2010; Gao et al, 2007; Gao & Stock, 2009).  
TCS allow the coupling of environmental stimuli with an adaptive response. The signal is 
transduced via a phosphotransfer between the sensor histidine kinase (HK) that is usually 
membrane bound and a cytosolic RR (See Figure 13). Typically, the HK αrylates at a 
conserved histidine residue in response to an external stimulus, taking a γ-phosphoryl group 
from ATP. This autophosphorylation is thus ATP-dependent. This high-energy phosphoryl 
group is then transferred to a conserved exposed aspartate residue in the RR. The 
phosphorylation of the RR induces conformational changes which transition the RR from the 
inactive state to the active state and affect the affinity of the effector domain for its target. 
The activated RR is then able to elicit the cellular response. The lifetime of the RR 
phosphorylation is controlled via dephosphorylation either by the kinase or by itself. The 
autophosphorylation of the HK, the phosphotransfer to the RR and the dephosphorylation of 
the RR all require Mg2+ cations and can be regulated by environmental signals. The level of 
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activation of the output response depends on the level of phosphorylation of the RR and not 
its absolute expression level. Therefore the system is limited by the HK to RR ratio. 
Additional proteins can act to regulate the HK or the RR and many TCS consist of more than 
two proteins. These additional proteins add to the complexity of the network and provide 
alternative targets for a more precise regulation (Casino et al, 2010; Gao & Stock, 2009; 
Perry et al, 2011; Stock et al, 2000). 
 
Figure 13: Schematic of a TCS.  
Activation of a response regulator (RR) by phosphotransfer from a histidine kinase (HK). The input domain of 
the HK detects the stimuli and autophosphorylates at a conserved histidine (His) residue in the dimerisation 
and phosphotransfer (DHp) domain. The phosphate is then transferred to a conserved aspartate residue (Asp) 
in the receiver domain (REC) of the RR thereby activating it. Once the RR is activated, its output domain is 
ready to elicit its specific responses. Adapted from (Gao & Stock, 2009). 
1.3.1. Histidine Kinases (HKs) 
HKs are modular proteins consisting of a variable input (sensing) domain (varying in 
function of the signal that the HK is responsible for sensing) attached to a conserved catalytic 
core by a linker domain. HKs are able to sense a wide array of stimuli such as small 
molecules, light, pressure, cell-envelope stress, redox potential and electrochemical gradients. 
These signals are either perceived by the HK directly through its sensory domain or by 
auxiliary signal transduction proteins. There are three main kinds of sensory domains: extra-
cytoplasmic domains allowing the perception of extracellular stimuli, membrane-spanning 
domains in order to sense membrane-associated stimuli and cytoplasmic sensory domains 
responsible for sensing internal stimuli.  
The cytoplasmic catalytic core consists of two domains: a well-conserved C-terminal 
catalytic and ATP binding (CA) domain carrying the catalytic activity of transferring 
phosphoryl group from ATP to the conserved histidine residue and a less-conserved 
dimerisation and histidine phosphotransfer (DHp) domain containing that conserved histidine 
residue (See Figure 14). In addition to their kinase activity, many HKs also exhibit a 
phosphatase activity towards their cognate RR. This phosphatase activity enables a rapid 
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silencing of the signalling pathway and is under the control of the DHp domain. It is also 
thought to act in order to supress non-specific phosphorylation. The DHp domain is 
responsible for the dimerisation. This dimerisation is necessary for the HK to be functional. It 
is thought that the detection of the stimulus changes the interactions within the HK dimer and 
that this perturbation is relayed to the core domain. The linker domain of the HK is thought to 
be essential for this signal transmission. Upon detection of the signal, the interface between 
the DHp and CA domain is modified allowing the CA domain to move, either to align the 
ATP molecule with the conserved histidine to allow autophosphorylation of the kinase or to 
present the aspartate of the RR for phosphorylation or dephosphorylation of the latter (Gao & 
Stock, 2009; Perry et al, 2011). The CA domain of the HK can host one ATP molecule. In the 
case of autophosphorylation, the conserved histidine in the DHp domain attacks the γ-
phosphate of the ATP. This process can happen in trans where the histidine from one 
monomer attacks the γ-phosphate of the ATP hosted by the CA domain from the other 
monomer or in cis with the DHp and CA domain from the same monomer. Some HKs 
autophosphorylate in trans while others do so in cis (Casino et al, 2010). 
The abundance of paralogous TCS in the bacterial cell raises the question of cross-
phosphorylation between non-cognate HKs and RRs. In most cases, there is a strong kinetic 
preference for cognate HK-RR phosphorylation. However, in some cases, one HK can 
activate multiple RRs (one-to-many) or multiple HKs can activate the same RR (many-to-
one) (Casino et al, 2010; Gao & Stock, 2009; Perry et al, 2011).  
 
Figure 14: Schematic of signal transduction in TCS.  
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The sensor domain of the Histidine kinase detects the stimuli and autophosphorylates at a conserved histidine 
(H) residue in the dimerisation and phosphotransfer (DHp) domain by attacking the ATP hosted in the catalytic 
and ATP binding (CA) domain. The phosphate is then transferred to a conserved aspartate residue (D) in the 
receiver domain (REC) of the response regulator thereby activating it. Once the RR is activated, its output 
domain is ready to elicit its specific response (DNA-binding, Enzymatic activities or Protein-binding). Adapted 
from (Perry et al, 2011). 
1.3.2. Response Regulators (RRs) 
Most RRs contain two domains: an N-terminal conserved regulatory or receiver (REC) 
domain linked to a variable effector domain (See Figure 14). However, about 17% of RRs 
consist of a stand-alone REC domain. The REC domain is involved in the catalysis of 
phosphoryl transfer from the HK and regulates the activity of the effector domain in a 
phosphorylation-dependent manner (Gao & Stock, 2009; Perry et al, 2011). The REC domain 
of the RR binds to its cognate HK by clinging to a helix in the DHp domain, under the 
conserved histidine. This arrangement places the phosphor-acceptor aspartate residue of the 
RR close to the phosphorylated histidine in the HK. Thus the partner specificity is conferred 
by the cytosolic part of the DHp domain of the HK containing the interacting helix and the 
part of the REC domain of the RR that interacts (Casino et al, 2010).  
The REC domain exists in equilibrium between the active and inactive form. Un-
phosphorylated, the REC domain mainly exists in the inactive state and phosphorylation 
shifts the equilibrium towards the active state. Phosphorylation takes place at a conserved 
aspartate residue and generates a high-energy acyl phosphate. This acyl phosphate provides 
the energy that drives a conformational change in the REC domain. The REC domain 
catalyses phosphoryl transfer and autodephosphorylation. Therefore, the phosphotransfer 
from the HK to the RR is the result of the contribution of both proteins. The catalytic activity 
of the RR explains the ability of most RRs to autophosphorylate using high-energy small 
phosphodonors such as acetyl phosphate. However, these types of phosphotransfer have been 
shown to be about 100 fold slower than with the cognate HK. The level of phosphorylation of 
the RR is determined by the rates of phosphorylation and dephosphorylation which are 
influenced by several factors: acyl phosphates are unstable, RRs catalyse 
autodephosphorylation and in many cases the HK phosphatase activity dephosphorylates the 
RR. RRs commonly dimerise or oligomerise upon phosphorylation. 
REC domains usually have on average 26% sequence identity and contain a few highly 
conserved residues. These residues consists of two aspartate or glutamate residues in the 
active site, the phosphor-acceptor aspartate which is responsible for coordinating an essential 
Mg2+ and a conserved lysine that forms a salt bridge with the phosphate in the active state. 
40 
 
The binding of the Mg2+ to the RR drives conformational changes that are then stabilised 
once the RR is phosphorylated.  
The effector domain is responsible for the output response. The wide variety of effector 
domains is responsible for the diversity of processes that are regulated by TCS. The effector 
domains of RRs are mainly DNA-binding, RNA-binding, enzymatic, or protein binding. 
However, the majority of RRs (63%) contain a DNA-binding effector domain. DNA-binding 
RRs act as TFs and modulate the transcription of their target genes by binding to their 
promoter region. They can function as activators or as repressors; regulating a single operon 
or 100 genes throughout the genome. Most DNA-binding RRs positively regulate their own 
expression and the expression of their cognate HK. The DNA-binding domain of RRs usually 
consists of some version of the classical helix-turn helix domain. These consist of winged-
helix domain (30% of all RRs, the OmpR/PhoB family), a four-helix helix-turn-helix (H-T-
H) domain (17% of all RRs, NarL/FixJ family) and an AAA+ATPase domain fused to a 
factor of inversion (Fis)-type H-T-H domain (10% of all RRs, NtrC/DctD family). But in 3% 
of all RRs, the DNA-binding domain consists of an unusual domain, the LytTR domain 
which consists mainly of β-sheets (See Figure 15) (Gao & Stock, 2009; Perry et al, 2011).  
 
Figure 15: Distribution of the different effector domains of response regulators. 
Pie chart with the different effector domains of response regulators (RRs). The effector domains are separated 
into two groups: the DNA-binding ones and the non-DNA-binding ones. The percentage of all RRs having a 
specific domain is indicated for the DNA-binding ones. Adapted from (Gao & Stock, 2009). 
The OmpR family of winged-helix DNA-binding domains contacts the DNA through α-
helices. One recognition helix interacts with the major groove of the DNA and the flanking 
loops interact with the minor groove. In the NarL and NtrC family, binding to the DNA is 
also mediated by α-helices (Stock et al, 2000).  
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1.3.2.1. The LytTR family of DNA-binding RRs 
The LytTR family of DNA-binding RRs was first identified by Nikolskaya and Galperin in 
2002. They analysed the sequences of bacterial genomes and identified a new kind of DNA-
binding domain that was present in RRs and displayed several conserved motifs. This novel 
domain displayed no significant structural or sequence similarity to the different types of H-
T-H DNA-binding domains and was predicted to consist mainly of β-sheets with only one or 
two α-helices. The RRs containing this LytTR DNA-binding domain all contained a CheY-
like receiver domain. Interestingly, LytTR domain-containing transcription factors (LDCTFs) 
that had been previously characterised were found to be mostly involved in the regulation of 
genes involved in virulence. The virulence genes regulated by these LDCTFs are either 
involved in virulence towards the host such as toxins or extracellular polysaccharides or 
virulence towards other bacteria such as bacteriocins (See Table 1) (Nikolskaya & Galperin, 
2002).  
TFs Organism Regulated processes  Reference 
AlgR Pseudomonas aeruginosa Alginate biosynthesis (Deretic et al, 1989) 
MrkE Klebsiella pneumoniae Type 3 fimbriae expression (Allen et al, 1991) 
LytR S. aureus Autolysis (Brunskill & Bayles, 1996a) 
VirR Clostridium perfringens Perfringolysin O production (Shimizu et al, 1994) 
AgrA S. aureus Toxins production (Recsei et al, 1986) 
ComE Streptococcus pneumoniae Competence (Pestova et al, 1996) 
CdtR Clostridium difficile Toxins production (Carter et al, 2007) 
SilA Streptococcus group A Toxins production (Hidalgo-Grass et al, 2002) 
FasA Streptococcus group A Toxins production (Malke & Steiner, 2004) 
StxR Lactobacillus sakei bacteriocins production (Vaughan et al, 2003) 
CbaR Carnobacterium piscicola bacteriocins production (Quadri et al, 1997) 
EntR Enterococcus faecium bacteriocins production (O'Keeffe et al, 1999) 
FsrA Enterococcus faecalis bacteriocins production (Qin et al, 2001) 
PlnC Lactobacillus plantarum bacteriocins production (Diep et al, 1996) 
PlnD Lactobacillus plantarum bacteriocins production (Diep et al, 1996) 
PlsR Lactobacillus plantarum bacteriocins production (Stephens et al, 1998) 
SppR Lactobacillus sakei bacteriocins production (Huhne et al, 1996) 
SapR Lactobacillus sakei bacteriocins production (Axelsson & Holck, 1995) 
BlpR Streptococcus peumoniae bacteriocins production (Lange et al, 1999) 
Table 1: Examples of LDCTFs and the function they regulate.  
This table contains examples of transcription factors (TFs) containing a LytTR domain. The name of is TF is 
listed, the bacterium it comes from, the main function of the gene(s) it regulates as well as a reference paper. 
Adapted from (Nikolskaya & Galperin, 2002).  
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The bioinformatical analysis of the sequence of LDCTFs identified a motif that was 
extremely conserved, the FhRhH[RK][SNQ]hhVN motif where h represents a hydrophobic 
amino acid (aa) and a cluster of positively charged residues (K and R) at the C-terminal end 
of the domain that was hypothesised to play a role in DNA-binding (Nikolskaya & Galperin, 
2002). The analysis of the genes regulated by LDCTFs established that these RRs bind to 
imperfect direct repeats and that their sequence pattern was [TA][AC][CA]GTTN[AG][TG] 
separated by a 12-13 bp spacer (de Saizieu et al, 2000; Diep et al, 1996; Nikolskaya & 
Galperin, 2002; Risoen et al, 1998; Ween et al, 1999). 
LDCTFs represent only 3% of all RRs and yet they are disproportionally involved in the 
regulation of virulence genes which raised a lot of interest for this new family of DNA-
binding RRs. 
The number of LDCTFs appears to correlate with genome size, with large genomes typically 
encoding more LDCTFs than small ones. Thus, although LDCTFs are mostly associated with 
virulence genes regulation, free-living bacteria that tend to have larger genomes encode more 
LDCTFs (Nikolskaya & Galperin, 2002). These bacteria are known to encode more TCS in 
general as they have to adapt to a variety of different environments. Almost all Firmicutes 
encode LDCTFs with the exception of Mycoplasma spp. that do not possess any TCS (Beier 
& Gross, 2006; Kiil et al, 2005). A census of all LDCTFs in bacterial genomes conducted in 
2007 identified 200 bacteria containing LDCTFs out of 413 genomes screened. A summary 
of this census can be found in Table 2. LDCTFs are only found in bacteria and are not present 
in archaea or eukaryotes (Nikolskaya & Galperin, 2002; Nikolskaya & Galperin, 2007).  
Organism Number of LDCTFs Frequency of LDCTFs 
Acidobacteria (2) 7-10 100% 
Actinobacteria (39) 1-2, mostly 1 51% 
Bacteroidetes (11) 3-23, avg 9 82% 
Cholobi/green sulphur bacteria(5) 0 0% 
Chlamydiae (7) 0 0% 
Chloroflexi (7) 0 0% 
Cyanobacteria (15) 0 0% 
Deinococcus/Thermus (3) 0 0% 
Firmicutes (70) * 1-10, mostly 2 or 3 91% * 
α-proteobacteria (58) ** 1-8, mostly 1 or 2 53% ** 
β-proteobacteria (38) 1 or 2, one has 4 66% 
γ-proteobacteria (92) 1-7, mostly 1 or 2 69% 
δ-proteobacteria (17) 1-3 53% 
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ε-proteobacteria (13) 1 15% 
Spirochaetes (7) 1 14% 
Thermotogae (6) 1 50% 
Table 2: Distribution of LDCTFs among bacteria.  
The first column contains the name of the Phylum and in bracket the number of member from that phylum. 
The second column contains the range of LDCTFs contained in that Phylum and if the range varies a lot, the 
number of LDCTFs contained in most member of the Phylum or an average (avg). The third column contains 
the percentage of members of the phylum that contain LDCTFs. * = excluding Mycoplasma spp. that do not 
contain LDCTFs. ** = excluding Rickettsia spp. that do not contain LDCTFs. Adapted from the updated version 
of supplementary figure S3 from (Nikolskaya & Galperin, 2002). This table was updated in 2007 with the 
additional bacterial genomes sequenced at that time (Nikolskaya & Galperin, 2007).  
In 2008, the first crystal structure of the LytTR domain of the most extensively characterised 
LDCTF, AgrA from S. aureus, was published and confirmed the structure predictions. The 
LytTR domain of the RR AgrA (PDB 3BS1) consists mostly of β-sheets (See section 
1.5.5.2). Interestingly, the structure enabled the discovery of a new method of contacting the 
DNA. Unlike H-T-H-containing TFs that bind to the DNA via α-helices, the AgrA LytTR 
domain binds DNA via three loops that separate the β-sheets (Sidote et al, 2008). The LytTR 
domain of AgrA will be discussed in more details in sections 1.5.5.2 and 4.1 
To this date, the structure of two more LDCTFs have been deposited in the Protein Data 
Bank (PDB): a putative methyl-accepting/DNA RR from Bacillus cereus in 2008 by Osipiuk 
et al. but not published (PDB 3D6W) and ComE (See Table 1) from Streptococcus 
pneumoniae (PDB 4CBV) in 2014 (Boudes et al, 2014). 
1.4. Staphylococcus aureus 
S. aureus is a Gram positive bacterium and a major human pathogen. It is present in the nasal 
cavity, anterior nares and skin of the carriers but the anterior nares are thought to be the 
primary reservoir. 30%-60% of the population will carry S. aureus intermittently and ~20% 
of the population are persistent carriers thus “almost always” carriers. It is still unclear what 
exact factors determine whether someone is likely to be a carrier or not but it appears to be 
linked with the nasal epithelium cells. Interestingly, S. aureus has a greater affinity for the 
nasal epithelium cells from carriers as opposed to non-carriers and for patients with eczema 
as opposed to patients without eczema and thus adheres better to the cells of these patients. S. 
aureus is a human commensal, however it is also a frequent source of community-acquired 
and hospital-acquired infections. These two lifestyles are linked as nasal carriage is an 
important risk factor for the development of S. aureus surgical wound infection. S. aureus is 
an important nosocomial pathogen and the second most common cause of bacteraemia in the 
hospital settings. A S. aureus carrier is more likely to be infected than a non-carrier and in 
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80% of cases, the patients were infected by their own strain of S. aureus. Despite an 
increased susceptibility, the rate of mortality from S. aureus bacteraemia is higher in non-
carriers than in carriers (Kluytmans et al, 1997; Peacock et al, 2001; Wertheim et al, 2005). 
Consequences of S. aureus infections are diverse and range from mild skin or soft tissue 
infections to life-threatening conditions such as endocarditis, bacteraemia, sepsis and toxic 
shock syndrome (Lowy, 1998). 
1.4.1. Historical background 
S. aureus was first identified in 1880 by a Scottish surgeon, Sir Alexander Ogston. He 
observed Gram positive micrococci forming masses that looked like bunches of grapes (that 
he later called Staphylococci, from the Greek staphyle meaning bunch of grapes) in the pus 
from an acute abscess. He observed next that the micrococci were always present in such 
abscesses in abundance. After trying different media to cultivate the micrococci he succeeded 
using newly-laid eggs. When he injected the micrococci cultivated in an egg or directly from 
the pus of abscesses into healthy animals they developed similar abscesses. He therefore 
demonstrated that the micrococci were causing the observed abscesses and validated Koch’s 
postulates (Ogston, 1880). Four years later, a German physician, Friedrich Julius Rosenbach 
noticed that there were two different kinds of Staphylococci exhibiting a different 
pigmentation. He called the white pigmented micrococci Staphylococcus pyogenes albus 
(later renamed Staphylococcus epidermidis as it colonises the skin) and the yellow pigmented 
ones Staphylococcus pyogenes aureus. The pyogenes part of the name was later abandoned 
and the bacteria referred to as Staphylococcus aureus (Rosenbach, 1884).  
1.4.2. S. aureus and antibiotic resistance  
Resistance to antibiotics has always been a problem with S. aureus. Resistance was first 
encountered in the mid-1940s when penicillin-resistant strains started to spread in hospitals 
shortly after the introduction of the drug. The acquisition of a plasmid encoding a β-
lactamase able to hydrolyse the β-lactam ring of penicillin was responsible for the resistance. 
The introduction of methicillin solved the problem until the first methicillin resistant S. 
aureus (MRSA) were reported in hospitals almost immediately after methicillin had been 
introduced in 1960. The acquisition of a single genetic element by the bacteria enabled them 
to be resistant to most commonly used antibiotics, β-lactams such as penicillins, 
cephalosporins and carbapenems. This large mobile genetic element, the staphylococcal 
cassette chromosome mec (SCCmec) encodes the mecA gene responsible for the methicillin 
resistance by encoding an additional penicillin binding protein (PBP2A) with reduced affinity 
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for β-lactam antibiotics. MRSA strains started to spread and had become endemic by the mid-
1980s in hospitals worldwide and the leading-cause of hospital-acquired infections. These 
strains were however strictly hospital associated (HA-MRSA) and thus targeting people that 
were already vulnerable. The early 1990s saw the apparition of a new type of MRSA, the 
community acquired MRSA (CA-MRSA). CA-MRSA infections were reported in patients 
with no link to the healthcare settings and that were otherwise healthy. These strains were 
hyper virulent, lead to worse clinical outcomes than HA-MRSA and thus a higher mortality 
rate. The rapid spread of the CA-MRSA in the community worldwide highlighted S. aureus 
as a global health problem and raised serious concern (Chambers & Deleo, 2009; Thurlow et 
al, 2012). 
The HA-MRSA and CA-MRSA pandemic lead to an increase in the use of vancomycin that 
was the only efficient antibiotic against MRSA. This triggered the appearance of the first 
vancomycin-intermediate S. aureus strains (VISA) in 1997, resistant to low doses of 
vancomycin. VISA strains have a thicker cell wall that absorbs the vancomycin and enables 
enough synthesis of new peptidoglycan for survival. These strains were unfit and therefore 
had a low endemic potential. However, the vancomycin-resistant S. aureus (VRSA) strains 
that have appeared in 2002 are more worrying as vancomycin is the preferred antibiotic for 
MRSA treatment and cases of VRSA have been reported in the USA, in India, in Iran and 
more recently in Europe and in Latin America. These strains acquired the vancomycin 
resistance gene cluster vanA from Enterococcus faecalis and have mostly emerged 
independently from poly-microbial infections treated with vancomycin. They appear to be 
less contagious than MRSA as they are not known to be transmitted by close contact. 
(Chambers & Deleo, 2009; Friaes et al, 2014; Lindsay, 2010; Rossi et al, 2014). 
1.4.3. Pathogenicity of S. aureus 
The pathogenic success of S. aureus can be attributed to a large array of virulence factors that 
are expressed in a growth-phase and cell density-dependent manner. S. aureus received its 
name because of its golden colour. This pigmentation is mediated by the staphyloxanthin 
which is also involved in virulence. It protects the bacterium against oxidative stress thus 
against neutrophil killing (Liu et al, 2005).  
The colonisation of the host is the first step of the infection process and involves adherence to 
the host tissues. In S. aureus, this step is mediated by a number adhesins called microbial 
surface components recognising adhesive matrix molecules (MSCRAMMs). A few examples 
of MSCRAMMs include protein A, which displays anti-phagocytic properties due to its 
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ability to bind to the Fc chain of immunoglobulins, fibronectin-binding proteins that allow 
adhesion to the host fibronectin and elastin and are essential for the invasion and clumping 
factor A involved in the resistance to phagocytic uptake (Lowy, 1998). 
Once the infection is established, the next step is to spread the infection through host tissue 
destruction. This step involves a plethora of secreted virulence factors such as the cytotoxins 
haemolysins (α, β, γ and δ), toxic shock syndrome toxin 1 (TSST-1), Panton-Valentine 
leukocidin (PVL), proteases, lipases and phenol-soluble modulins (PSMs). The TSST-1 binds 
to T cells and causes an expansion of clonal T-cells and results in a massive release of 
cytokines that mediate the toxic shock syndrome. Haemolysins mediate the lysis of red blood 
cells through pore formation for α-haemolysin which is critical for virulence. β and δ 
haemolysins act synergistically to prevent phagocytosis. The proteases and lipases are 
involved in host tissue destruction. PSMs are involved in neutrophil and red blood cells 
killing, biofilm formation and dispersal. PVL is a bi-component toxin, composed of two 
secreted proteins S (slow) and F (fast) and is able to lyse white blood cells (Dinges et al, 
2000; Giese et al, 2011; Lowy, 1998; Peschel & Otto, 2013)  
1.4.4. TCS in S. aureus 
There are 16 or 17 TCS clearly identified as such in S. aureus (Kuroda et al, 2001). The 
strains that have the SCCmec cassette (Ito et al, 2001) have 17 TCS as a homolog of the 
KdpD/E TCS is encoded on this cassette. The strains that do not have the cassette encode 16 
TCS (Hanssen & Ericson Sollid, 2006). The 16 TCS identified in the NCTC8325 strain are 
listed in Table 3. For the sake of clarity, only one function was listed in this table. The 
different functions of each TCS will be detailed in the text below and the different DNA-
binding domains they contain listed in Figure 16. This section is meant as an overview of the 
main functions assumed by TCS in S. aureus and does not provide a complete description of 
all the functions of each TCS. 
The nomenclature for the same TCS in S. aureus vary in the literature, therefore to facilitate 
comprehension, the TCS will be referred to using the most recent name and the previous 
names will be listed as well. For the TCS that have not been characterised in S. aureus but are 
homologous to a TCS that has been characterised in another bacteria, the function of the 
characterised TCS will be described (See Table 3 and Figure 16). 
 
 
 
47 
 
HK name HK number RR name RR number Function 
AgrC SAOUHSC_02264 AgrA SAOUHSC_02265 Virulence genes regulation 
unassigned SAOUHSC_00185 unassigned SAOUHSC_00184 Unknown 
LytS SAOUHSC_00230 LytR SAOUHSC_00231 Autolysis 
GraS SAOUHSC_00666 GraR SAOUHSC_00665 Antibiotic resistance 
SaeS SAOUHSC_00714 SaeR SAOUHSC_00715 Virulence genes regulation 
DesK SAOUHSC_01313 DesR SAOUHSC_01314 Unknown in S. aureus 
ArlS SAOUHSC_01419 ArlR SAOUHSC_01420 Biofilm formation 
SrrB SAOUHSC_01585 SrrA SAOUHSC_01586 Virulence genes regulation 
PhoP SAOUHSC_01799 PhoR SAOUHSC_01800 Unknown in S. aureus 
AirS SAOUHSC_01981 AirR SAOUHSC_01980 Nitrate respiration 
VraS SAOUHSC_02099 VraR SAOUHSC_02098 Cell wall biosynthesis 
KpdD SAOUHSC_02314 KdpE SAOUHSC_02315 Virulence genes regulation 
HssS SAOUHSC_02644 HssR SAOUHSC_02643 Heme sensing 
NreB SAOUHSC_02676 NreC SAOUHSC_0267C Unknown in S. aureus 
BceS SAOUHSC_02956 BceR SAOUHSC_02955 Antibiotic resistance 
WalK SAOUHSC_00021 WalR SAOUHSC_00020 Cell wall biosynthesis 
Table 3: The 16 TCS identified in NCTC 8325.  
This table lists the two component systems (TCS) identified in the N315 strain and the gene they correspond to 
in the NCTC 8325 strain. The table contains the name of the histidine kinase (HK) and the corresponding 
response regulator (RR) (when assigned) and their accession number as well as their function, when available. 
More details can be found for each TCS in the text below. This list was compiled based on the TCS reported in 
the N317 strain (Kawada-Matsuo et al, 2011; Kuroda et al, 2001) and in the MW2 strain (Matsuo et al, 2010). 
The KEGG pathways database (Kanehisa et al, 2014), the AureusDB (http://aureusdb.biologie.uni-
greifswald.de/index.shtml) and the BioCyc database (Caspi et al, 2014) were used to identified the TCS that 
were not annotated in the NCTC 8325 genome. 
 
Figure 16: Repartition of the different types of DNA-binding domains in response regulators (RRs) from S. 
aureus NCTC 8325.  
Pie chart representing the proportion of each type of DNA-binding domain. The DNA-binding domain types are 
colour coded and the percentage of each is indicated. The DNA-binding domains of each of the 16 RRs from S. 
aureus NCTC 8325 have been identified using the P2CS database (Barakat et al, 2011).  
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1.4.4.1. The AgrCA TCS 
The AgrCA TCS is a key component in the ability of S. aureus to regulate the expression of 
colonisation and virulence factors in response to environmental cues (Novick, 2003). It is 
responsible for the upregulation of secreted virulence factors and the downregulation of the 
synthesis of cell surface-associated virulence factors that takes place during the late 
exponential phase (Peng et al, 1988; Recsei et al, 1986). The AgrA RR directly regulates 
phenol soluble modulins (PSMs) and the bsaA gene that is essential for survival under 
oxidative stress (See section 1.5.5.4) (Queck et al, 2008; Sun et al, 2012b). However, most of 
the genes regulated by AgrCA (over 200) are regulated via RNAIII. RNAIII is the effector 
RNA of the agr operon that is activated by AgrA at the transcriptional level (Cheung et al, 
2011; Ji et al, 1995; Morfeldt et al, 1995; Morfeldt et al, 1996; Novick et al, 1995; Novick et 
al, 1993). The AgrCA TCS also regulates biofilm formation in S. aureus (Vuong et al, 2000; 
Yarwood et al, 2004). Therefore the AgrCA TCS is involved in the regulation of virulence 
genes, biofilm formation and resistance to oxidative stress as well as a number of other 
processes.  
This section is meant as an overview of the role of AgrCA in S. aureus. This TCS will be 
described in more detail later in this chapter (See section 1.5). 
1.4.4.2. The LytSR TCS 
The LytSR TCS is essential for normal biofilm development and is important to control cell 
lysis during biofilm formation. The LytR RR regulates genes involved in cell death and lysis 
such as peptidoglycan (murein) hydrolases and thereby represses cell wall hydrolytic activity 
(Brunskill & Bayles, 1996b; Sharma-Kuinkel et al, 2009). Therefore, LytSR mutants display 
increased autolysis activity (Brunskill & Bayles, 1996a). In addition, LytSR is involved in the 
adaptive response to antimicrobial peptides perturbing the cell membrane most-likely by 
detecting subtle changes in the transmembrane potential. LytSR mutants have been shown to 
have increased susceptibility to cationic antimicrobial peptides in vitro (Yang et al, 2013). 
1.4.4.3.  The GraSR TCS  
The GraSR (ApsSR) TCS is actually a three-component system consisting of the GraS, GraR 
and GraX proteins. It is required for growth of S. aureus at high temperatures, for resistance 
to oxidative stress and for cationic antimicrobial peptide sensing and resistance (Falord et al, 
2012; Falord et al, 2011). The involvement of the GraSRX in resistance against antimicrobial 
peptides makes it an important system for the virulence of S. aureus in vivo (Li et al, 2007). 
GraSRX also controls the stress response and cell wall metabolism signal transduction 
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pathways. The GraSRX is subject to regulation by the agr system thereby linking agr to 
antimicrobial agent susceptibility. It is therefore strongly expressed during the exponential 
phase and repressed by agr during the stationary phase (Matsuo et al, 2011). 
1.4.4.4. The SaeSR TCS  
SaeRS is an important regulator of virulence factors and a key element of S. aureus virulence 
regulation (Novick & Jiang, 2003; Rogasch et al, 2006). It is required in order for S. aureus 
to cause infections through its regulation of genes involved in adhesion and invasion and 
affects bacterial survival during an infection (Liang et al, 2006). SaeRS has been shown to be 
critical for the pathogenesis of S. aureus in a murine infection model. It is responsible for the 
upregulation of virulence gene transcription. It is also linked with other TCS: SaeRS 
regulates the ArlSR TCS which negatively regulates secreted virulence genes and acts 
synergistically with the agr. It lies downstream of agr in the exoproteins activation pathway 
(Novick & Jiang, 2003; Nygaard et al, 2010) 
1.4.4.5. The DesKR TCS  
The DesKR TCS has not been investigated in S. aureus but has been characterised in another 
Gram positive bacterium, Bacillus subtilis. In B. subtilis, DesKR is responsible for the control 
of gene expression at low temperatures, mainly membrane lipids. It is involved in the 
adjustment of membrane lipid composition at cold temperature. The RR DesR activates a 
lipid desaturase which is responsible for the change in membrane composition under cold 
temperature in order to regulate membrane fluidity (Aguilar et al, 2001). 
1.4.4.6. The ArlSR TCS 
The ArlSR TCS is involved in autolysis and is also a repressor of biofilm development. The 
disruption of the arlS gene increases the activity of peptidoglycan hydrolases in the cell wall 
leading to autolysis (Fournier et al, 2001; Toledo-Arana et al, 2005). ArlSR is also indirectly 
responsible for the decreased production of virulence factors by downregulating their 
transcription. Mutations in the ArlSR TCS result in an increased production of secreted 
proteins. ArlSR regulates sarA and agr therefore its effect on virulence factors is mainly 
dependent on them. It stimulates SarA and downregulates RNAIII transcription (Fournier et 
al, 2001)  
1.4.4.7. The SrrBA TCS 
The SrrBA TCS acts in the global regulation of S. aureus virulence. It is responsible for the 
regulation of exotoxins and cell surface-associated virulence factors in response to the level 
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of oxygen in the environment. This regulation is partly agr mediated as RNAIII expression is 
inversely dependent on SrrBA. SrrA regulates agr by binding to the P2 and P3 promoters 
(Pragman et al, 2004; Yarwood et al, 2001). Mutations in SrrBA result in a decrease in 
virulence of the bacteria in rabbit endocarditis model and knockout strains exhibit a growth 
defect. The expression of SrrBA is necessary for growth in low oxygen or on a media poor in 
nutrient (Pragman et al, 2007; Pragman et al, 2004). SrrBA is also a major activator of 
intracellular adhesins and polysaccharide intracellular adhesins in an anaerobic environment 
which contributes to the protection of S. aureus against non-oxidative defence mechanisms 
(Ulrich et al, 2007). 
1.4.4.8. The PhoPR TCS 
The PhoPR TCS has not been characterised in S. aureus but in B. subtilis it controls the 
synthesis of the ATPases, alkaline phosphodiesterase and glycerophosphoryl diester 
phosphodiesterase and lipoproteins during phosphate starvation (Antelmann et al, 2000; 
Hulett et al, 1994).  
1.4.4.9. The AirSR TCS 
The AirSR (YhcSR) TCS has been mainly characterised by two different research groups that 
do not seem to validate each other’s findings. Therefore there is controversy as to its precise 
functions. It was first shown to be essential for growth in vitro. Its downregulation results in 
increased susceptibility to the cell wall synthesis inhibitor phleomycin (Sun et al, 2005). 
AirSR is also involved in the modulation of the nitrate respiratory pathway under anaerobic 
conditions. Nitrate induces the transcription of AirSR under anaerobic conditions. In turn, 
AirSR directly positively regulates the transcription of the nitrate reductase narG and the 
oxygen responsive NreABC TCS. This enables the modulation of the nitrate respiratory 
pathway of S. aureus under anaerobic conditions. The downregulation of AirSR eliminates 
the enhancing effect of nitrate on bacterial growth under anaerobic conditions and results in a 
dramatic decrease in transcription of the genes involved in nitrate respiration (Yan et al, 
2011). In order to be fully active the AirS needs to be oxidised with a [2Fe-2S]2+cluster. Over 
oxidation either by prolonged O2 exposure or contact with H2O2 or NO leads to the 
inactivation of the AirS kinase activity. Mutation in the AirSR TCS impacts the expression of 
~355 genes under anaerobic conditions. The mutant strain displays an increased resistance to 
H2O2, vancomycin, norflaxin and ciproflaxin under anaerobic conditions. Therefore the 
AirSR is a redox-dependent global regulatory system playing an important role in gene 
regulation using redox active Fe-S cluster under oxygen limited conditions (Sun et al, 2012a). 
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The deletion of AirSR results in the downregulation of genes involved in cell-wall 
metabolism, reduced autolysis and reduced viability with vancomycin. AirSR is able to 
directly bind and regulate genes functioning in cell wall metabolism, protection against 
phagocytosis and autolysis. The involvement of AirSR in cell wall biosynthesis and turnover 
is linked to vancomycin resistance (result of a thickened cell wall). However, in this study it 
was to found to be essential, which could be the result of strain variation (Sun et al, 2013). 
1.4.4.10. The VraSR TCS 
The VraSR TCS is responsible for the coordination of important steps in cell wall 
biosynthesis. It is induced by exposure to cell wall affecting antibiotics such as 
glycopeptides, beta-lactams, bacitracin, vancomycin and knockout strains display increased 
susceptibility to these antibiotics (Gardete et al, 2006; Kuroda et al, 2003). 
1.4.4.11. The KdpDE TCS 
The TCS KdpDE upregulates the cap operon, responsible for the synthesis of capsular 
polysaccharides. They are important cell wall components that can interact with the host 
immune system and allow to resist uptake and killing by phagocytes. The cap operon is a 
major determinant of S. aureus virulence (Zhao et al, 2010). KdpDE is also a global regulator 
of virulence genes and activates the transcription of genes encoding cell wall associated 
proteins and polysaccharides synthesis genes while repressing the transcription of toxin genes 
in response to external K+ concentration. In addition, the transcription level of KdpD is 
affected by external K+ concentration. It decreases as the level of external K+ increases. This 
indicates that S. aureus might modulate its infectious status through sensing specific external 
K+ stimuli in different environments. KdpDE is strongly upregulated by agr, and might be an 
important regulator in order to coordinate external K+ with agr during pathogenesis. In the 
environment, high levels of KdpD help to activate the transcription of cell wall proteins and 
polysaccharides synthesis genes beneficial for colonisation. In the host, high K+ leads to a 
decrease in KdpD transcript and low expression of cell wall proteins but high production of 
extracellular toxins and enzyme facilitating local invasion. Therefore KdpD plays an 
important role in the pathogenesis of S. aureus (Xue et al, 2011). KdpD acts also as specific 
c-di-AMP binding protein and receptor for c-di-AMP (Corrigan et al, 2013). 
1.4.4.12. The HssSR TCS  
The HssSR TCS is the heme sensor system. It is necessary for growth with high 
concentration of heme. It responds to heme exposure and activates the expression of the 
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heme-regulated transporters, the efflux pumps. These pumps protect the cells against heme-
mediated damage. Heme is an essential source of iron but can be toxic when in excess due to 
its reactivity. The inactivation of HssSR results in increased virulence in a vertebrate 
infection model. Without HssSR, S. aureus cannot sense and excrete the excess heme and 
therefore exhibits an increased virulence factor expression and secretion which leads to 
increased host tissue damages. HssSR is only activated by extracellular heme and specifically 
recognizes host derived heme. Therefore HssSR enables the detection of the host internal 
tissues as heme is sensed as a marker of internal host tissues and regulates virulence to avoid 
inflicting excessive host tissue damage (Torres et al, 2007) HssRS also modulates the 
susceptibility to the antimicrobial peptide plectasin. Mutations in HssRS make S. aureus 
more resistant to pectasin and eurocin therefore provides susceptibility to these antimicrobial 
peptides (Thomsen et al, 2010). 
1.4.4.13. The NreBC TCS 
The NreBC TCS has not been yet characterised in S. aureus but has been in S. carnosus. It is 
actually a three component system composed of the NreA, NreB and NreC genes. NreA is a 
nitrate receptor which controls the phosphorylation level of the HK NreB, an oxygen sensor, 
in a nitrate dependent manner. In turn, NreB acts to control NreC. NreA interacts with NreB 
but not with NreC. There is therefore nitrate/oxygen co-sensing performed by the NreABC 
system (Nilkens et al, 2014). Deletion mutants have been shown to be severely impaired in 
nitrate and nitrite reduction and to have growth defects. NreABC is responsible for enhancing 
the transcription of genes involved in nitrate reduction and transport and a nitrite reductase. It 
is also involved in regulating transcription in the absence of oxygen (Fedtke et al, 2002).  
1.4.4.14. The BceSR TCS  
The BceRS (BraSR) TCS regulates two transporter that determine susceptibility to bacitracin, 
an antimicrobial peptide. It might therefore provide a mechanism of resistance to 
antimicrobial agents targeting cell wall biosynthesis in the membrane (Hiron et al, 2011; 
Kawada-Matsuo et al, 2011). 
1.4.4.15. The WalKR TCS 
The WalKR (YycFG, VicKR) is the only TCS that is universally accepted as being essential 
for survival (Martin et al, 1999). It is the master regulator of cell wall formation. WalKR 
activates the transcription of genes involved in cell wall degradation, controls autolytic 
activities by positively regulating the synthesis of autolysins (cell wall hydrolases) and 
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positively regulates biofilm formation. Without WalKR, the peptidoglycan biosynthesis and 
turnover is significantly decreased, the growth is therefore slower and the cells are unable to 
form biofilms. WalkKR mutants are also unable to lyse and are hypersensitive to macrolide 
and lincosamide antibiotics and vancomycin due to a thickened cell wall (Dubrac et al, 2007; 
Shoji et al, 2011). 
1.4.4.16. Summary of S. aureus TCS 
The S. aureus TCS regulate a wide range of functions essential for bacterial survival and 
adaptation to changing environments. Some functions are regulated by different TCS in order 
to enable a better modulation and to respond to different environment cues. This section has 
provided a summary of the functions that are regulated by more than one TCS in S. aureus. 
This illustrates that almost all the function essential for bacterial life are tightly regulated by 
one or more TCS (See Table 4).  
 Function TCS involved 
Cell wall metabolism VraSR, WalKR, KdpDE 
Biofilm formation ArlSR, AgrCA, WalKr, LytSR 
Autolysis LytSR, ArlSR, WalKR 
Antibiotic resistance VraSR, GraSR, ArlSR, SrrRS, BceRS, AgrCA, LytSR, HssSR, WalKR 
Virulence factors regulation ArlSR, GraSR, SaeRS, VraSR, SrrRS, KdpDE, AgrCA 
Redox response SrrAB, AgrCA 
Regulated by agr GraSR, ArlSR, SrrRS, SaeRS 
Involved in agr regulation ArlSR,SrrAB 
Anaerobic respiration SrrAB, AirSR 
Table 4: List of processes regulated by more than one two component system (TCS). 
 The functions regulated by more than one TCS are listed and the name of the TCS involved are listed. 
1.5. The accessory gene regulator (agr) operon 
It is essential for bacteria to exchange information in order to act as a population. This 
mechanism, called quorum-sensing is universal in the microbial world. In S. aureus, the 
ability to switch gene program once a certain threshold of population has been reached and 
transition from a colonisation state to the invasion mode is mediated by quorum sensing via 
the agr operon. The agr operon is the main quorum-sensing system in S. aureus (Singh & 
Ray, 2014).  
The agr operon consists of two transcriptional units, RNAII and RNAIII, transcribed by two 
divergent promoters, P2 and P3, respectively. RNAII encodes the quorum sensing system of 
the operon consisting of the agr B, D, C and A genes (See Figure 17). The agrD gene 
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encodes a pro-peptide which is processed and secreted by the transmembrane AgrB, with the 
help of the SpsB peptidase, thus releasing the finalised autoinducing peptide (AIP). The AIP 
is the quorum signalling molecule of the operon. AgrC and AgrA are members of a TCS in 
which AgrC is the transmembrane receptor HK which senses the cell density-dependent 
accumulation of the AIP. Once a certain threshold of AIP concentration has been reached, the 
AIP binds to AgrC. Upon binding the AIP, AgrC autophosphorylates in an ATP-dependent 
manner. The autophosphorylation of AgrC leads to the activation of the LytTR domain-
containing DNA-binding RR AgrA via phosphotransfer. The activated AgrA is then able to 
bind to direct tandem repeats at the P2 and P3 promoter and thus activate transcription of 
these two promoters. AgrA therefore stimulates its own synthesis in an autocatalytic circuit as 
mentioned in section 1.4.4.1 (Novick & Geisinger, 2008). RNAIII is the pleiotropic effector 
RNA molecule of the operon and is responsible for the downregulation of cell surface-
associated virulence factors and the upregulation of the secreted virulence factors (main 
examples listed in section 1.4.3). RNAIII is involved in the regulation of over 200 genes and 
thus has a tremendous metabolic burden. This is probably the reason for the very high 
frequency of spontaneous mutations inactivating the agr operon. The C-terminal part of 
RNAIII encodes a toxin, δ-haemolysin (Cheung et al, 2011; Novick & Geisinger, 2008).  
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Figure 17: Schematic representation of the organisation of the agr operon and the auto-catalytic circuit. 
agrD encodes a propeptide that is processed and secreted by the transmembrane AgrB with the help of SpsB 
releasing the finalised AIP. AgrC senses the cell density-dependent accumulation of the AIP and 
autophosphorylates upon binding the AIP. The phosphorylated AgrC is then able to activate AgrA via 
phosphotransfer. The phosphorylated AgrA is then able to bind to specific direct repeats at the agr IR and 
activate transcription at the P2 and P3 promoter. The P3 promoter encodes RNAIII, the pleiotropic effector 
RNA of the operon. RNAIII is responsible for the upregulation of secreted virulence factors and the 
downregulation of cell surface-associated virulence factors. By activating the P2 promoter, AgrA creates an 
autocatalytic circuit as it stimulates its own transcription.  
1.5.1. agr interference 
There are 4 agr specific groups in S. aureus resulting from allelic variation in the agr B, D 
and C genes which correspond to 4 different strain pathotypes. These 3 genes have evolved in 
parallel in order to remain compatible. The agr operon of each group is mutually inhibited by 
the AIP from the other groups in a mechanism where the foreign AIP “blocks” the AgrC 
receptor thus rendering it unavailable for its cognate AIP. This mechanism is a mode of 
bacterial interference through inhibition of the synthesis of virulence factors. The sequence of 
AgrB is variable except for the first 34 aa. AgrC is conserved except for the N-terminus 
responsible for the interaction with the AIP. AgrD is variable except for its C-terminal 
charged tail and essential cysteine residue involved in the thiolactone ring formation. 
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Therefore, only the regions involved in the specificity of AgrD processing and for ligand-
receptor interactions are variable (See Figure 18). The different groups exhibit differences in 
the timing and the magnitude of the agr response (Dowell et al, 2001; Dufour et al, 2002; 
Geisinger et al, 2012; Ji et al, 1997; Lyon et al, 2002). 
 
Figure 18: Conserved and variable regions in agrB, D, C and A.  
Schematic of the agr operon. The conserved regions are displayed in white and the variable ones in grey. The 
number above the genes indicates the number of the residues at the border between the conserved and 
variable areas (Thoendel et al, 2011). 
1.5.2. AgrB  
AgrB is a cysteine endopeptidase transmembrane protein responsible for the proteolytic 
processing of AgrD. AgrB consists of 6 transmembrane segments, 4 hydrophobic ones and 2 
hydrophilic ones. AgrB is an endopeptidase and two residues (cysteine 84 and histidine 77) 
form the catalytic centre responsible for the cleavage of AgrD at its C-terminal processing 
site. The interaction between AgrB and the AgrD propeptide is group specific, i.e. the AgrB 
from group 1 is responsible for the processing of the AgrD propetide from that same group. 
The region responsible for this group specificity differs between different groups. The first 
transmembrane α-helix and extracellular loop are essential for group specific interaction 
between AgrB1 and AgrD1 (See Figure 19A). In AgrB2, the two hydrophilic regions are 
required for the specific processing of AgrD2 (See Figure 19A). Recently, a random 
mutagenesis study enabled the identification of a number of residues in AgrB that are 
important for the processing of AgrD (See Figure 19B). This study also reported that the 
model of AgrB topology that had been used until then was wrong and that the C-terminal and 
N-terminal end of AgrB were in fact located inside the cell and not outside as was previously 
thought (See Figure 19B) (Qiu et al, 2005; Thoendel & Horswill, 2013; Zhang et al, 2002; 
Zhang & Ji, 2004). 
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Figure 19: Old and new model of the transmembrane topology of AgrB. 
A: Old model of AgrB1 where the N and C-terminus are intracellular. The aa residues that are identical 
between AgrB1 and AgrB2 are highlighted in black (Zhang & Ji, 2004). 
 B: New model of AgrB1 where the N and C-terminus are extracellular. The aa that lead to decrease 
autoinducing peptide (AIP) production when mutated are shaded in grey. The numbers indicated correspond 
to the residues numbers (Thoendel & Horswill, 2013).  
1.5.3. AgrD 
AgrD is a membrane protein and is anchored in the membrane via its N-terminal region. This 
membrane localisation is essential in order for AgrD to be processed into a mature AIP. AgrD 
is composed of three different parts: the 24 N-terminal residues are part of an amphipathic 
leader, the central 8 residues constitute the AIP and the 14 C-terminal residues that are 
predominantly charged. The C-terminal charged tail of AgrB contains 9 residues that are 
essential for AIP production and the endopeptidase activity of AgrB (Kavanaugh et al, 2007; 
Thoendel & Horswill, 2009; Zhang et al, 2004). 
The processing of AgrD into the finalised AIP consists of five steps for which both AgrB and 
AgrD are required (See Figure 20). Firstly, AgrD is localised to the cytoplasmic membrane 
via its N-terminal leader. Secondly, the C-terminal tail of AgrD is removed by AgrB using its 
endopeptidase activity. Thirdly, a conserved cysteine residue in AgrD catalyses the formation 
of the thiolactone ring through thioester exchange and the release from AgrB. Fourthly, the 
AIP precursor is exported through the membrane by an unknown mechanism probably 
involving AgrB. Finally, a signal peptidase, SpsB removes the N-terminal leader (Kavanaugh 
et al, 2007; Qiu et al, 2005; Zhang et al, 2002; Zhang et al, 2004) 
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Figure 20: Model of the autoinducing peptide (AIP) synthetic pathway.  
Step 1: AgrD localises to the cytoplasmic membrane via its N-terminal leader. Step 2: The C-terminal tail of 
AgrD is removed by the endopeptidase activity of AgrB. Step 3: Formation of the thiolactone ring through 
thioester exchange and release from AgrB. Step 4: The AIP precursor is exporter through the membrane via an 
unknown mechanism. Step 5: SpsB removes the N-terminal leader of AIP precursor (Thoendel & Horswill, 
2013).  
The processed product of AgrD is a thiolactone peptide pheromone responsible for the 
activation of the agr operon processed from the 46 aa AgrD precursor and AgrC is its 
receptor. The AIP varies from seven to nine aa depending on the compatibility group and all 
groups contain a conserved cysteine residue 5 aa from the C-terminus (See Figure 21). The 
sulfhydryl group of that cysteine is involved in a thiolactone ring with the α-carboxyl group 
of the peptide and is required for the interaction with AgrC. The ring and hydrophobic tail are 
necessary and sufficient for activation of AgrC by the AIP and for inhibition (Dufour et al, 
2002; Ji et al, 1997; Ji et al, 1995; Lyon et al, 2002; Mayville et al, 1999; Wright et al, 2004; 
Zhang et al, 2002).  
 
Figure 21: Structure of the AIP from the 4 different agr groups.  
The sulphur atom of the cysteine and the carbonyl from the C-terminal involved in the thioester linkage are 
shown. Residues in the ring are shown in white while the ones from the tail are shaded in grey. The residues 
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that are critical for receptor activation are marked with an asterisk. For AIP-III the C-terminal asterisk 
illustrates that adding additional aa prevents receptor activation (Lyon et al, 2002). 
 
1.5.4. AgrC 
AgrC is the sensor transmembrane receptor HK of the agr operon and a member of the family 
of peptide-inducible HKs. AgrC consists of an N-terminal sensor domain containing 6 
membrane spanning α-helixes (aa 1-200 in AgrC1), a linker region (aa 201-221 in AgrC1), a 
cytoplasmic domain consisting of the DHp domain (aa 222-290 in AgrC1) containing the 
conserved histidine constituting the autophosphorylation site (H239 in AgrC1) and a C-
terminal CA domain (aa 293-430 in AgrC1) responsible for accepting an ATP molecule (See 
Figure 22). The DHp and the CA domain are required for autophosphorylation but the DHp 
domain is sufficient for phosphotransfer (Gao & Stock, 2009; Thoendel et al, 2011; Wang et 
al, 2014). 
The interaction of AgrC with the AIP regulates the catalytic activity of AgrC and the 
autophosphorylation of AgrC is only triggered by the AIP. The ligand-binding site is located 
in the third extracellular loop of the protein, in the N-terminal part of the sensory domain and 
consists of a hydrophobic pocket. When the sensory domain is missing, the truncated AgrC 
has the ability to autophosphorylate spontaneously in the absence of any signal. Therefore the 
sensory domain must act to prevent spontaneous autophosphorylation. The AIP makes two 
types of interactions with AgrC: a hydrophobic interaction involving residues in the C-
terminal hydrophobic tail of the AIP and sequence specific contacts that trigger the activation 
or inactivation of the receptor (Lina et al, 1998; Wright et al, 2004).  
Mutations that lead to constitutively active AgrC have been identified and target residues 
located either in the last transmembrane helix or in the DHp domain, close to the histidine 
responsible for autophosphorylation. The constitutive mutants containing mutations in the 
DHp domain were not sensitive to inhibition with the AIP from another group and were 
therefore “locked” in the active state. On the contrary, constitutively active mutants 
containing a mutation in the sensory domain were inhibited by certain AIP from other groups 
that were able to reverse the constitutive activity of AgrC. A residue in last extracellular loop, 
I171, was identified as the determinant of inhibition as the mutation I171K this residue 
reduced the sensitivity of AgrC to inhibition by AIPs from other groups. Instead, the AgrC 
bearing this mutation exhibited a broadened specificity and could be activated by the AIP 
from several other groups (See Figure 22). The signal recognition mechanism appears to be 
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confined to the N- terminus of the protein, the membrane associated and extracellular 
components that are more variable. This suggests that these regions have evolved in order to 
respond to different ligands while the C-terminal part of the protein has been conserved in 
order to preserve the catalytic activity (Geisinger et al, 2009; Thoendel et al, 2011). 
 
 
Figure 22: Topology of AgrC1.  
The mutations coloured in green represent the differences between AgrC1 and AgrC4 in the sensor domain. 
The residue involved in broadened specificity, I171 is coloured in red and the mutations leading to a 
constitutive activity of AgrC are coloured in blue. The numbers correspond to the number of the residues 
(Novick & Geisinger, 2008).  
AgrC is an obligate dimer, like all HKs and dimerisation happens before any interaction with 
the AIP (See Figure 23). Mutant receptor studies have demonstrated that the activation of one 
monomer by the AIP triggers trans-autophosphorylation and that one sensory domain is 
sufficient for activation. Similarly, a mutant dimer containing a constitutively active 
monomer and a WT monomer displayed full AIP-independent activity as observed with a 
dimer of two constitutively active AgrC mutants. Therefore, the activation of any monomer 
triggers the symmetric activation of both kinases domains and the autophosphorylation 
activity of AgrC happens in trans (George Cisar et al, 2009). 
Very recently, the mechanism of activation/inhibition by the AIP was uncovered. It was 
shown that the sensory and the kinase domain are connected via a helical linker. The binding 
of the AIP to the sensor domain of AgrC triggers a twisting of the linker in different 
directions depending whether the AIP is the cognate AIP (counter clockwise rotation) or an 
inhibitor (clockwise rotation). Furthermore, it was demonstrated that AgrC lacks the 
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phosphatase activity present in some HKs and that AgrA alone is responsible for its 
dephosphorylation. This implicated that the AIP cannot modulate the rate of AgrA 
dephosphorylation. (Wang et al, 2014) 
 
Figure 23: Domain architecture of the AgrC dimer.  
Adapted from Wang et al, 2014. 
Very recently, the first crystal structure of the AgrC CA domain in the presence of ATP was 
reported (aa 278-430) and consists of a 6 stranded β-sheet stacked against 4 α-helices (See 
Figure 24). The dimerisation helix and the catalytic histidine residue (H239) could not be 
modelled as a result of poor electron density (Srivastava et al, 2014).  
 
 
Figure 24: Crystal structure of the AgrC CA domain. 
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Ribbon representation of the CA domain of AgrC crystallised in presence of ATP depicted in blue. The 6 β-
sheets, the 4 α-helix and the N- and C-terminus are labelled in black. The black dotted line represents the 
residues that could not be modelled onto the structure, aa 389-393. Pymol, PDB 4BXI. 
The structure of the CA domain of AgrC is essentially similar to those of kinases from the 
same family, apart from a few key differences. In AgrC the β1-sheet is part of a β-sheet with 
the 5 other strands whereas is other related kinases structure this sheet forms a linker with the 
DHp domain. This β-sheet also assumes the role of covering the nucleotide binding pocket 
and is called the ATP-lid. In AgrC it is shorter than in other structures. In the AgrC structure, 
α-helices α3 and α4 are at the entrance of the active site in a conformation that appears to 
block it. This conformation is different than that observed with structures of related kinases 
bound to ATP (Srivastava et al, 2014). 
In the same study, the timing of the autophosphorylation of the AgrC CA domain was 
investigated by means of a time-course experiment. The results revealed that AgrC CA 
domain achieves autophosphorylation in vitro after 5 min and is saturated within 20 min at 
25°C. It was observed that the phosphorylated AgrC CA domain is stable for 1h at 25°C 
(Srivastava et al, 2014). 
1.5.5. AgrA 
AgrA is the RR of the agr operon and is responsible for activating transcription at both the P2 
and the P3 promoter when activated. The AgrC HK is responsible for the activation of AgrA. 
AgrA consists of an N-terminal CheY-like receptor domain (aa 1-136) and a C-terminal 
LytTR DNA-binding domain (137-238) (Novick & Geisinger, 2008). 
AgrA functions as a dimer and the dimerisation of AgrA is activation dependent. The 
incubation of AgrA with acetyl phosphate converts the AgrA monomers into dimers 
(Srivastava et al, 2014). 
1.5.5.1. The AgrA CheY-like receptor domain 
 The structure of the AgrA CheY-like receiver domain has not been resolved but can be 
predicted based on the crystal structure of the CheY RR. Similarly, the changes taking place 
in the AgrA receptor domain upon phosphorylation have not been characterised. CheY 
consists of a stand-alone receiver domain from Salmonella typhimurium and E. coli. CheY 
contains five parallel β-sheets surrounded by five α-helices (See Figure 25). Five residues in 
CheY have been identified as important for phosphorylation: D12, D13, D57, T87 and K109. 
Residues D12, D13 and D57 have carboxylated side chains that form a conserved acidic 
pocket in CheY (D8, D9 and D59 in AgrA) (Lukat et al, 1990). This acidic pocket has been 
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shown to be important for the binding Mg2+ ions that are essential for the phosphorylation of 
CheY (Lukat et al, 1991; Lukat et al, 1990). In addition, D57 is the phosphor-acceptor site of 
CheY (Sanders et al, 1989). Residues D12 and D13 and D57 bind to the Mg2+ ions and 
residues T87 and K109 are important for an event taking place after the phosphorylation 
event, potentially a conformational change essential to reach the active state or for the 
stabilisation of the active state. Another residue, Y106 is thought to be involved in signal 
transduction via a rearrangement of its side chain (Appleby & Bourret, 1998; Lee et al, 2001; 
Lukat et al, 1991; Stock et al, 1993; Zhu et al, 1996) 
Several crystal structures have been resolved for CheY: with and without Mg2+ bound (See 
Figure 25) and activated. The coordination of the metal cation induces conformational 
changes in the side chains of aspartate 57 and lysine 109 residues which result in the abolition 
of the salt bridge interaction present between these two residues in the structure without 
magnesium. This liberates the aspartate 57 for the phosphoryl transfer reaction. In the 
activated structure (with beryllium fluoride), the beryllium fluoride is bound to D57 and 
forms a hydrogen bond with T87 and a salt bridge with K109. The hydroxyl group of T87 
forms a hydrogen bond with an active site acceptor (probably activate D57) and the aromatic 
side chain of Y106 is buried in a hydrophobic pocket. The activated structure revealed that 
only modest changes were taking place upon phosphorylation of CheY and were mainly 
localised to one region known to be flexible in inactive CheY, the α4 helix and the β4-sheet 
(See Figure 25) (Lee et al, 2001; Stock et al, 1993). 
 
Figure 25: Crystal structure of the inactive CheY. 
Ribbon representation of the inactive CheY from Salmonella typhimurium CheY is depicted in green. The 5 
residues potentially involved in phosphorylation, D12, D13, D57, K110 and the residue involved in signal 
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transduction Y106 are coloured in red and labelled in black. The N- and C-terminus and the α4 region and β4 
region where most of changes upon phosphorylation take place are labelled. Pymol, PDB 2CHF. 
1.5.5.2. The AgrA LytTR domain 
The crystal structure of the isolated AgrA LytTR domain bound to a 15 bp DNA fragment 
containing the 9-bp consensus binding sequence (based on the P2 binding sequence) was 
reported in 2008 and consists of a 10 stranded β-fold (See Figure 26). A number of residues 
involved in contacting the DNA and maintaining the structural integrity of the protein were 
identified. The binding of AgrA to the promoter DNA induced a substantial bend in the DNA 
(38°) as it conforms to the AgrA surface (Sidote et al, 2008). The LytTR domain of AgrA 
will be discussed in more detail in section 4.1. 
 
Figure 26: Crystal structure of the AgrA LytTR domain. 
Ribbon representation of the AgrA LytTR domain-DNA complex crystal structure (the LytTR domain and DNA 
are coloured in cyan and grey, respectively). The N-terminus and C-terminus are indicated. Pymol, PDB 3BS1. 
1.5.5.3. AgrA and transcription activation at the P2 and P3 promoters 
AgrA binds to a pair of direct repeats located in the agr intergenic region (agrIR) separated 
by 12 bp at the P2 and the P3 promoter and activates the transcription of both promoters. The 
activation of AgrA with acetyl phosphate, a small phosphodonor, enhances its binding to both 
promoters demonstrating that AgrA needs to be activated in order to activate transcription. 
AgrA has a higher affinity for the P2 direct repeats due to a 2 bp difference in the sequence of 
the repeats. At position 1 and 2 in the downstream repeat, the P2 promoter has an AC and the 
P3 promoter a CT. Mutation of the CT motif in the P3 repeat to AC lead to a higher affinity 
of AgrA for the mutated P3 than P2. The area protected by AgrA upon binding (footprint) 
overlaps the -35 promoter element at both the P2 and the P3 promoter (See Figure 27) 
(Koenig et al, 2004). The consensus binding sequence for LDCTFs has been identified as 
[TA][AC][CA]GTTN[AG][TG] (Nikolskaya & Galperin, 2002). 
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Figure 27: AgrA binding sites and footprint at the P2 and P3 promoters.  
DNA sequence of the agr IR. -35 refers to the -35 element (5’-TTGACA-3’) and -10 refers to the -10 element (5’-
TATAAT-3’).The nucleotide length of the spacer between the -10 and -35 promoter elements is indicated for 
the P2 and the P3 promoter. The published -10 and -35 promoter elements are highlighted in yellow and the 
putative -10 of the P3 promoter is boxed in blue. Adapted from (Koenig et al, 2004). 
The position of the -10 and -35 promoter elements of the P2 and the P3 promoter were 
inferred based on the 5’ end of the RNAII and RNAII transcripts, respectively. The 5’ end of 
RNAII and RNAIII were mapped using primer extension and nuclease protection assay 
(Janzon et al, 1989; Novick et al, 1993). Thus the published position of the -10 and -35 
promoter element for both P2 and P3 promoters are indicated in yellow in Figure 27. Position 
-11 of the P3 promoter differs from the consensus -10 sequence although it is one of the 
mostly highly conserved position of this promoter element (See sections 1.1.1 and 1.1.3) 
(Feklistov & Darst, 2011; Zhang et al, 2012). However, the study of the sequence adjacent to 
the -10 of the P3 promoter revealed that if the -10 (5’-TTTAAT-3’) was shifted by two nt 
downstream, the resulting new -10 element (5’- TAATAT -3’) would have position -11 
conserved (See Figure 27 and Figure 28). Thus it is possible that the published position for 
the -10 of the P3 promoter is incorrect.  
 
Figure 28: Conservation of the -10 and -35 promoter elements of the P2 and P3 promoters. 
Conservation of the -10 and -35 promoter elements of the P2 and P3 promoter (the published one and the 
putative one illustrated in Figure 27) compared to the consensus promoter elements. -35 refers to the -35 
element (5’-TTGACA-3’) and -10 refers to the -10 element (5’-TATAAT-3’). The red numbers above the 
sequence correspond to the position of each base with regards to the transcriptional start site. The nucleotides 
that can vary from the consensus sequence without affecting promoter activity drastically and are thus less 
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conserved are underlined in black. The nucleotides of the P2 or P3 promoter that differ from the consensus 
sequence are highlighted in yellow. The extended -10 TG motif is indicated for the P3 promoter.  
The spacer length at the P2 and the P3 promoter differs from the optimal spacer length of 17 
nucleotides (nt) (Aoyama et al, 1983). More significantly at the P3 promoter where the spacer 
is 20 nt long and slightly at the P2 promoter where the spacer is 18 nt long. Thus the P3 
promoter appears to be a weaker promoter than the P2. In addition, the -10 promoter element 
of the P3 promoter has a weaker conservation (5 out of 6) compared to the consensus than the 
-10 element of the P2 promoter (6 out of 6) (See Figure 28). However, P3 has an extended -
10 TG motif at position -15 and -14 (respectively) which has been shown to compensate for 
the sub-optimally placed -35 promoter elements (Burr et al, 2000). Indeed the extended -10 
promoter element was shown to be essential for optimal promoter activity (Reynolds & 
Wigneshweraraj, 2011). In vivo and in vitro studies have shown that shortening the P3 
promoter to the optimal length of 17 nt significantly increases its activity and reduces the 
effect of the activation by AgrA (Morfeldt et al, 1996; Reynolds & Wigneshweraraj, 2011). 
These findings and the fact that AgrA significantly bends the DNA led to the hypothesis that 
the bending activity of AgrA is responsible for its activation function. The binding of AgrA 
would shorten the promoter spacer length to the optimal length and thereby increase 
transcription by facilitating open and closed complex formation (RPo and RPc) (Reyes et al, 
2011; Sidote et al, 2008). 
The RNA polymerase (RNAp) can bind to the P2 and the P3 promoter equally well in the 
absence of AgrA and initiate transcription from both promoters. However, open complexes 
(RPo) formed at the P3 promoter are less stable than the P2 ones and the level of basal 
transcription (without AgrA) is higher at the P2 promoter (~20-fold) than at the P3 promoter. 
However, the increase of transcription observed in presence of AgrA is significant at the P3 
promoter (~15 fold) but marginal at the P2 promoter (~2-fold). AgrA was also shown to 
increase promoter occupancy by the RNAp at both P2 and P3 promoters (Reynolds & 
Wigneshweraraj, 2011). These findings are in concordance with a model where AgrA 
activates transcription via bending the DNA which would have a more significant at the P3 
promoter because of its longer spacer length. Moreover, the increased promoter occupancy 
observed in presence of AgrA suggests that AgrA could also be involved in the recruitment 
of the RNAp. This theory is reinforced by the fact that the AgrA footprint at the P2 and the 
P3 promoter significantly overlaps with the -35 promoter element of both promoters. 
Therefore the agr promoters resemble a class-II-like promoter (Reynolds & Wigneshweraraj, 
2011). In class II promoters, the TF facilitates the binding of the RNAp to the promoter to 
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increase RPc formation by recruiting the RNAp and is some cases facilitate the conversion 
from RPc to RPo (See Figure 9) (Lee et al, 2012).  
1.5.5.4. AgrA regulation outside of the agr operon 
AgrA directly upregulates the expression of phenol-soluble modulins PSMαs and PSMβs by 
directly binding to their promoter region. There are 7 PSM peptides in S. aureus, four are part 
of the PSMα operon, three of the PSMβ operon and the last is δ-haemolysin which is encoded 
by RNAIII. Both PSM operons are under RNAIII-independent activation via AgrA. The 
AgrA foototprint overlaps with the -10 and -35 promoter elements of the PSMα promoter 
(Queck et al, 2008).  
AgrA is also responsible for the repression on the bsaA gene, an essential gene for survival 
under oxidative stress. Upon oxidative stress, a disulphide bond is formed between two 
cysteine residues in the AgrA LytTR domain (C199 and C228) which leads to the 
dissociation of AgrA from the bsaA promoter and in turn the activation of that promoter. 
When one of the cysteine is mutated into a serine (C199S) the disulphide bond is not formed 
and AgrA inhibits the bsaA gene even under oxidative stress leading to an increase 
susceptibility to oxidative stress (See Figure 29). This function illustrates that there is a link 
between the quorum sensing function of the agr operon and oxidation sensing and that link is 
AgrA. It is also the first case of AgrA acting as a repressor (Sun et al, 2012b).  
 
Figure 29: Model of oxidation sensing via AgrA.  
Under WT conditions, the oxidation of AgrA leads to a disulphide bond formation between C199 and C228 and 
the dissociation of AgrA from the DNA. With the C199S mutation, the disulphide bond cannot be formed and 
therefore AgrA stays on the DNA preventing the activation of the bsaA promoter. This blockage of the bsaA 
gene renders the mutated strain susceptible to H202 (Sun et al, 2012b). 
1.5.5.5. Interactions of AgrA with AgrC 
In vitro analysis of the phospho-transfer between AgrA and AgrC using different 
recombinant proteins lacking one of the domains revealed that both the DHp and the CA 
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domain of AgrC are required for efficient phosphotransfer to AgrA and that the AgrA LytTR 
domain is not required for the phosphotransfer. The phosphotransfer reaction revealed to be 
very fast with 50% of phosphoryl group transferred from AgrC to AgrA within a min. These 
experiments were performed in presence of a 3-fold excess of AgrA. Phosphotransfer 
between AgrC and two non-cognate RRs proved to be poor supporting the fact that AgrC 
only phosphorylates AgrA (Srivastava et al, 2014).  
The crystal structure of the AgrC CA domain was used to construct a mechanistic model of 
the interaction between this domain and the receiver domain of AgrA (See Figure 30). The 
AgrC catalytic domain dimer was modelled based on the dimeric structure of a related kinase, 
HK853 from Thermotoga maritima and the AgrA receiver domain based on the CheB RR 
from Salmonella enterica. The AgrA receiver domains were then modelled onto the predicted 
AgrC-CA dimer by in silico docking. In this model, the AgrA receiver domains are stacked 
on the dimerisation helices of AgrC (Srivastava et al, 2014).  
 
Figure 30: Model of the interaction between the AgrC Ca-DHp dimer and a dimer of AgrA receiver domain. 
Two different perspectives are shown as well as a zoom on the direct interacting region (Srivastava et al, 
2014). 
The complex model revealed that the cognate/non-cognate discrimination is probably driven 
by specific sequence and structural features at the interface between the HK and the RR. 
Several residues involved in specifics contact were identified in the AgrA receiver domain 
and in AgrC. The interacting segment in the AgrA receiver domain contains residues located 
on both sides of the putative phosphorylation site D59. Further experiments to characterise 
the interaction between AgrA and AgrC revealed that their interaction is influenced by the 
presence of ATP (Srivastava et al, 2014).  
1.5.6. RNAIII 
RNAIII is a 514 nt RNA and the effector of the agr operon (Novick et al, 1993). It has a 
complex secondary structure that is well conserved among staphylococci although the 
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sequence is not, and consists of 14 hairpin structures connected by unpaired nucleotides (See 
Figure 31) (Benito et al, 2000). RNAIII contains three sites of long-range interaction where 
the distant nucleotides come together and form helices. They divide RNAIII into three 
domains. The 5’ domain contains the first 31 nt and hairpin 1. The central domain contains nt 
32-382, hairpins 2-11. It encodes δ-haemolysin (See Figure 31) (Janzon et al, 1989), contains 
most of the regions responsible for the upregulation of α-haemolysin (in green in Figure 31) 
and contains hairpin 7 which is involved in the negative post-translational regulation of cell 
surface-associated virulence factors and Rot. The 3’ domain contains nt 383 to 514, hairpins 
12-14 and is mainly involved in the translational inhibition of cell surface-associated 
virulence factors and the spa gene (protein A) (Benito et al, 2000; Thoendel et al, 2011). 
 
Figure 31: Secondary structure of RNAIII. 
The stemloops are numbered and the letters indicate long-range interactions that establish domains. The start 
and end codon of hld are boxed and labelled. The green letters represent the nucleotides that basepair with 
and activated hla translation. The nucleotides involved in translation inhibition are coloured in red (Thoendel 
et al, 2011).  
The mechanism of the translation of δ-haemolysin is unclear. Its Shine-Dalgarno (SD) 
sequence is located at the base of hairpin 3 which suggest that the ribosomes might not 
recognize it in the secondary structure. However, ribosomes have been shown to be able to 
bind to native RNAIII (Benito et al, 2000). The δ-haemolysin SD and start codon are also 
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part of the region involved in the upregulation of α-haemolysin via base pairing (Balaban & 
Novick, 1995).  
The half-life of RNAIII is greater than 45 min, which is considered long (Benito et al, 2000; 
Huntzinger et al, 2005). The expression of secreted virulence factors is upregulated at the 
post-transcriptional level by countering a translation-blocking secondary structure in their 
mRNA leader that hides the SD from the ribosomes (Morfeldt et al, 1995). The repression of 
the cell surface-associated virulence factors (such as protein A) occurs also at the 
translational level but by a different mechanism involving the pairing of RNAIII with the 
translation-initiation regions of their transcript (Novick et al, 1993). This base pairing hides 
the SD sequence from the ribosomes and therefore prevents translation (Thoendel et al, 
2011). This post-transcriptional repression is irreversible as it also involves a cleavage event, 
by the endoribonuclease RNAseIII that binds to RNAIII (an endoribonuclease that cleaves 
double-stranded RNAs (Thoendel et al, 2011)) (Geisinger et al, 2006). The cleavage by 
RNAseIII results in the destabilisation of the mRNA and sometimes the removal of the SD 
(Huntzinger et al, 2005). The same mechanism of repression is used by RNAIII to inhibit the 
major transcription factor Rot, a fibrinogen binding protein and coagulase (Boisset et al, 
2007; Chevalier et al, 2010; Geisinger et al, 2006). The repression of Rot by RNAIII is 
responsible for most of the RNAIII downregulated and upregulated genes as Rot upregulates 
the translation of cell-associated virulence factors and downregulates the translation of 
secreted virulence factors (Geisinger et al, 2006; Said-Salim et al, 2003). The targets of Rot 
downregulation include the haemolysins α, β and γ, extracellular proteases, urease, lipase and 
enterotoxin B. The genes upregulated by Rot include protein A, coagulases and clumping 
factor B. There is a significant overlap between agr regulated and Rot regulated genes (Said-
Salim et al, 2003). It should be noted that these effects are not entirely due to Rot as the 
overlap of targets is not perfect and RNAIII has direct targets as well, as described above. For 
a list of TCS regulated by RNAIII refer to section 1.4.4.16. 
1.5.7. The regulation of the agr operon 
The regulation of the agr operon is a very complex process and involves large number of 
regulators. It is not in the scope of this section to discuss all of them in detail. Instead I will 
give a brief overview of the main factors acting to regulate agr.  
The regulation of agr includes RRs and transcription factors (TFs) (See Table 5) and 
environmental cues such as pH, and glucose (via CcpA). (Regassa et al, 1992; Seidl et al, 
2006). 
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Regulator Effect on agr 
SarA + 
SarR - 
SarU + 
SarZ + 
MgrA + 
CcpA + 
ArlSR + 
SarX - 
SarT - 
Rsr - 
SrrAB - 
σ
B - 
CodY - 
Table 5: Transcriptional regulators involved in the regulation of the agr operon. 
List of the transcriptional regulators involved in the regulation of the agr operon and whether they activate (+) 
or inhibit (-) it.  
For more information about ArlSR and SrrBA, refer to sections 1.4.4.6 and 1.4.4.7. 
1.5.7.1. SarA 
The Staphylococcal accessory regulator (SarA) is part of a large family of TFs (the SarA 
family) involved in the regulation of virulence genes in S. aureus and was the first member 
characterised (Cheung et al, 1992). SarA is a global regulator of transcription and is involved 
in the regulation many genes (over 100) involved in a variety of processes. SarA activates 
transcription at the agr operon through direct binding to the agr IR (Rechtin et al, 1999). 
SarA also represses cell surface-associated virulence factors while upregulating secreted 
virulence factors, like agr. Some of this regulation is carried out via agr but SarA has also 
been shown to regulate certain virulence factors directly by binding to their promoter region. 
Many studies have been conducted to determine the overlap and differences between the agr-
mediated effects of SarA from its direct effects (Dunman et al, 2001). Interestingly, the SarA 
binding site at the agr IR overlaps with the AgrA footprint at the P2 promoter (See Figure 32) 
(Koenig et al, 2004; Sterba et al, 2003). Furthermore, it has been shown that SarA is required 
for maximum transcription from the P2 promoter (but not the P3 promoter). SarA bends the 
DNA upon binding, and is therefore thought to activate transcription in a mechanism similar 
to the one proposed for AgrA (Reyes et al, 2011). 
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Figure 32: AgrA binding sites and footprint, SarA and SarR binding sites at the P2 and P3 promoters  
DNA sequence of the agr IR. -35 refers to the -35 element (5’-TTGACA-3’) and -10 refers to the -10 element (5’-
TATAAT-3’). The published -10 and -35 promoter elements are highlighted in yellow, the SarA palindromic 
repeats are boxed in black and the SarR palindromic repeats are boxed in green. Adapted from (Koenig et al, 
2004). 
1.5.7.2. SarR 
SarR is a member of the SarA family and the negative regulator of SarA. SarR regulates SarA 
by binding to its promoter region (Manna & Cheung, 2001). SarR binds to the agr IR and its 
binding sites are located in the vicinity of the SarA binding sites (See Figure 32) (Manna & 
Cheung, 2006b). SarR is a repressor of the P2 promoter and competes for binding at the agr 
IR. SarR binds more avidly than SarA and thus can displace SarA and repress the P2 
promoter (but not the P3) in presence of SarA and AgrA. As both AgrA and SarA bend DNA 
but not SarR it is though that the inhibition by SarR involves preventing the DNA from 
bending (Reyes et al, 2011). 
1.5.7.3. SarU 
SarU is a SarA homolog and a positive regulator of the agr operon (Manna & Cheung, 2003). 
1.5.7.4. SarZ  
SarZ is a SarA paralog and is activated by MgrA. SarZ is involved in virulence gene 
regulation and is an activator of the agr operon (Ballal et al, 2009; Kaito et al, 2006).  
1.5.7.5. MgrA 
MgrA is also called Rat and is a TF related to the SarA family and a member of the MarR 
family. It is involved in the regulation of cell wall turnover, autolysis and the upregulation of 
secreted toxins and proteases and is a global regulator of virulence genes expression. MgrA 
also positively regulates the TCS LytSR and ArlSR (See section 1.4.4). MgrA positively agr 
by binding to the agr region and also directly upregulates α-haemolysin by binding to its 
promoter (Ingavale et al, 2005; Ingavale et al, 2003; Luong et al, 2003). 
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1.5.7.6. CcpA 
CcpA, the carbon catabolite protein is a TF that activates agr in the presence of glucose. 
CcpA regulates the carbon metabolism but is also a major regulator of virulence gene 
expression via its effect on agr (Seidl et al, 2006). 
1.5.7.7. SarX 
SarX is a TF member of the SarA family. SarX is activated by MgrA. SarX is a negative 
regulator of agr and therefore indirectly act on the genes regulated by agr. SarX regulates agr 
by binding to the agr IR (Manna & Cheung, 2006a). 
1.5.7.8. SarT 
SarT is a SarA homolog that is repressed by SarA and agr. SarT represses α-haemolysin and 
agr, most-likely by repressing SarU which is an activator of agr (Manna & Cheung, 2003; 
Schmidt et al, 2001). 
1.5.7.9. RsR 
RsR is a repressor of the agr operon. The mechanism of repression of the agr by RsR is 
unclear as it does not bind to the agr IR (Tamber et al, 2010). 
1.5.7.10. σB 
σ
B is an alternative σ factor involved in extracellular stress response. σB is also responsible 
for the activation of surface proteins, pigment production and the downregulation of secreted 
toxins and proteases. This regulation has been shown to be agr mediated as σB is a repressor 
of the agr operon and activates SarA. This regulation was uncovered because S. aureus 
strains from the NCTC 8325 exhibited an increased agr activity that was shown to be due to a 
mutation inactivating σB. The exact mechanism of σB regulation of agr is unclear (Bischoff et 
al, 2001; Kullik et al, 1998). 
1.5.7.11. CodY 
CodY is a TF involved in the adaptation to nutrient stress and nutrient limitation. It is also a 
regulator of virulence factors in response to nutrient availability and represses biofilm 
formation. CodY is a sensor of intracellular concentrations of isoleucine, leucine, valine and 
GTP. CodY negatively regulates agr when the nutrients levels are high. When the nutrients 
are scarce, CodY does not affect agr. CodY binds only weakly to the agr IR and the 
mechanism of repression by CodY at the agr operon is unknown. CodY regulation appears to 
affect differently the P2 and the P3 promoter. It has been shown that in a CodY mutant agr is 
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overexpressed and that this overexpression is dependent on phosphorylated AgrA and AgrC 
and results in an increased production of AIP. SarA is not involved in the CodY dependent 
regulation of agr (Majerczyk et al, 2008; Roux et al, 2014; Thoendel et al, 2011). 
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1.6. Objectives 
LytTR domain-containing transcription factors (LDCTFs) are involved in the transcriptional 
regulation of virulence genes in a number of important human pathogens. However, the 
mechanism of this regulation remains unclear. The most extensively studied LDCTF AgrA, a 
key player of S. aureus virulence, has been investigated for nearly 30 years yet the precise 
mechanism of transcription activation via AgrA remains cryptic. The chief objective of this 
thesis is to elucidate the individual contributions of aa residues in the LytTR domain of 
LDCTFs to transcription activation using the S. aureus AgrA as a model. In this regard, the 
specific aims include: 
I. The development of an experimental system to study AgrA in vivo. 
II. The construction, screening and characterisation of a library of single alanine 
mutants in the AgrA LytTR domain. 
III. Further characterisation of putative transcription activation deficient (TAD) 
mutants identified using in vivo and in vitro techniques. 
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CHAPTER TWO 
2. Materials and methods 
2.1. General Methods 
2.1.1. Composition of growth media 
All of the bacterial growth media were autoclaved for sterilisation at 120°C for 25 minutes 
(min). Table 6 contains the different media, when they were used and their composition. 
Media Composition (1L) Use 
Lysogeny Broth (Luria-Bertani, 
LB) (Sigma) 
10 g Tryptone, 5 g Yeast Extract, 5 g NaCl E. coli growth media 
Lysogeny Agar (Luria-Bertani 
Agar, LA) (Sigma) 
10 g Tryptone, 5 g Yeast extract, 5 g Sodium 
chloride, 10 g Agar 
E. coli growth media 
Tryptic Soy Broth (TSB) (BD) 17 g Bacto™ Tryptone (Pancreatic Digest of 
Casein), 3 g BactoSoytone (Peptic Digest of 
Soybean Meal), 2.5 g Glucose ( = Dextrose), 5 g 
Sodium Chloride, 2.5 g Dipotassium Hydrogen 
Phosphate 
S. aureus growth media 
Tryptic Soy Agar (TSA) (BD) 15 g Bacto™ Tryptone (Pancreatic Digest of 
Casein), 5 g BactoSoytone (Papaic Digest of 
Soybean Meal), 5 g Sodium Chloride, 15 g Agar 
S. aureus growth media 
Super Optimal Broth with 
Catabolite repression (SOC) 
(BD) 
20 g Tryptone, 5 g Yeast Extract, 0.5 g Sodium 
Chloride, 2.4 g Magnesium Sulfate (anhydrous), 
186 mg Potassium Chloride, 20 mM glucose 
Heat-shock 
transformation 
Brain Heart Infusion Broth with 
Sucrose (BHI + sucrose) 
(Oxoid) 
12.5 g Brain infusion solids, 5 g Beef heart 
infusion solids, 10 g Proteose peptone, 2 g 
Glucose, 5 g Sodium chloride, 2.5 g Disodium 
phosphate, 0.5 M Sucrose 
Electroporation 
Columbia Blood Agar (Fluka) 23 g Special nutrient substrate, 5 g Sodium 
Chloride, 1 g Starch, 15 g Agar, 5% sheep blood 
(Sigma) 
Blood Agar plate 
haemolysis assay 
Table 6: Composition of growth media.  
The name, composition for 1L and use is listed for each media. 
When appropriate, the sterile growth media were supplemented with antibiotics in order to 
select for the bacterial strain or plasmid of interest. The antibiotics were filter sterilised 
before use and are listed in Table 7. All agar plates and liquid cultures were incubated at 
37°C, and the liquid cultures were then shaken at 180 rpm in a shaking incubator, unless 
stated otherwise. E. coli cultures were grown in LB or LA and S. aureus cultures in TSB or 
TSA, unless otherwise stated.  
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Antibiotic Stock concentration Final 
Concentration 
Storage Abbreviation 
Ampicillin 100 mg/ml, in ethanol 100 µg/ml -20°C AmpR 
Kanamycin 50 mg/ml, in H2O or 
90 mg/ml, in H2O 
50 µg/ml or  
90 µg/ml 
-20°C KanR 
Chloramphenicol 7.5 mg/ml, in ethanol 7.5 µg/ml -20°C CmR 
Anhydrotetracycline 200 µg/ml, in ethanol 200 ng/ml -20°C Atet 
Table 7: Summary of the antibiotics used in this work. 
The name, stock concentration, final concentration, storage condition and abbreviation are listed for each 
antibiotic. Kanamycin was used at 50 µg/ml to select for E. coli and at 90 µg/ml to select for S. aureus.  
2.1.2. GFP growth curves using a multiwall plate reader 
Seed cultures were grown at 37 °C, shaken at 700 rpm for 17 hours (h) in a THERMOstar 
(BMG Labtech) plate incubator by directly inoculating a colony from a freshly transformed 
TSA plate into 200 µl of TSB medium supplemented with the appropriate antibiotics in a 96-
well black microtitre plates with clear bottoms (Corning). The experimental growth curves 
were also performed in 96-well microtitre plates in a POLARstar Omega multiwell plate 
reader (BMG Labtech). The seed cultures were diluted 1 : 50 in a final volume of 200 µl of 
fresh TSB medium supplemented with the appropriate antibiotics and incubated at 37 °C, 
shaken at 700 rpm for 17 h. Simultaneous growth (OD600 nm) and GFP fluorescence 
measurements (with excitation and emission filters of 485 and 520 nm respectively) were 
performed. At least three biological replicates (each defined as a single colony) were 
performed for each growth curve.  
2.1.3. Blood agar plate heamolysis assay 
The S. aureus strains to be tested were streaked out on fresh TSA plates complemented with 
the appropriate antibiotics and grown overnight. TSB seed cultures were inoculated and 
grown for 17 h, and then 100 µl aliquots were taken and pelleted. The cell pellet was 
resuspended in 20 µl TSB and doted onto Columbia Agar containing 5% sheep’s blood and 
left to grow for 17 h at 37°C and then 24 h at 4°C prior to image capture of the plates using a 
Gel DocTM EZ system (BIO-RAD). 
2.1.4. General lab reagents and solutions 
 
Acrylamide proto gel (Solution I) 30% (w/v) acrylamide, 0.8% (w/v)  
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(National diagnostics) bisacrylamide stock solution (37.5: 1) 
  
Acrylamide Solution II   1.5 M Tris-HCl, pH 8.8, 0.3% (w/v) SDS 
Acrylamide Solution III   0.5 M Tris-HCl, pH 6.8, 0.4% (w/v) SDS 
 
DNA loading dye (6x) 10 mM Tris-HCl (pH 7.6), 0.03% (w/v)  
(Fermentas)  bromophenol blue, 0.03% (w/v) xylene, 60% 
(v/v) glycerol, 60 mM EDTA.   
 
Protein Kinase A buffer (PKA) (2x) 80 mM Tris-HCl (pH 6.4), 400 mM NaCl, 50 
mM MgCl2, 4 mM DTT, 50% (v/v) glycerol 
 
Phosphate Buffered Saline (PBS) (10x) 80 g NaCl, 2 g KCl, 11.5 g Na2HPO4•7 H20, 2 g 
KH2PO4 in 1 l dH2O, pH 7.4 
 
Tris Magnesium buffer (TM) (10x)  10 mM Tris-HCl (pH 8.0), 10 mM MgCl2 
 
Transblot buffer (20x)   24.2 g Tris, 150 g glycine, dH2O to 1 L. 
 
Transblot buffer (1x) 20ml 20x transblot buffer, 40 ml methanol, 
dH2O to 400 ml. 
Tris Borate EDTA (TBE) (10x)  0.89 M Tris-borate, 0.02 M EDTA, pH 8.3 
(Lonza) 
Tris Buffered Saline (TBS) (10x)  50 mM Tris, 150 mM NaCl, pH 7.6  
 
TBS Tween 20 (TBSTT) (10x)  TBS with 0.1% (v/v) Tween 20 
 
Tris Glycine (TG) (10x)   0.25 M Tris base and 1.92 M glycine                            
(National Diagnostics) 
 
Tris Glycine SDS (TGS) (10x)  0.25 M Tris base, 1.92 M glycine, 1% 
(w/v)(National Diagnostics)  SDS 
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Tris-HCl stock (1M) 121 g Tris base in 800 ml water, adjust to 
desired pH with concentrated HCl. (Mix and 
make up to 1L) 
Urea gel system concentrate 237.5 g acrylamide, 12.5 g methylene bis- 
(National Diagnostics) acrylamide, 7.5 M urea, dH2O to 1 L. 
 
Urea gel system diluent   7.5 M urea. 
(National Diagnostics) 
2.1.5. Bacterial strains and plasmids 
A list of all the bacterial strains used in this work can be found in Table 8, all the plasmids 
used in this work can be found in Table 9 and all the plasmids constructed in this work can be 
found in Table 14 (See section 8.1.2).  
Strain Genotype Reference 
E. coli XL1 blue recA1 endA1 gyrA96 thi-1 hsdR17 supE44 
relA1 lac [F´ proAB lacIqZ∆M15 Tn10 (Tetr)] 
Stratagene 
E. coli BL21 (DE3) F–ompT gal dcm lon hsd SB(rB
-mB
-) λ(DE3 [lacI 
lacUV5-T7 gene 1 ind1 sam7 nin5]) 
Stratagene 
E. coli DC10B ∆dcm dam+ ∆hsd RMS endA1 recA1 (Monk et al, 2012) 
E. coli ER2566 fhuA2 lacZ::T7 gene1 [lon] ompT gal sulA11 
R(mcr-73::miniTn10--TetS)2 [dcm] R(zgb-
210::Tn10--TetS) endA1 ∆(mcrC-mrr)114::IS10 
New England Biolabs 
S. aureus SH1000 Functional rsbU derivative of 8325-4 rsbU+ (Horsburgh et al, 2002) 
S. aureus SH1000- agr-deficient SH1000 because of mutation 
H174L in agrA 
(Tsompanidou et al, 2011) 
S. aureus SH1001 SH1000 agr::tet (Horsburgh et al, 2002) 
S. aureus RN4220 MNNG mutagenized derivative of RN450, 
accepts foreign DNA 
(Peng et al, 1988) 
S. aureus SH1000agr IR P3-GFP pCL55agr IR P3-GFP integrated in SH1000 (James et al, 2013) 
S. aureus SH1000- agr IR P3-GFP pCL55agr IR P3-GFP integrated in SH1000
- This study 
S. aureus SH1001 agr IR P3-GFP pCL55agr IR P3-GFP integrated in SH1001 (James et al, 2013) 
Table 8: Bacterial strains used in this work.  
The name, genotype and reference are listed for each strain. 
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to determine DNA length. The gel was run at 110 V in 1x TBE for approximately 40 min 
before being visualised using a Safe Imager Blue Light Transilluminator (Invitrogen). Gel 
images were captured using a Gel DocTM EZ system (BIO-RAD). 
2.2.6. Gel extraction and PCR purification of DNA 
To extract and purify DNA from agarose gels the QIA quick gel extraction kit (QIAGEN) 
was used. The DNA was purified according to the manufacturer’s instructions. This first 
involved cutting the DNA band of interest out from the agarose gel using a sterile blade and 
the Safe Imager Blue Light Transilluminator to visualise it. The gel band was then placed into 
a clean a microcentrifuge tube and dissolved at 50oC in 300 µl QG binding buffer (from the 
kit) per 100 mg of gel. Isopropanol was added to the gel fragment at a 1:1 (w/v), to the 
weight of the gel slice, and the solution was bound to the column (NBS Biologicals) using a 
microcentrifuge at 14,000 x g for 1 min. The column was then washed through PE buffer and 
then the DNA eluted in 25 or 50 µl of ddH2O. The concentration of the sample was measured 
using a NanoVue Plus (GE Healthcare) spectrophotometer and the sample was stored at -
20°C. 
The products of the PCR reactions were purified as the method above using the QIAquick 
PCR purification kit (QIAGEN) except that the PCR reaction was re-suspended in 5 volumes 
binding buffer PB (from the kit) and then bound to the column. Then the protocol above was 
followed as described. 
2.2.7. Polymerase chain reaction (PCR) 
The genes of interests were amplified from chromosomal DNA (section 2.2.1) or from 
plasmid DNA (section 2.2.2) using Herculase II Fusion DNA polymerase (Agilent) and the 
relevant oligonucleotides (primers). The primers were synthesised by Sigma and can be 
found in Table 13 (See section 8.1.1). Typically, a standard PCR reaction of 50 µl total 
volume contained 50-100 ng template DNA, 0.25 µM of each primer, 10 mM dATP, dGTP, 
dCTP and dTTP, 10 µl 5x reaction buffer and 5 units of DNA polymerase mixed altogether. 
The PCR reaction was conducted in 0.2 ml thin-walled PCR tubes in a GenePro thermocycler 
(BIOER) according to the following protocol: 95ºC for 2 min, then thirty repetitions of 95ºC 
for 20 sec, 54ºC (or Tm- 5ºC) for 30 sec, 72ºC for 30 sec/kb and then a last step at 72ºC for 3 
min. The annealing temperature of 54 ºC was standardly used instead of varying the melting 
temperature (Tm) according to each primer set but was modified according to the primer Tm 
when needed. 
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For the amplification of staphylococcal DNA the standard PCR protocol was modified in 
order to facilitated the binding of the primers to very AT rich sequence. The staphylococcal 
PCR protocol consisted of 95ºC for 2 min, 95ºC for 20 sec, 45ºC for 30 sec, 72ºC for 30 
sec/kb then thirty repetitions of 95ºC for 20 sec, 54ºC (or Tm- 5ºC) for 30 sec, 72ºC for 30 
sec/kb and then a last step at 72ºC for 3 min. 
Because Herculase is a high fidelity enzyme, it does not have a polyadenylating activity. 
Therefore, The PCR products destined to be ligated into the pGEM-T easy vector (Promega) 
were polyadenylated using the GoTaq DNA polymerase (Promega) which polyadenylates 
linear DNA ends. Typically, 7 µl of PCR purified product was mixed with 5 units of Go Taq 
polymerase, 2 µl 5x Go Taq Buffer and 0.2 mM dATP in a 10 µl reaction and incubated at 72 
ºC for 20 min.  
PCR was also used to confirm the presence of cloned genes in the appropriate vector within 
individual colonies (termed colony PCR). This was performed by resuspending a single 
colony in 10 µl LB and using 8 µl of this suspension in a 50 µl PCR reaction (as described 
above). The remaining 2µl were spotted onto a LB agar plate with appropriate antibiotics in 
order to maintain the tested colony for future use. For colony PCR the GoTaq DNA 
polymerase was used with the following protocol : 95ºC for 15 min, then thirty repetitions of 
95ºC for 30 sec, 54ºC (or Tm- 5ºC) for 30 sec, 72ºC for 1 min/kb and then a last step at 72ºC 
for 5 min. Similarly as for standard PCR, with Staphylococcal colonies, the protocol was 
modified to include 95ºC for 30 sec, 45ºC for 30 sec, 72ºC for 1 min/kb before the thirty 
repetitions.  
2.2.8. Site directed mutagenesis (SDM) 
Site directed mutagenesis (SDM) was conducted to construct the library of single alanine 
mutants using the pSN-P2-agrA plasmid as template and the high fidelity PfuUltra Fusion II 
HS DNA polymerase (Agilent) and the relevant complementary oligonucleotides (See Table 
15, Table 16 and Table 17). The 50 µl reaction contained ~100 ng template DNA, 0.1 µM of 
each primer, 10 mM dATP, 10 mM dGTP, 10 mM dCTP and 10 mM dTTP, 5 µl 10x 
PfuUltra reaction buffer and 2.5 unit of PfuUltra DNA polymerase mixed. The PCR reaction 
was performed according to the following protocol: 95ºC for 50 sec, 95ºC for 50 sec, 45ºC 
for 1 min, 72ºC for 2 min and 30 sec then fifteen repetitions of 95ºC for 50 sec, Tm- 5ºC for 1 
min, 68ºC for 2 min and 30 sec and then a last step at 68ºC for 7 min. The negative control 
reaction included everything but the primers and was treated exactly as the others samples 
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were. A separate negative control was performed for each different annealing temperature. 
Two separate PCR reactions were performed for each primer pair.  
After the PCR reaction was completed, the pSN-P2-agrA template plasmid was degraded 
using the DpnI restriction enzyme. This enzyme specifically digests methylated DNA with 
the target sequence 5’-GmGATC-3’. After the PCR reaction, only the remaining template 
DNA is methylated and therefore will be specifically degraded. 6 µl of 10 x buffer 4 (New 
England biolabs), 3 µl ddH2O, and 20 units DpnI were added to each PCR reaction. The 
samples were incubated for 2-3 h at 37ºC. The two PCR reactions for each primer pair were 
then pooled together before being purified using the QIA quick PCR purification kit (section 
2.2.6) and eluted in 30 µl ddH2O. 15 µl of purified SDM product were used to transform E. 
coli XL1 blue competent cells (See section 2.2.12) the rest was stored at -20°C. The next day, 
the transformation plates were checked for colonies. If the transformation plates for the 
primer pair had a satisfactory amount of colonies compared to the corresponding negative 
control (at least 2-fold more), two colonies per primer pair were selected and used to 
inoculate liquid culture for plasmid purification (See section 2.2.2). If the ratio was not 
satisfactory, the SDM was repeated with a different annealing temperature. The purified 
plasmids were then sent to sequencing using the appropriate primer to verify that the 
mutation had been successfully incorporated.  
2.2.9. Sequencing  
The samples for sequencing were sent to GATC Biotech and sequenced using Sanger ABI 
3730xl. The reactions sent to sequencing contained 25 pmoles of the appropriate primer and 
500 ng of DNA in a total volume of 10 µl. All sequencing results were analysed using 
BioEdit sequence Alignment Editor (Hall, 1999).  
2.2.10. pGEM-T easy vector ligation 
The use of the pGEM-T easy vector simplifies molecular cloning in the case of problem with 
the restriction digest of the insert, especially in case of blunt end cutting. The pGEM-T easy 
was used to clone into the pTYB2 and the pCN34-itet vectors (See Table 9).  
The ligation of DNA into the linear pGEM-T easy vector requires purified DNA with 
polyadenylated ends. The polyadenylated PCR products required for direct ligation into the 
linear pGEM-T easy vector with poly-thymine tails using T4 DNA ligase (Promega) were 
prepared as in section 2.2.7. A typical 10 µl ligation reaction consisted of 1 µl pGEM-T easy 
vector, 3 µl insert DNA, 5 µl x2 ligase buffer and 1 unit T4 DNA ligase. The reaction was 
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then incubated at 4oC overnight and then transformed into competent E. coli XL1 blue (See 
section 2.2.12). 
2.2.11. Vector ligation 
Ligations were setup using either insert DNA digested from pGEM-T easy plasmids (section 
2.2.10) or insert DNA digested from PCR reactions (section 2.2.4) for ligation into the 
corresponding restriction enzyme digested plasmid DNA (section 2.2.4). A typical 10 µl 
ligation reaction consisted of 50-100 ng of plasmid DNA, 3-fold excess (150-300 ng) of 
insert DNA, 5 units of T4 DNA ligase (Fermentas) and 1 µl of 10x T4 DNA ligase buffer. 
The reaction was then incubated at RT for 1 hour and the enzyme heat inactivated at 65oC for 
10 min before transformation into competent E. coli XL1 blue (See section 2.2.12). 
2.2.12. Chemically Competent cells preparation (E. coli cells) 
Chemically competent cells were prepared using the CaCl2 method and used with E. coli XL1 
and DC10B strains. The E. coli strain of interest was streaked out onto an LA plate and 
incubated at 37°C overnight. A seed culture was prepared by inoculating 5 ml of LB with a 
single bacterial colony and incubating at 37°C overnight. 200 ml of LB was inoculated with 
200 µl of seed culture and cells were grown at 37°C shaking until mid-exponential phase, 
OD600 nm = 0.4-0.45. The culture was then centrifuged at 3200 x g for 10 min at 4°C. The cell 
pellet was resuspended in 40 ml of pre-chilled 100 mM CaCl2 and 15% (v/v) glycerol 
solution. Cells were then incubated on ice, in a 4°C room overnight. The cells were 
centrifuged again at 3200 x g for 10 min at 4°C. The pellet was then resuspended in 6 ml of 
pre-chilled 100 mM CaCl2 and 15% (v/v) glycerol solution. Cells were either used 
immediately or aliquoted into 50 µl volumes, snap frozen in liquid nitrogen and stored at -
80°C. 
2.2.13. Heat shock transformation 
To transform purified E. coli plasmid DNA (section 2.2.2) or ligation product (section 2.2.10 
or 2.2.11) into competent E. coli strains (section 2.2.12) aliquots of the appropriate cells were 
taken from -80oC and thawed on ice for 5 min. ~100 ng of plasmid DNA was added to each 
aliquot and incubated on ice for 30 min. The cells were then heat shocked by placing the cell 
aliquot into a 42oC water bath for 1 min and then promptly placing the aliquot back on ice for 
2 min. 950 µl of SOC media were added to the cells under sterile conditions and the cells 
placed in a shaking incubator at 37oC for 1 hour to recover. The cells were then pelleted at 
7,000 x g for 2 min and the supernatant removed. The pellet was resuspended in 50 µl of the 
???
?
???????????????????????????????????????????????????????????????????????????????????????????
?????????????????????????????????????????????????????????????????????????????
??????????????????????????????????????????????????????????????
?????????????????? ?????? ????? ????????? ?????? ???? ???????? ??????? ??? ???????? ???? ??? ???????
????????????????????????????????? ????????????????????????????????????????????????????????????
????? ??????????? ?? ????? ???????? ???? ????????? ??? ???????????? ?? ??? ??? ???? ????? ?? ???????
??????????????????????????????????????????????????????????????????????????????????????????
??? ??? ????? ???????? ???? ?????? ????? ?????? ??? ????? ???????? ???? ?? ??? ???? ???????? ???? ?????
???????????????????????????????????????????????????????????????????????????????????????????
?????????????????????????????????????????????????????????????????????????????????????????????
?????? ???????????? ??? ?? ??? ??? ???? ?? ???????? ???????? ?????????? ???? ?????? ????? ??????? ?????
??????????????????????????????????????????????????????????????????
????????????????????????
????????????????????????????????????????????????????????????????????????????????????????????
???? ????? ?????? ????? ??????????????? ??? ??? ?? ???????????? ?????????? ???????????? ????????? ???????
???????????? ???????? ???? ??? ???????????? ??????? ????? ???????? ???? ????????? ????? ???????
????????? ??????? ??? ????? ??? ????? ?????? ????????? ??????? ??? ??? ?? ??????? ?????????? ??? ????
??????????????????????????????????????????????????????????????????????????????????????????
???????????????????
??? ?????????????????????????????????? ????????????????????????????? ???? ???????????? ???????????
?????? ????? ?????? ???? ??????? ??? ???? ???? ??? ????? ????? ??? ????????? ?????? ??? ????????????
????????????????? ?????? ??? ?? ?????????????????? ??????? ???????????? ???? ????????? ????????
????????????????????????????????????????????????????????????????????????????????????????????????
????????????????????????????????????????????????????????????????????????????????????????????
???????? ?????? ???? ??????????????? ?????? ?? ????? ??????? ?????????? ????? ???? ??????????
??????????????Ω?????????????μ?????????????????????????????????????????????????????????????????
??????????????????????????????????????????????????????????????????????????????????????????
???????????????????????????????????????????????????????????????????????????????????????????????
????????????????????????????????????????????????????????????????????????????????????????????
???? ????????? ???? ???? ?? ???????? ??????? ???? ??????? ????? ?? ???? ?????? ??????????? ????
???????????? ????????????? ???? ???? ?????? ???? ?????????? ??? ????? ?????????? ??? ?????? ???????
????????????
88 
 
2.3. General protein methods 
2.3.1. Protein Expression 
The proteins overexpressed in this work were expressed using two similar systems (the 
pTYB2 and the pET system) and three different expression conditions. The three different 
expression conditions will be therefore listed in this section as well as the principle of the 
expression systems. 
The S. aureus core RNA polymerase was purified from S. aureus SH100 cells without use of 
an overexpression system. The expression method is described below as well.  
2.3.1.1. The pTYB2 and the pET systems  
The pTYB2 and the pET system are two similar expression systems. In both cases, the 
expression vector contains a T7 promoter located upstream of the multiple cloning site 
(MCS), and as well as a copy of the lacI repressor and a lac operator sequence just 
downstream of the T7 promoter. This T7 promoter region is specifically recognised by the 
bacteriophage T7 DNA dependent RNA polymerase (T7 RNAp). The two expression strains 
used to propagate these vectors (E. coli BL21 (DE3) and E. coli ER2566, Table 8) contain a 
chromosomal copy of the T7 RNAp under the control of a lac promoter. The BL21 (DE3) 
strain is a DE3 λ prophage lysogen carrying the T7 RNAp under the control of the lacUV5 
promoter and the lacI repressor. The ER2566 strain contains the T7 RNAp inserted in the 
lacZ gene and therefore also under the control of the lac promoter. The gene of interest 
cloned in the MCS of any of the two vectors will therefore be under the control of the T7 
promoter and the T7 RNAp. The expression of the gene of interest and of the chromosomal 
T7 RNAp is inhibited by the lac I repressor which occupies the lac operator sequence, 
therefore blocking the lac promoter. The addition of the inducer isopropyl β-D-1-
thiogalactopyranoside (IPTG), the molecular mimic of allolactose, outcompetes and displaces 
the lac repressor therefore releasing both lac promoters and allowing the production of T7 
RNAp. The T7 RNAp is then able to bind to the T7 promoter of the pET or pTYB2 vector 
and transcribe the target gene encoded in the MCS. Unlike allolactose, IPTG is non-
hydrolysable and therefore remains at a constant level. However, in the absence of the 
inducer, a basal level of transcription is still present due to the dynamic equilibrium between 
occupied and unoccupied operator sites by the repressor protein. Therefore a low level of 
target protein is expressed in the absence of the inducer. The pET28b+ vector (See Table 9) 
encodes a six-histidine tag (6His tag) at the target protein N-terminus for nickel affinity 
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chromatography (See section 2.3.4.1). This system was used to express the S. aureus proteins 
AgrA and AgrC-HK. The pTYB2 vector encodes a self-cleavable intein-tag with a chitin-
binding domain at the target protein C-terminus for Intein Mediated Purification with an 
Affinity Chitin-binding Tag (IMPACT) (See section 2.3.4.3). This system was used to 
express the S. aureus AgrA, AgrAL171A, AgrAE181A, AgrAH200A, AgrAY229A and AgrAR233A. 
2.3.1.2. Expression of [6His]-AgrA in pET28b+ 
The [6His]-AgrA protein is under the control of the pET system (See section 2.3.1.1). The 
pJR28-[6His]agrA plasmid (See Table 9) was transformed, as detailed in section 2.2.13, into 
E. coli BL21 (DE3) (See Table 8). The transformation plate was used to inoculate 1 l of LB 
media with the corresponding antibiotics in a 2 l flask. The culture was grown in a shaking 
incubator at 37oC without induction until the culture reached OD600 nm = 1. The cells were 
then pelleted at 4,000 x g for 20 min and the cell pellet stored at -20°C overnight, ready for 
protein purification. 1 ml samples were taken after inoculation and before the cells were 
pelleted. These samples were centrifuged at 17,000 x g and the pellet was resuspended in 100 
µl of ddH2O for future SDS-PAGE analysis (See section 2.3.3). 
2.3.1.3. Expression of AgrC-HK in pET28b+ 
AgrC-HK is under the control of the pET system (See section 2.3.1.1). The pSN-agrC-HK 
(See Table 14) was transformed, as detailed in section 2.2.13, into E. coli BL21 (DE3) (Table 
8). The transformation plate was used to inoculate 1 l of LB media with the corresponding 
antibiotics in a 2 l flask. The culture was grown in a shaking incubator at 37oC to OD600 nm = 
0.4-0.45, then transferred into a shaking incubator 25oC for 30 min before the addition of the 
inducer (1 mM IPTG for pET vectors). The cultures were then grown for a further 3 h at 25oC 
shaking. Cells were then pelleted at 4,000 x g for 20 min and the cell pellet stored at -20oC 
overnight, ready for protein purification.1 ml samples were taken before and after induction. 
These samples were centrifuged at 17,000 x g and the pellet was resuspended in 100 µl of 
ddH2O for future SDS-PAGE analysis (See section 2.3.3). 
2.3.1.4. Expression of AgrA , AgrAL171A, AgrAE181A, AgrAH200A, AgrAY229A and 
AgrAR233A in pSN-agrA, pSN-agrA L171A, pSN-agrAE181A, pSN-agrAH200A, pSN-agrAY229A 
and pSN-agrAR233A 
AgrA is under the control of the pTYB2 system. The pSN-agrA, pSN-agrA L171A,pSN-agrA 
E181A,pSN-agrA H200A,pSN-agrA Y229A and pSN-agrA R233A (See Table 14) were transformed, 
section 2.2.13, into E. coli ER2566 (Table 8). The transformation plates were used to 
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inoculate 5 ml seed cultures of LB media with the corresponding antibiotics that were grown 
at 37oC overnight. 1ml of each seed culture was used to inoculate 100ml of LB media with 
the corresponding antibiotics in 1 l flasks. The cultures were grown in a shaking incubator at 
37oC to OD600 nm = 0.6, then transferred in a shaking incubator at 16
oC for 30 min before the 
addition of the inducer (0.25mM IPTG). The cultures were then grown overnight at 16oC 
shaking. Cells were then pelleted at 4,000 x g for 20 min and the cell pellets were used for 
protein purification immediately.1 ml samples were taken before and after induction. These 
samples were centrifuged at 17,000 x g and the pellet was resuspended in 100 µl of ddH2O 
for future SDS-PAGE analysis (See section 2.3.3). 
2.3.2. Expression of the S. aureus core RNA polymerase (RNAp) 
The S. aureus SH1000 strain (See Table 8) was streaked out onto a TSA plate and incubated 
at 37oC overnight. A 100 ml TSB starter culture was inoculated with the plate and incubated 
at 37oC overnight. 6 2 l flasks containing 1 l of TSB were each inoculated with 10 ml of 
starter culture and grown in a shaking incubator at 37oC to OD600 nm = 0.5. Cells were pelleted 
by centrifugation at 4oC at 5,000 x g for 20 min and the cell pellet re-suspended in 100 ml of 
RNAp lysis buffer A (10mM Tris-HCl pH 7.5, 1 M KCl, 15 mM MgCl2, 5 mM EDTA and 
10 mM 2-mercaptoethanol) before re-centrifugation and the pellet was stored at -20oC 
overnight. 
2.3.3. SDS-Polyacrylamide gel electrophoresis (SDS-PAGE) 
Sodium dodecyl sulphate (SDS) polyacrylamide gel electrophoresis (PAGE) was used to 
resolve protein for visualisation by coomassie staining or western blot. SDS-PAGE gels were 
prepared at an appropriate percentage according to the molecular weight of the protein of 
interest (the acrylamide percentage is inversely proportional to protein size). Solutions were 
prepared as described in Table 10 with the addition of APS and TEMED immediately prior to 
pouring. The resolving solution was quickly poured into the 1 mm thick space between two 
Mini-PROTEAN glass plates (BIO-RAD) to 1 cm below the well level. The rest was filled 
with isopropanol to level the gel solution. Once the gel was set, the isopropanol was decanted 
and the top of the gel was washed with ddH2O. Residual ddH2O was removed by absorption 
with Whatmann paper. The stacking gel was then prepared and poured on top of the resolving 
gel and either a 10 or 15 well comb inserted. Once set, the gels were either used immediately 
or wrapped in wet paper towel and clingfilm and stored at 4°C for future use.  
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 Resolving gel 10% Resolving gel 12.5% Stacking gel 4% 
Acrylamide solution I 3.25 ml 4.1 ml  0.6 ml 
Acrylamide solution II 2.5 ml 2.5 ml - 
Acrylamide solution III - - 1 ml 
H2O 4.2 ml 3.4 ml 2.4 ml  
10% (w/v) APS 100 µl 100 µl 40 µl 
TEMED (Sigma) 10 µl 10 µl 4 µl 
Table 10: Composition of the SDS resolving and stacking gels used in this study.  
The composition of 10% and 12.5% resolving gel and 4% stacking gel is listed. 
The gels were assembled in a Mini-PROTEAN Tetra Electrophoresis gel tank (BIO-RAD) 
with 1x Tris Glycine SDS (TGS, National Diagnostics) buffer and pre-warmed by running at 
200 V. Protein samples were prepared by mixing 20 µl or 40 µl of protein sample with 20 µl 
or 40 µl of 2x Laemmli buffer (4% (w/v) SDS, 20% (v/v) glycerol, 10% (v/v) 2-
mercaptoethanol, 0.004% (w/v) bromophenol blue, 0.125 M Tris-HCl, pH 6.8, Sigma), 
incubated at 95oC for 5 min and then briefly centrifuged. Samples from the IMPACT 
purification were mixed with a loading buffer that did not contain any thiol, as they would 
have released the intein tag from the protein. The 3x SDS Sample buffer was used (187.5 mM 
Tris-HCl pH 6.8, 6% (w/v) SDS, 30% glycerol and 0.03% (w/v) bromophenol blue) with the 
IMPACT samples. The samples were then loaded into the pre-warmed gel alongside 8 µl of 
Page Ruler Prestained protein ladder (Fermentas) to help determine protein size and the gel 
run at 100 V for 10 min and then 200 V for approximately 40 min or until the dye front 
reached the bottom of the gel. The gel was then removed from the glass plates, washed with 
dH2O for 5 min and then stained with 20 ml of Bio-safe coomassie stain (BIO-RAD) for 30 
min. The gel was then destained in dH2O through several washing steps. The GelDoc EZ 
imager was used to capture the gel images. For western blotting (See section 2.3.8), the gel 
was removed from the glass plates and equilibrated in 1x Transblot buffer. 
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2.3.4. Protein purification 
2.3.4.1. Nickel affinity chromatography 
Proteins with a 6His tag ([6His]-AgrA (section 2.3.1.2) and AgrC-HK (section 2.3.1.3)) were 
purified using Nickel affinity chromatography. Nickel has a strong affinity for histidines. The 
6His-tagged proteins will therefore bind to the nickel column allowing their separation from 
the other proteins present in the whole cell lysate. 6His-tagged proteins will remain bound to 
the column until the addition of imidazole. Imidazole will act as a molecular mimic of the 
histidine imidazole ring side-chain and at a high concentration displace the 6His-tagged 
proteins from the nickel column resulting in the pure protein being eluted. 
Cell pellets containing expressed target proteins stored at -20oC were thawed on ice for 20 
min and re-suspended in 30 ml Lysis buffer (100 ml nickel buffer A + 1 protease inhibitor 
tablet (Roche)). 500 mg of lysozyme (Sigma) were sprinkled on top of the cell suspension 
before the cells were sonicated for 12 min (30 sec on-off cycle) at 40% amplitude using a 
Vibra cell sonicator (SONICS) until lysed. The lysed sample was spun in a high speed 
centrifuge tube at 4oC at 32,000 x g for 30 min to separate the soluble from the insoluble 
protein fraction. The supernatant was removed and stored on ice for loading onto a HiTrapTM 
Chelating HP nickel column (GE Healthcare) and a 40 µl sample was taken for SDS-PAGE 
analysis (section 2.3.3). The cell pellet was resuspended in 30 ml nickel buffer A (25 mM 
NaH2PO4 pH 7, 500 mM NaCl, 5% (v/v) glycerol) and a 40 µl sample was taken for SDS-
PAGE analysis (section 2.3.3). The Fast Protein Liquid Chromatography (FLPC) system 
(ÄKTA prime™, GE healthcare) was prepared by washing the system through with pre-
cooled nickel buffer A and B (nickel buffer A + 1 M imidazole). The nickel column was 
loaded with 0.1 M NiSO4 and equilibrated with 3 column volumes of nickel buffer A, B and 
then A. The nickel column was attached to the FPLC system, with caution taken to reduce air 
blockages, and the sample loaded into the column at 0.5 ml per min. The column was then 
washed at 2 ml per min with 2 column volumes of buffer A followed by 3% buffer B and 
then buffer A again. A 40 ml gradient was then started at 1 ml per min, where the buffer 
composition was slowly increased from 0% (v/v) buffer B to 100% (v/v) buffer B to elute and 
collect column bound proteins in 1 ml fractions. Samples were taken throughout the 
purification steps in order to check the presence of the protein and to determine which elution 
fraction to dialyze through SDS-PAGE electrophoresis (See section 2.3.3). [6His] AgrA was 
dialysed in antibody storage buffer (10 mM Tris-HCl, pH 8.0, 50 mM NaCl, 0.1 mM EDTA, 
10% (v/v) glycerol) and AgrC-HK was dialysed in HK storage buffer (10 mM HEPES(4-(2-
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hydroxyethyl)-1-piperazineethanesulfonic acid)-KOH pH 8, 50 mM KCl, 0.1 mM EDTA, 1 
mM DTT and 10% (v/v) glycerol) overnight at 4°C using Spectra/Por 3 dialysis tubing 
(Spectrum) and the protein concentration measured (See section 2.3.5). Protein samples were 
aliquoted into microcentrifuge tubes and stored at -80oC. 
2.3.4.2. Immunoaffinity chromatography 
Immunoaffinity chromatography was used for the extraction of S. aureus SH1000 core RNAp 
(section 2.3.2) using the polyol responsive 8RB13 affinity resin (Neoclone) (Bergendahl et al, 
2003). The cell pellet was thawed on ice and re-suspended in 100 ml of RNAp lysis buffer B 
(10 mM Tris-HCl, pH 7.5, 50 mM KCl, 15 mM MgCl2, 5 mM EDTA and 10 mM 2-
mercaptoethanol) containing 1 tablet of RNase inhibitors (Roche) and 200 µl of 2 mg/ml 
lysostaphin. The cells were lysed by passing the cell suspension three times through a French 
pressure cell press (SIM-AMINCO) pre-chilled to 4oC and pre-washed with RNAp buffer A, 
at 11,000 psi. The soluble fraction was collected through centrifugation at 4oC at 32,000 x g 
for 30 min. All further steps were carried out at 4oC. The nucleic acid and RNAp were 
precipitated by the addition of 0.6% (v/v) polyethyleneimine (PEI) (Sigma) from a 10% stock 
(pH7.9 using HCl), gradually added and mixed over 15 min before a further 30 min mixing. 
The precipitate was pelleted in a high speed centrifuge tube at 32,000 x g for 20 min and the 
pellet thoroughly re-suspended in 10 ml RNAp wash buffer (10 mM Tris-HCl pH 7.9, 0.1 
mM EDTA, 300 mM NH4Cl, 5% (v/v) glycerol and 0.1 mM DTT). The suspension was re-
centrifuged at 32,000 x g for 20 min and re-suspended in 10 ml RNAp elution buffer (RNAp 
wash buffer adjusted to pH 7 + 1 M NH4Cl), before further centrifugation at 32,000 x g for 
20 min. The supernatant was collected and gently mixed in a glass beaker with 0.4 g 
(NH4)SO4 (Sigma)/ml supernatant, gradually added over 15 min, followed by a further 30 
min mixing. The precipitate was pelleted at 32,000 x g for 10 min and the pellet stored at -
20oC overnight. 
The (NH4)SO4 pellet was thawed on ice and re-suspended in 10 ml TE buffer (50 mM Tris-
HCl pH 7.9 and 0.1 mM EDTA) and spun at 5000 rpm for 10 min at 4oC to remove insoluble 
materials. The supernatant was then passed three times through a prewashed column (BIO-
RAD), with 10 ml TE buffer, packed with 1 ml 8RB13 polyol responsive antibody resin 
(Neoclone) to maximise RNAp contact time. The column was then washed with 10 ml TE 
buffer plus 0.15 M NaCl followed by 10 ml TE buffer plus 0.5 M NaCl. The remaining 
bound protein, including RNAp, were eluted with 5 ml TE buffer plus 0.75 M NaCl and 40% 
propylene glycol (Sigma), with 1 ml elution fractions collected. 20 µl samples taken 
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throughout the purification were analysed through SDS PAGE analysis (See section 2.3.3) 
and fractions containing >95% homogeneity of S. aureus core RNAp were concentrated 
through centrifugation at 5,000 x g using Amicon Ultra-4 spin columns (Millipore), with a 5 
kDa cut-off, before being dialysed in standard storage buffer and stored at -80oC, as in 
section 2.3.4.1. 
2.3.4.3. Intein mediated purification with an affinity chitin-binding tag 
(IMPACT) 
AgrA, AgrAL171A, AgrAE181A, AgrAH200A, AgrAY229A and AgrAR233A (See section 2.3.1.4) 
were purified using the IMPACTTM kit (New England Biolabs) according to the 
manufacturer’s instructions. Briefly, the cells were lysed in 6 ml column buffer (20 mM Tris-
HCl pH 9, 1 M NaCl and 1 mM EDTA) through sonication for 12 min (30 sec on-off cycle) 
at 40% amplitude and centrifuged in a high speed centrifuge tube at 4oC at 32,000 x g for 30 
min to remove cellular debris. The pellet was resuspended in 6 ml column buffer and the 
supernatant was then loaded on a 10 ml gravity flow column (BIO-RAD) packed with 2 ml 
Chitin Resin (New England Biolabs) prewashed with 12 ml column buffer. The column was 
washed with 40 ml of column buffer and the protein was cleaved from the intein tag after 
incubation for 16 h at 4°C in 6 ml of cleavage buffer (column buffer + 200 mM DTT). 40 µl 
samples taken throughout the purification were analysed through SDS PAGE analysis 
(section 2.3.3) The protein was concentrated using Amicon Ultracel-10K (Millipore) and 
dialysed in low glycerol storage buffer (10 mM Tris-HCl pH 8, 50 mM NaCl, 0.1 mM 
EDTA, 1 mM DTT and 20% (v/v) glycerol) as in section 2.3.4.1. The proteins were aliquoted 
and stored at -20°C.  
2.3.5. Determination of protein concentration by Bradford microassay 
The Bradford assay is a colorimetric protein assay that is based on the absorbance shift of the  
Coomassie Brilliant Blue G-250 dye. The dye exists in three different forms, a blue one 
(anionic), a green one (neutral) and a red one (acidic). Under acidic conditions, the dye is 
therefore mainly in its red form. However, when the dye binds to proteins it is converted to a 
stable un-protonated blue form. Therefore, the amount of blue dye is a measure for the 
protein concentration and can be estimated by use of an absorbance reading. The absorbance 
of the bound blue dye is at OD595 nm so the increased absorbance at OD595 nm is proportional to 
the bound dye and thus to the amount of protein in the sample.  
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The concentration of the purified proteins in the different storage buffers was determined 
using the Bradford reagent dye (Quick start Bradford 1x Dye reagent, BIO-RAD) which 
contains the Coomassie Brilliant Blue G-250 dye. The protein concentration was calculated 
using a standard curve constructed with the absorbance of known concentration of protein 
bovine serum albumin (BSA) standards. Typically, the standard curve contained serial 
dilutions of BSA standards ranging from 0.05 mg/ml to 2 mg/ml. 
 5 µl of protein sample and of each BSA sample were pipetted in clear flat-bottomed 96-well 
plate (Sterillin) and 250 µl of Bradford reagent were added to each sample. The 96-well plate 
was incubated at RT for 15 min and then the absorbance of the protein samples at 595 nm 
was determined using the POLAR star Omega plate reader. 
 
2.3.6. Polyclonal antibody production 
Purified [6His]-AgrA (section 2.3.4.1) was sent to Eurogentec for rabbit immunisation. Two 
different rabbit were immunised with the protein. Bleeds were taken pre-immunisation, 21 
days after immunisation and after termination (final bleed). Anti-peptide ELISA analysis was 
conducted for the final bleed prior to shipping. 
2.3.7. Affinity purification of antibody serum 
50 µg untagged AgrA (section 2.3.4.3) was resolved by SDS-PAGE and transferred to a 
polyvinylidenedifluoride (PVDF) membrane (BIO-RAD) as per the western blotting protocol 
(refer to section 2.3.8). The membrane was then stained with Ponceau S solution (Sigma) for 
5 min and rinsed with dH2O to visualise the protein. The section of the membrane containing 
the AgrA protein was cut and transferred to a 50 ml falcon tube. The membrane was blocked 
with 25 ml of 1x PBS with 5% fat-free milk powder for 1 hour and then incubated with 25 ml 
of 1x PBS with 5% fat-free milk powder and 5 ml of final bleed antibody serum at 4°C 
overnight. The membrane was rinsed twice in 1x PBS for a few sec each time and then the 
antibody was eluted with 4 ml of 100 mM glycine pH 2.7 for exactly 2 min. The eluate was 
transferred into a 15 ml falcon tube containing 300 µl 1.5 M Tris-HCl, pH 8.8 to neutralise 
the acid and was then dialysed against 500 ml PBS twice over 8 h. The antibody was then 
aliquoted and frozen at -20°C. 
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2.3.8. Western blotting 
The S. aureus samples for Western blot were prepared differently than standard samples for 
SDS-PAGE analysis (See section 2.3.3). 1 ml or 200 µl of S. aureus culture at OD600 nm = ~2 
were spun down and resuspended in 500 µl or 100 µl of ddH2O. 25 µl or 5 µl of 2 mg/ml 
lysostaphin were added to the sample and it was incubated 30 min at 37°C. Then 500 µl or 
100 µl of 2x Laemmli buffer were added to the sample and the sample was boiled for 5 min 
at 95°C and briefly spun down. The samples were then resolved using the appropriate 
percentage SDS-PAGE (See section 2.3.3). The gel was then equilibrated in 1x transblot 
buffer for 10 min. At the same time, a gel-sized sheet of PVDF membrane was soaked in 
methanol for 10 s, in water for 5 min and then equilibrated in 1x transblot buffer for 10 mins. 
Meanwhile, eight gel-sized sheets of Whatmann paper were soaked in 1x transblot buffer. 
The blot was assembled onto a Trans-Blot Turbo transfer system (Bio-RAD) in the form of a 
sandwich. The “bread” on either side was constituted by the 4 Whatmann paper pieces, the 
“meat” was represented by the PVDF membrane, above the terminal 4 Whatmann paper 
pieces and the “salad” was represented by the gel, above the membrane. Any bubbles were 
then removed by rolling over the blot with a stripette. The proteins in the gel were transferred 
onto the membrane by running at 10 V for 1 hour. The membrane was then blocked in 25 ml 
1x TBS with 5% fat-free milk powder and 37.5 µl of 5 mg/ml human immunoglobulin G 
(hIgG, Sigma) overnight at 4°C. The membrane was washed twice for 10 min each in TBSTT 
and for a further 10 min in TBS. The membrane was then incubated for 1 hour in 20 ml 1x 
TBS with 5% fat-free milk powder, 30 µl of 5 mg/ml hIgG and 80 µl the primary antibody, 
the agrA polyclonal antibody. The membrane was then washed twice for 10 min each in 
TBSTT and for a further 10 min in TBS. The membrane was then incubated for 1 hour in 20 
ml 1x TBS with 5% fat-free milk powder, 30 µl of 5 mg/ml hIgG and 6.7 µl of the secondary 
antibody, the anti-rabbit–horseradish peroxidase-conjugated antibody (Dako). After the 
incubation the membrane was washed 5 times for 10 min each in TBSTT. The blot was then 
placed with the protein face down on premixed ECL prime western blotting detection reagent 
(GE Healthcare, 500 µl of reagent A and 500 µl of reagent B) and incubated for 5 min. The 
blot was then briefly dried with tissue paper and placed between the two transparent sheets of 
a X-ray film cassette. The blot was either exposed on CL-XPOsure Film (Thermo Scientific) 
for the appropriate amount of time (10 s to 30 min usually) and developed using a CURIX 60 
developer (AGFA) or visualised using a LAS-3000 imaging system (Fujifilm).  
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2.4. General biochemical methods 
2.4.1. Probe labelling with 32P 
Typically, 20 pmoles of single stranded oligonucleotides or double stranded DNA (PCR 
products or restricted fragment) were labelled with 35 µCi γ-32P-ATP (500 Ci/mmol-
PerkinElmer) using a T4 ligase (Promega) to form 32P labelled DNA promoter probes for 
electrophoretic mobility shift assays (section 2.4.2 and 2.4.3) or DNA bending assay (section 
2.4.6). T4 DNA ligase catalyses the joining of the 5’-phosphate and 3’-hydroxyl groups of 
adjacent nucleotides and therefore is able to transfer the 32P labelled γ-phosphate from γ-32P-
ATP to the free hydroxyl group of DNA oligonucleotides. Typically, 20 µl labelling reactions 
contained 20 pmoles of DNA, 35 µCi γ-32P-ATP, 2 µl x10 T4 DNA ligase buffer A (300 mM 
Tris-HClpH7.8, 100 mM MgCl2, 100 mM DTT and 10 mM ATP, Promega) and 10 units of 
T4 kinase . Reactions were incubated at 37oC for 30 min before the kinase was denatured at 
70oC for 10 min. For oligonucleotides, duplex DNA was formed in 40 µl reactions with the 
20 µl of 32P labelled single stranded oligonucleotides, 40 pmoles of the complementary single 
stranded unlabelled oligonucleotide and 4 µl x10 TM buffer (10 mM Tris-HCl pH 10 and 1 
mM MgCl2) made up to 40 µl in distilled water to give a 500 nM final DNA concentration. 
Reactions were heated in a heat block at 95oC for 5 min before the slow cooling of the 
reactions through placing the heat block at RT overnight. The DNA duplex was then stored at 
-20oC. 
2.4.2. Electrophoretic gel mobility shift assay (EMSA) with acetyl phosphate 
activation 
Phosphorylation of AgrA was carried out by pre-incubating 3 µM AgrA with 50 mM acetyl 
phosphate (Sigma) and 5 mM MgCl2 for 1 h at 37°C. 10 µl binding reactions were set up in 
reaction buffer (10 mM HEPES pH 7.6, 50 mMKCl, 1 mM EDTA, 2 mM DTT, 0.5% (v/v) 
TritonX-100 and 5% (v/v) glycerol) using 1 µM final concentration of phosphorylated AgrA 
and 10 nM of a 214 base pairs long γ-32P-labelled DNA fragment representing the agr 
operon intergenic region including the P2 and P3 core promoter sequences up to position +11 
of the P2 promoter and +15 of the P3 promoter (See Figure 81). The phosphorylated AgrA 
was incubated in reaction buffer for 10 min at 37°C before adding the DNA probe. The 
reactions were incubated at 37°C for another 10 min and stopped with native gel loading dye 
(reaction buffer + 50% (v/v) glycerol and 0.05% (w/v) bromophenolblue) and resolved on a 
4-20% (w/v) gradient native polyacrylamide gel (BIO-RAD). The gel was run in 1x TG 
buffer (National diagnostics) using the Mini-PROTEAN Tetra Electrophoresis system (BIO-
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RAD) and pre-warmed by running at 100 V for 30 min before loading the samples. The gel 
was run at 100 V for 2 hour and 20 min before drying for 1 hour on Whatmann paper 
(Whatmann) using a gel dryer (Scie-Plas-GD4534) and pump (KNK lab).The dried gel was 
visualized and quantified using a GE Typhoon FLA 2000 Phosphor Imager and the Image 
Quant TL software, respectively.  
2.4.3. Electrophoretic gel mobility shift assay (EMSA) with AgrC-HK activation 
These were conducted exactly as in the previous section 2.4.2 but without the pre-incubation 
step. Instead, 10 µl reactions were set up in reaction buffer with 200 nM AgrA, 800 nM 
AgrC-HK and 0.5 mM dATP. The rest was exactly as in the previous section. 
2.4.4. Short RNA synthesis assay with AgrC-HK activation 
Short RNA synthesis assays measure the transcriptional output of RNAp promoter 
complexes. By providing the RNAp with only a short dinucleotide primer complementary to 
the promoter template strand transcriptional start site and also only the next complimentary 
nucleotide in radiolabeled form only short RNA synthesis can occur.  
10 µl binding reactions were setup. 50 nM S. aureus core RNAp and 200 nM S. aureus σA 
were incubated for 5 min at 37oC in presence of 0.25 µl RNasin® Plus RNase Inhibitor 
(Promega) in reaction buffer. Simultaneously, 200 nM of AgrA was incubated for 5 min at 
37oC in presence of 800 nM AgrC-HK, 500 nM dATP and 10 nM P3-IR promoter probe (See 
Figure 81). After the 5 min incubation, both reactions were mixed and incubated for another 1 
min at 37oC before the addition of the elongation mix (0.5 mM GpA dinucleotide primer, 3 
µCi α-32P-UTP (800 Ci/mmol-PerkinElmer) and 100 µg/ml heparin) to allow dinucleotide 
primed short RNA synthesis to occur. Reactions were incubated at 37oC for a further 10 min 
before the addition of 2 µl of transcription stop dye (3% (w/v) xylene cyanol, 3% (w/v) 
bromophenol blue and 20 mM EDTA in deionized formamide). Reactions were loaded and 
resolved on a 20% (w/v) urea denaturing gel (20 ml system concentrate, 2.5 ml system 
dilutent, 2.5 ml 10x TBE (Lonza), 150 µl 10% APS, 20 µl TEMED) using a Mini-PROTEAN 
Tetra Electrophoresis system. The gel was pre-warmed by running at 200 V for 30 min before 
loading the samples. The gel was run at 200 V for 50 min. The wet gel was visualized and 
quantified using a GE Typhoon FLA 2000 Phosphor Imager and the Image Quant TL 
software, respectively.  
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2.4.5. Full length in vitro transcription assay with acetyl phosphate activation 
Full length transcription assays were performed to measure the formation and transcriptional 
output of RNAp promoter complexes formed on supercoiled templates over time. 
Phosphorylation of AgrA was carried out by pre-incubating 3 µM AgrA with 50 mM acetyl 
phosphate and 5 mM MgCl2 for 1 h at 37°C. 10 µl microliter binding reactions were set up in 
transcription buffer (40 mM Tris–acetate (pH 7.9), 100 mM NaCl, 20 mM MgCl2 and 0.2 
mM DTT). 50 nM S. aureus core RNAp and 200 nM S. aureus σA, 1 µM AgrA, 10 nM 
pJRP2+P3 (See Table 9) and 0.25 µl RNasin® Plus RNase Inhibitor were incubated at 37°C for 
5 min separately and then mixed and incubated for another 5 min. RNA synthesis was 
initiated by adding an elongation mix containing 0.5 mM ATP, CTP and GTP; 0.25 mM 
UTP; 0.75 µCi of α-32P UTP; 1 µl of 100 µg/ml heparin per reaction was added to the 
elongation mix for single-round transcription reactions. The reaction was incubated for a 
further 10 min at 37 °C. The reactions were stopped with transcription stop dye and resolved 
on a 10% (w/v) urea-denaturing polyacrylamide gel (28 ml system concentrate, 35 ml system 
dilutent, 7 ml 10x TBE, 560µl 10% APS, 28 µl TEMED). The gel was cast and run using the 
Sequi-Gen Sequencing cell (BIO-RAD) in 1x TBE. The gel was pre-run at 40 W for 1 hour 
or until the gel running apparatus had reached the optimal running temperature of 80°C. The 
samples were then loaded and the gel run at 40 W for 3h until the bands were sufficiently 
resolved, based on the loading dye position. (on a 10% urea gel, bromophenol blue runs like a 
10 nucleotide product and xylene cyanole like a 55 nucleotides product).The gel was then 
dried for 3 h on Whatmann paper using a gel dryer and pump.The dried gel was visualized 
and quantified using a GE Typhoon FLA 2000 Phosphor Imager and the Image Quant TL 
software, respectively.  
2.4.6. DNA bending assays 
The DNA bending plasmid pAM1847 containing the AgrA binding site (Reyes et al, 2011) 
was digested with the EcoRI, HindIII, BstNI, EcoRV, NheI and BamHI restriction enzymes 
(section 2.2.4). The fragments were purified (section 2.2.6) and individually labeled with γ-
32P ATP (section 2.4.1). 7 ng of the labeled fragments were then incubated with 1 µM of 
phosphorylated AgrA in reaction buffer with 0.3 µg of sonicated calf thymus (Sigma) at RT 
for 20 min. The reactions were stopped with native loading dye and resolved on a 4.5% (w/v) 
native polyacrylamide gel (3 ml Solution I, 2 ml 10x TG, 15 ml H2O, 200 µl APS, 20 µl 
TEMED). The gel was run in 1x TG buffer (National diagnostics) using the Mini-PROTEAN 
Tetra Electrophoresis system (BIO-RAD) and pre-warmed by running at 100 V for 30 min 
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before loading the samples. The gel was run at 100 V for 1 hour and 40 min before drying for 
30 min on Whatmann paper using a gel dryer and pump. The dried gel was visualized and 
quantified using a GE Typhoon FLA 2000 Phosphor Imager and the Image Quant TL 
software, respectively.  
2.4.7. Acetyl Phosphate phosphorylation of AgrA 
γ-32P acetyl phosphate was synthesized with 0.3 unit of acetate kinase (Sigma) and 10 µCi γ-
32P-ATP in 7.5 µl of AKP buffer (25 mM Tris–HCl pH 7.4, 60 mM KOAc, 10 mM MgCl2; 
final pH 7.6) in a 10 µl reaction for 20 min at RT (Quon et al, 1996). 1.46 µM AgrA was then 
added to the γ-32P acetyl phosphate and the reaction was incubated at 37°C for 1 hour before 
stopping with the addition of 2x Laemmli buffer. The samples were loaded on a 12.5% SDS-
PAGE gel and the gel was run at 200 V for 50 min (section 2.3.3). The gel was dried for 1 
hour on Whatmann paper using a gel dryer and pump. The dried gel was visualized and 
quantified using a GE Typhoon FLA 2000 PhosphorImager and the Image Quant TL 
software, respectively.  
2.4.8. AgrC-HK phosphorylation of AgrA 
Two separate 10 µl reactions were set up. The first one contained 5µM AgrC-HK, 5 µCi γ-
32P-ATP, 2 mM DTT, 5 mM MgCl2, 500 nM dATP and 5 mM DTT in HK storage buffer and 
the second one 10 µM AgrA and 5 mM MgCl2 in HK storage buffer. Both reactions were 
incubated for 1 hour at 30°C then 5 µl were taken from each reaction and incubated together 
in a new reaction tube for 1 hour at 30°C. The reactions were stopped with the addition of 
Laemmli buffer and loaded on a 10% SDS-PAGE gel. The gel was run at 200 V for 50 min 
(section 2.3.3) and dried for 1 hour on Whatmann paper using a gel dryer and pump. The 
dried gel was visualized and quantified using a GE Typhoon FLA 2000 Phosphor Imager and 
the Image Quant TL software, respectively.  
2.5. In silico method 
2.5.1. Molecular Dynamics (MD) Simulations (performed by Dr. Robert Weinzierl) 
The protonation states of residues present in the LytTR DNA-binding domain in PDB 4G4K 
(Sidote et al, 2008) were computed using H++ (Gordon et al, 2005). The resulting atomic 
coordinates were embedded in a TIP3P (Jorgensen, 1983) cubic water box extending for a 
minimum of 15 Å beyond the protein structure. The assembly was charge-neutralized, 
adjusted to 150 mM NaCl and parameterized with the AMBER99SB (Ponder & Case, 2003) 
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force field. Simulations were run on Nvidia GPUs certified to carry out accurately 
reproducible calculations using the AMBER 12 package (Salomon-Ferrer, 2013). The 
parameterized structures were energetically minimized by rapid descent and repeated 
annealing minimization before equilibration at 300 Kelvin and one atmosphere of pressure 
(NPT ensemble). For all MD simulations, the bond length between hydrogen and heavy 
atoms was fixed using the SHAKE algorithm (Ryckaert, 1977). The time-step was 2 femtosec 
and the Particle Mesh Ewald (Essmann, 1995) cut-off distance was set to 8 Å. The simulation 
engine was pmemd.cuda, a CUDA-accelerated MD production engine based on a hybrid 
single-/double precision (SPFP) algorithm. Conventional MD simulations were initially 
carried out for 50 nanosec (ns) to obtain representative values for the total potential and 
dihedral energy values for adjustment in the subsequent dual-boost accelerated MD (aMD) 
production runs. For boosting the dihedral potential, an energy contribution of 3.5 
kcal/mol/residue per degree of freedom was assumed. A boost factor (α) factor of 0.2 was 
used for adjustment of the dihedral and potential energy in all aMD simulations. All aMD 
simulations lasted 100 ns, but are likely – due to the acceleration - to represent protein 
motions occurring in the tens to hundreds of microsec range in real time (Pierce et al, 2012). 
Trajectories were processed, visualized and analyzed using the Visual Molecular Dynamics 
(VMD) suite (Humphrey et al, 1996). 
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CHAPTER THREE 
3. Development of an experimental system to study AgrA activity in vivo  
3.1. Introduction 
3.1.1. The P1, P2 and P3 promoters 
In the early days of study of the agr operon, two promoters able to drive the expression of 
AgrA were identified, P1 and P2 (See Figure 33 and Figure 34). P1 is a weak constitutive 
promoter located about 100 bp upstream of agrA, in the 3’end of agrC (Peng et al, 1988), P2 
is a strong promoter located about 2kb upstream of agrA in the agr IR, more active in the 
post-exponential phase of growth responsible for the transcription of RNAII (Janzon et al, 
1989; Morfeldt et al, 1988).The P3 promoter is a strong promoter also located in in the agr IR 
but on the opposite strand from the P2 and P1 promoters and responsible for the transcription 
of RNAIII, the effector RNA of the agr operon involved in the temporal regulation of 
virulence factors (See Figure 33 and section 1.5 for more details). P2 and P3 are divergent 
promoters (Janzon & Arvidson, 1990; Morfeldt et al, 1988; Novick et al, 1993). Both the P2 
and the P3 promoters are activated by AgrA (Janzon et al, 1989). 
 
Figure 33: Schematic of the P1, P2 and P3 promoters of the agr operon. 
The P2 and the P3 promoter are activated by the phosphorylated AgrA. P2 encodes the RNAII transcript 
consisting of the argB, agrD, agrC and agrA genes. P3 encodes RNAIII, the pleiotropic effector RNA of the 
operon responsible for the upregulation of the secreted virulence factors and the downregulation of the cell 
surface-associated virulence factors.  
 As mentioned in section 1.5.5.3, the -10 and -35 promoter elements of the P2 and P3 
promoters have been mapped based on the start of the RNAII and RNAII transcripts (Janzon 
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et al, 1989; Novick et al, 1993). However, the transcriptional start site of the P1 promoter has 
not been determined and therefore the precise position of the P1 -10 and -35 promoter 
elements is also unknown. 
P1 driven AgrA was shown to weakly complement agrA activity in an agr deficient strain 
(Peng et al, 1988) whereas P2 driven AgrA was able to fully complement under similar 
conditions (Morfeldt et al, 1988). Both promoters were mentioned in the literature until the 
mid-nineties when it became widely accepted that P2 was indeed the primary agrA promoter 
(Novick et al, 1995) and articles mentioning P1 became scarce. However, P1-agrA constructs 
(See Figure 34) were used to complement AgrA activity until much later, with more or less 
success depending on the S. aureus strain used (Adhikari et al, 2007; Traber & Novick, 2006; 
Tsompanidou et al, 2011). It can be noted that none of these complementation restored the 
full AgrA activity. However, the best results were obtained in the strains of the NCTC 8325 
lineage bearing a mutation in rbsU, encoding a phosphatase responsible for the activation of 
the S. aureus alternative sigma factor σB (Kullik et al, 1998). This is interesting as σB is 
thought to antagonise agr activity (Novick, 2003). Indeed, SH1000, the rbsU repaired strain 
has been shown to display important differences in growth patterns and exoproteins 
production, the latter resulting from a decreased agr activity, compared to other strains of the 
NCTC 8325 lineage (Horsburgh et al, 2002; Novick, 2003).  
 
Figure 34: The P1 and the P2 promoter. 
DNA sequence of the P1 promoter used to complement for AgrA activity by Peng et al. and the P2 promoter. -
35 refers to the -35 element (5’-TTGACA-3’) and -10 refers to the -10 element (5’-TATAAT-3’). The P1 promoter 
-10 and -35 promoter elements have not been identified. Therefore, the two putative -10 and -35 promoter 
elements present in the sequence are highlighted in magenta and labelled in magenta but not underlined. The 
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sequence of the P2 promoter contains the agr intergenic region, starting immediately after the -35 promoter 
element of the P3 promoter.  
3.1.2. The S. aureus haemolysins 
The haemolytic activity of S. aureus on blood plates was first observed over a century ago 
(Julianelle, 1922). It is primarily mediated by the ability of the staphylococcal haemolysins α, 
β, γ and δ to lyse red blood cells (Coleman et al, 1986). The vast majority of S. aureus strains 
contain all the corresponding genes, hla, hlb, hlg and hld, respectively (Vandenesch et al, 
2012). However, hlb is a preferential site for bacteriophage insertion. Therefore, the large 
majority of human clinical isolates are β-haemolysin-negative (van Wamel et al, 2006). The 
activity of α and δ haemolysins on blood agar plates can be used as a surrogate for agr 
function (Adhikari et al, 2007) and all four haemolysins are under the control of the agr 
operon (Bronner et al, 2000; Recsei et al, 1986) 
3.1.2.1. α-haemolysin  
α-haemolysin (α-toxin) has been extensively studied for about 100 years. α-haemolysin 
monomers are secreted and integrate into the target cell membrane to form a cylindrical 
heptamer leading to the formation of a pore. This pore allows the influx/efflux of ions and 
small molecules leading to osmotic swelling and eventually cell death (Dinges et al, 2000). 
3.1.2.2. β-haemolysin 
β-haemolysin (Sphyngomyelinase C) is also called the “hot-cold” haemolysin because its 
haemolytic activity is enhances by incubation below 10°C following incubation at 37°C 
(Bigger, 1933). It is a sphyngomyelinase and hydrolyses sphingomyelin, a plasma membrane 
lipid (Doery et al, 1963). Sphingomyelin is rich in cholesterol and sphyngomyelinase 
treatment of the lipid bilayer leads to aggregation of cholesterol. The exact mechanism 
leading to cell death remains unclear but it is thought that it might be due to destabilisation of 
the plasma membrane (Ira & Johnston, 2008; Vandenesch et al, 2012) 
3.1.2.3. γ-haemolysin 
γ-haemolysin is a bi-component toxin consisting of two non-associated secreted proteins, 
termed S (slow) and F (fast) (Woodin, 1959). γ-haemolysin cannot be identified on blood 
agar plates as its activity is inhibited by agar (Prevost et al, 1995). The γ-haemolysin proteins 
bind sequentially to the host cell surface as monomer then oligomerise into an octamer 
consisting of four S elements alternating with four F elements. The mature octamer forms a 
pore across the membrane leading to host cell lysis (Vandenesch et al, 2012). 
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3.1.2.4. δ-haemolysin 
The δ-haemolysin (δ-toxin) open reading frame is located at the 5’ end of RNAIII and is 
therefore closely linked with the agr operon (Janzon et al, 1989). It is secreted and forms an 
α-helix with hydrophobic and hydrophilic domains on opposite sides (Freer & Birkbeck, 
1982). There are three hypotheses explaining its haemolytic activity. δ-haemolysin could bind 
to cell surface and aggregate to form a pore, bind to the cell surface and destabilise the 
plasma membrane or act as a detergent and solubilize the membrane (Verdon et al, 2009). 
3.1.3. The L54a phage and pCL55 
The S. aureus structural lipase gene (glycerol ester hydrolase: geh) is negatively regulated by 
lysogenic conversion by the prophage L54a (Lee & Iandolo, 1985). This is a temperate 
prophage which is capable of both lysogenic and lytic life style (Duval-Iflah, 1972). While in 
a lysogenic lifestyle, it inactivates the extracellular lipase of its host by integrating on the S. 
aureus chromosome thus disrupting the lipase structural gene (Lee & Iandolo, 1986b). Curing 
of the phage restores the lipase activity of the strain (Lee & Iandolo, 1985). The integrative 
recombination of L54a occurs between the specific viral attachment site (attP) on the 
bacteriophage genome and the attB site on the host chromosome. This leads to the creation of 
two attachment sites, attL and attR generated on the left and right side of the insertion. The 
recombination is not only site specific but also orientation specific. The four att sites share an 
18 bp identical core region. The attB site is localised near the 3’end of the geh open reading 
frame (Lee & Iandolo, 1986a). Thus the lysogens will display a lipase negative activity as the 
insertion disrupts aa 635 to 644 of the 690 aa enzyme. This activity can be tested on egg yolk 
agar plates (Lee & Iandolo, 1985). The integration of the phage requires the viral integrase 
(int) gene whereas the excision necessitates the integrase and excisionase (xis) viral genes 
(Ye & Lee, 1989). 
pCL55 is a single copy integration vector based on the recombination system of the prophage 
L54a. It is capable of autonomous replication in E. coli but not in S. aureus as it carries a 
single origin of replication solely compatible with E. coli. This plasmid contains both the attP 
and the int sites enabling its integration on the chromosome of the host at the geh locus in an 
orientation specific manner (See Figure 35). Integration can be easily tested as correct 
integration will produce a lipase negative phenotype. Because the plasmid does not contain 
the xis gene necessary for excision it can be stably maintained even without selective 
pressure. Therefore it provides a straight forward method to integrate a single copy of the 
desired gene on the chromosome of S. aureus (Lee et al, 1991). 
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Figure 35: pCL55 map. 
Ap
R
 represent the ampicillin resistance gene. int represents the integrase gene. attP represents the viral 
attachment site. CmR represent the chloramphenicol resistance gene. ori represents the origin of replication. 
Adapted from (Lee et al, 1991). 
The pCL55 plasmid was used to construct a GFP transcriptional fusion in the laboratory by 
Ellen James. The P3 promoter and the agr intergenic region (IR) up to, but not including, the 
-35 promoter of the divergent P2 promoter were cloned upstream of the gene encoding GFP 
with an optimal Shine-Dalgarno (SD) sequence thus creating the pCL55 agr IR P3-GFP (See 
Figure 36). This construct enabled to quantify the level of activation of the P3 promoter by 
measuring the GFP fluorescence emitted (James et al, 2013).  
 
Figure 36: Sequence of the agr IR P3-GFP of the pCL55 agr IR P3-GFP construct. 
The agr intergenic region, starting immediately after the -35 promoter element of the P2 promoter and 
stopping upstream of RNAIII of the pCL55 agr IR P3-GFP construct. -35 refers to the -35 element (5’-TTGACA-3’) 
and -10 refers to the -10 element (5’-TATAAT-3’).The bold boxes highlighted in red represent the -35 and -10 
promoter element of the P3 promoter, the +1 site is highlighted in yellow, the Shine-Dalgarno sequence is bold 
highlighted and the start codon of the GFP reporter is highlighted in green.  
The stability of the integrated construct was tested and after 24 h of growth in TSB without 
antibiotic selection, and all the colonies tested had retained the construct. To test whether the 
presence of a second copy of the agr IR affected the expression of the agr operon, mRNA 
level of agrA (P2 transcription), hld (P3 transcription) were compared relative to gyrB 
(constitutively expressed gyrase) by qRT PCR. No obvious differences in the level of mRNA 
of agrA and hld were detected between the strain bearing the reporter and an empty strain. 
Blood agar haemolysis was used to illustrate that the reporter strain was not compromised for 
β-haemolysis. In addition, the growth rates of the reporter strain in TSB were very similar to 
that of the empty strain (James et al, 2013). 
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Therefore it was concluded that the presence of the GFP reporter does not affect the strain in 
any way and that construct can be used to portray the regulatory events taking place at the 
native agr operon.  
3.2. Objectives 
The overall objective of this chapter was to develop tools to study transcription activation by 
AgrA in vivo. In this regard, the specific aim included:  
I. Purify AgrA to send for antibody production then purification of the polyclonal 
antibody obtained 
II. Characterise the SH1000- agr-deficient strain 
III. Development of a method to measure transcription activation at the P3 promoter by 
AgrA in vivo  
IV. Complement the SH1000- agr-deficient strain  
3.3.  Polyclonal AgrA antibody production and purification 
AgrA was expressed under the control of the pET expression system, as in section 2.3.1.1 in 
the E. coli BL21 (DE3) expression strain (See Table 8) without induction, as in section 
2.3.1.2. The vector pET28b+ encoding an N-terminal 6His tag was used. The [6His]-AgrA 
was then purified by a single step nickel affinity chromatography, as in section 2.3.4.1. The 
SDS-PAGE gel shown in Figure 37 contains the samples taken during the purification and 
illustrates that the [6His]-AgrA was eluted from the nickel column at high concentration (See 
Figure 37, lanes 13-14). The most concentrated elution fractions, lanes 13 to 15 were 
collected and dialysed into antibody storage buffer. The total [6His]-AgrA concentration 
obtained was of 1.4 mg and was sufficient to send for antibody production (Eurogentec, see 
section 2.3.6). 
 
Figure 37: Nickel affinity chromatography of [6His]-AgrA. 
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Image of a 12.5% (w/v) SDS-PAGE gel from the nickel affinity purification of [6His]-AgrA. M = Marker, L = 
whole-cell lysate, IS = insoluble fration, S = soluble fraction, FT = flow-through and W = low imidazole wash. 
The molecular weight of the marker is shown in kDa and the migratory position of [6His]-AgrA is indicated with 
an arrow. 
The polyclonal serum of both of the immunised rabbits was tested by Western Blot (section 
2.3.8) in order to select the best candidate for purification. (See Figure 38) 
 
Figure 38: Western blot of rabbits 369 and 370. 
Western blot analysis comparing the affinity of the serum from each rabbit for AgrA. MM = magic marker and L 
= whole cell lysate. The lane number and kDa of the magic marker bands are indicated. 
The serum fron rabbit 370 recognised AgrA in whole cell lysate with high affinity and only 
one band specific for AgrA was detected (See Figure 38, lane 5). Therefore, an aliquot of 
serum from rabbit 370 was purified against pure untagged AgrA, as described in section 
2.3.7. The purified polyclonal antibody against AgrA was tested by Western Blot (as in 
section 2.3.8) and compared to the serum (See Figure 39). The purified antibody displayed a 
cleaner signal than the serum.  
 
Figure 39: Western blot comparing the affinity of the serum and the polyclonal antibody against AgrA for AgrA. 
Western blot analysis comparing the specificity of the serum and the polyclonal antibody against AgrA for 
AgrA. MM = magic marker and L = whole cell lysate. The lane number and kDa of the magic marker bands are 
indicated.  
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3.4. Characterisation of the SH1000- agr operon-deficient strain 
Initially we acquired a mutant S. aureus strain displaying an agr–defective phenotype that we 
were kindly given by Jan Maarten van Dijl from the University of Groningen, Netherlands. 
This strain, called SH1000-, had been phenotypically characterised as lacking haemolytic 
activity and successfully complemented with a plasmid-borne ArgA, suggesting a mutation in 
the agrA gene (Tsompanidou et al, 2011). However, the spontaneous mutation in the agr 
operon responsible for the phenotype had not been identified. Thus, the agrC and agrA genes 
of this strain were sequenced, as they are the mutational hotspots of the operon, and the 
mutation identified by Ellen James. The point mutation at aa H174 in agrA resulted in a non-
synonymous change from a histidine to a leucine residue. This position had been previously 
identified by Sidote et al (Sidote et al, 2008) as important for maintaining the overall 
structure of the protein through salt bridges interactions with two glutamate residues at 
position 226 and 163 (See Figure 40).  
 
Figure 40: Salt bridges between H174, E226 and E163 on the AgrA LytTR domain crystal structure. 
Ribbon representation of the AgrA LytTR domain-DNA complex crystal structure (the LytTR domain and DNA 
are coloured in cyan and grey, respectively). H174, E163 and E226 are highlighted in red, labelled in black and 
the salt bridge interactions indicated by dotted lines. Pymol, PDB 3BS1. 
The growth rate of the mutant strain was tested and compared to that of the WT SH1000 
strain by growth curve in a multiwell plate reader, as in section 2.1.2 (See Figure 41).  
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Figure 41: Growth curve of SH1000 and SH1000
-
. 
Graph showing growth curves (OD600 nm) of the S. aureus SH1000 (blue) and SH1000
-
 (red) strains grown in TSB. 
The black line highlights the 8 h’ time point corresponding to the beginning of the stationary phase for the 
SH1000 strain. Data obtained from three biological replicates.  
The SH1000- strain displayed a different growth pattern consisting of a longer lag phase and 
exponential phase as the cells did not seem to reach stationary phase but kept on growing 
linearly. This growth pattern seems to indicate a deficiency in quorum sensing consistent with 
a defective agrA.  
In order to determine whether the mutant AgrA was stably produced, whole-cell extract from 
the SH1000- strain were tested by Western blotting using the polyclonal antibody raised 
against AgrA and compared with the WT (WT) strain SH1000 (See Figure 42 and section 
3.3).  
 
Figure 42: Western blot of SH1000 and SH1000
-
. 
Western blot analysis comparing the AgrA protein level between the SH1000 and SH1000
-
 strains in whole-cell 
lysates using a polyclonal antibody against AgrA (for full image, see Figure 51). 
The SH1000- mutant AgrAH174L (Figure 42, box 2) was barely detectable when compared 
with WT AgrA from SH1000 (Figure 42, box 1) that was expressed 5 fold higher.  
To assess whether the AgrAH174L mutant retained the ability to activate transcription at the P3 
promoter, the SH1000- strain and the WT SH1000 strain were doted on blood agar plates (See 
Figure 43 and section 2.1.3).  
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Figure 43: Blood agar plate of SH1000 and SH1000
-
. 
Sheep blood agar haemolysis assay comparing the haemolytic activity of the SH1000
-
 and SH1000 strains. Data 
obtained from three biological replicates, representative image shown. 
The production of haemolysins responsible for the characteristic β-haemolysis of blood, 
visible on blood agar plates as a clear halo around the colony in strain SH1000 (See Figure 
43, box 1), is abolished in the absence of AgrA. Therefore and as expected, the SH1000- 
strain (See Figure 43, box 2) produced no such halo when plated on blood agar meaning that 
the mutant AgrAH174L is unable to activate transcription at the P3 promoter. 
After characterising the SH1000- strain we can indeed conclude that it is an agrA deficient 
strain. Moreover, we can hypothesise that the salt bridges interactions between residues 
H174, E226 and E163 in the AgrA LytTR domain are important for maintaining the activity 
of the protein.  
3.5. Development of a method to measure transcription activation at the P3 
promoter by AgrA in vivo 
As shown in the previous section (section 3.4), the ability of AgrA to activate transcription at 
the P3 promoter can be assessed in vivo using blood agar plates. However, this does not target 
the P3 promoter itself but rather the ability of RNAIII to activate transcription of the 
haemolysins, adding an extra regulatory step. In order to look at expression of the P3 
promoter itself directly, a P3-GFP reporter approach was used. The pCL55agr IR P3-GFP reporter 
has been developed and tested previously in the laboratory (See Table 9 and James et al, 
2013). This system enables to quantify the level of activation of the P3 promoter by AgrA 
through GFP readings. Thus, the pCL55agr IR P3-GFP was transduced in the SH1000 and 
SH1000- strains by Ellen James (See Figure 44). 
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Figure 44: Schematic representation of the SH1000
-
agr IR P3-GFP strain. 
Schematic representation of the SH1000
-
agr IR P3-GFP strain (with defective agrAH174L on its chromosome) 
containing the pCL55agr IR P3-GFP reporter inserted ectopically on the chromosome at the geh locus. There are two 
copies of the P3 promoter, one at the geh locus and one at the agr operon. The agrA gene of the SH1000-agr IR P3-
GFP strain bears the H174L mutation. 
 Both strains were then used in growth curves in triplicates using a multiwell plate reader 
(See section 2.1.2) for 17 h, and the OD600 nm and the GFP fluorescence units (GFP-Fluo) 
were measured every 30 min. To take into account the differences in growth rates, the GFP 
readings were normalised according to the OD600 nm (See Figure 45).  
 
Figure 45: GFP growth curve of SH1000agr IR P3-GFP and SH1000
-
agr IR P3-GFP. 
Graph showing GFP expression [as GFP fluorescence units (GFP-Fluo)] as a function of growth (OD600 nm) over 
time for the S. aureus SH1000agr IR P3-GFP (blue) and SH1000
-
agr IR P3-GFP (red) strains grown in TSB. The black line 
highlights the 8 h’ time point corresponding to the early stationary phase for the SH1000agr IR P3-GFP strain. Data 
obtained from three biological replicates. 
As expected from the results obtained in section 3.4, the SH1000agr IR P3-GFP strain displayed 
increasing GFP fluorescence over time as AgrA was able to activate transcription at the P3 
promoter leading to the production of GFP. On the contrary, SH1000- agr IR P3-GFP displayed a 
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constant low level of fluorescence illustrating that AgrAH174L is unable to activate 
transcription at the P3 promoter. The 8 h’ time point, highlighted in Figure 45, was taken as a 
representative time point as it is the beginning of stationary phase (See Figure 41) and 
provides a simplified representation of the results. From here onwards, the GFP growth 
curves will be represented as bar charts displaying the 8 h’ time point (See Figure 46). 
 
Figure 46: Bar chart of SH1000agr IR P3-GFP (blue) and SH1000
-
agr IR P3-GFP (red). 
Graph showing GFP expression [as GFP fluorescence units (GFP-Fluo)] as a function of growth (OD600 nm) for the 
S. aureus SH1000agr IR P3-GFP and SH1000
-
agr IR P3-GFP strains grown in TSB for 8 h. Data obtained from three 
biological replicates. 
3.6. Complementation of the SH1000-agr IR P3-GFP agrA-deficient strain 
In section 3.5, the pCL55agr IR P3-GFP reporter was used successfully to illustrate the differences 
in P3 transcription between a strain containing a functional AgrA (SH1000 agr IR P3-GFP) and 
one with a defective one (SH1000- agr IR P3-GFP). However, this was a clear cut result which 
does not give much indication about the sensitivity of the system and its ability to detect 
subtle variations in transcription activation. Therefore, the SH1000-agr IR P3-GFP was 
complemented using two different constructs in the high copy number shuttle vector, pCN34 
(Charpentier et al, 2004). As mentioned in section 3.1.1, Tsompanidou et al attempted to 
complement the SH1000- strain but only achieved a weak complementation because they 
were using a P1 driven agrA. We decided to try to complement using two different 
constructs: pSN:agrC832-1261-agrA containing agrA upstream of the 3’ end of agrC 
(424bp) including the P1 promoter (See Figure 34) and pSN-P2-agrA, containing agrA under 
the control of the P2 promoter, the agr intergenic region (IR) and a strong Shine-Dalgarno 
sequence. The pSN-P2-agrAH174L was also constructed to assess whether the overexpression 
of the mutant AgrAH174L could lead to some activity. The SH1000
-
agr IR P3-GFP strain was 
transformed with all three constructs and their ability to complement the strain was assessed 
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by GFP growth curves (See Figure 47). The SH1000-agr IR P3-GFP and SH1000agr IR P3-GFP strains 
were also transformed with the empty pCN34 vector, pSN-P2-empty as a control.  
 
Figure 47: Bar chart of the different SH1000
-
agr IR P3-GFP complementations. 
Graph showing GFP expression [as GFP fluorescence units (GFP-Fluo)] as a function of growth (OD600 nm) for the 
S. aureus strains SH1000agr IR P3-GFP + pSN-P2-empty (blue), SH1000
-
agr IR P3-GFP + pSN-P2-empty (red), SH1000
-
agr IR 
P3-GFP + pSN:agrC832-1261-agrA (green), SH1000
-
agr IR P3-GFP + pSN-P2-agrA (purple)and SH1000
-
agr IR P3-GFP + pSN-
P2-agrAH174L (orange) grown in TSB for 8 h. Data obtained from three biological replicates. 
The complementation with the pSN:agrC832-1261-agrA was weak, displaying only a 3-fold 
increase compared to the negative control and over 10-fold less transcription than the pSN-
P2-agrA construct. This is not surprising as P1 driven AgrA was never shown to fully 
complement (see section 3.1.1). However, as expected, the pSN-P2-agrA construct was able 
to fully complement, displaying an even higher level of fluorescence than the WT strain 
SH1000agr IR P3-GFP with the pSN-P2-empty. This is due to the fact that AgrA is overexpressed 
on a high copy number plasmid, hence giving a higher signal because there are 25-30 
additional agrA copies in the cell. But it is also an indication that in the SH1000agr IR P3-GFP 
strain, the system is not saturated; more AgrA can lead to more transcription. In addition, it 
indicates that the chromosomal copy of agrAH174L present in the SH1000
- strain does not act 
as a sink for the phosphates transferred by AgrC to activate AgrA. The pSN-P2-agrAH174L 
complementation displays more or less the same signal as the SH1000-agr IR P3-GFP strain with 
the pSN-P2-empty. This illustrates that even when overexpressed, AgrAH174L remains non-
functional. For a clearer comparison, the activity of each strain was calculated compared to 
the SH1000-agr IR P3-GFP with pSN-P2-agrA set at 100% activity (See Figure 48). From now on, 
the GFP growth curves will be presented in comparison to the pSN-P2-agrA 
complementation, “WT” set at 100%. 
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Figure 48: Bar chart of the different SH1000
-
agr IR P3-GFP complementations compared to the pSN-P2-agrA 
complementation. 
Graph showing GFP expression [as GFP fluorescence units (GFP-Fluo)] as a function of growth (OD600 nm) for the 
S. aureus strains SH1000agr IR P3-GFP + pSN-P2-empty (blue), SH1000
-
agr IR P3-GFP + pSN-P2-empty (red), SH1000
-
agr IR 
P3-GFP + pSN:agrC832-1261-agrA (green) and SH1000
-
agr IR P3-GFP + pSN-P2-agrAH174L (orange) compared to 
SH1000
-
agr IR P3-GFP + pSN-P2-agrA (purple) set at 100%, grown in TSB for 8 h. Data obtained from three biological 
replicates. 
The results obtained with the GFP growth curves were confirmed using blood agar plates and 
by western blot (See Figure 49, Figure 50 and Figure 51). 
The result of the blood agar plate experiment was consistent with that of the GFP growth 
curves (See Figure 49). The SH1000-agr IR P3-GFP strain with the pSN-P2-empty or with the 
pSN-P2-agrAH174L produced no sign of haemolysis. The SH1000
-
agr IR P3-GFP strain with the 
pSN:agrC832-1261-agrA showed signs of weak haemolysis, which was only visible after 
incubation at 4°C, indicating that β-haemolysin was most likely responsible for the faint halo 
surrounding the colony (See section 3.1.2). The SH1000-agr IR P3-GFP with pSN-P2-agrA and 
SH1000agr IR P3-GFP strain with the pSN-P2-empty strains were both highly haemolytic, as 
expected. 
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Figure 49: Blood agar plate complementation SH1000
-
agr IR P3-GFP. 
Sheep blood agar haemolysis assay comparing the haemolytic activity of the for the S. aureus strains SH1000agr 
IR P3-GFP + pSN-P2-empty, SH1000
-
agr IR P3-GFP + pSN-P2-empty, SH1000
-
agr IR P3-GFP + pSN:agrC832-1261-agrA, 
SH1000
-
agr IR P3-GFP + pSN-P2-agrAH174L and SH1000
-
agr IR P3-GFP + pSN-P2-agrA . Data obtained from three biological 
replicates, representative image shown. 
The western blot was performed using whole-cell lysate of each strain and without adding 
human immunoglobulin (HIgG). HIgG is routinely added when performing western blots 
(See 2.3.8) in S. aureus to prevent the staphylococcal immunoglobulin binding proteins Spa 
(protein A) and Sbi from binding to the antibodies and giving background signal. However, 
this step is not necessary when working with strains producing functional AgrA as both Spa 
and Sbi are negatively regulated by the agr operon (see section 1.5.6). Thus, in the SH1000agr 
IR P3-GFP strain with the pSN-P2-empty and the SH1000
-
agr IR P3-GFP with pSN-P2-agrA strain 
that are both producing a functional AgrA there was no sign of IgG binding proteins and only 
one band specific for AgrA was detected (see Figure 50, lanes 3 and 4). However, in the 
SH1000-agr IR P3-GFP strain with the pSN-P2-empty or with the pSN-P2-agrAH174L and in the 
SH1000-agr IR P3-GFP strain with the pSN:agrC832-1261-agrA , no specific band for AgrA could 
be distinguished. Instead there was a variety of bands of different sizes, ranging from 40 to 25 
kDa, most likely corresponding to degradation products from Spa and Sbi (See Figure 50, 
lanes 3, 5 and 6). The band pattern observed for these three strains was similar to that of 
RN4220, which also contains a dysfunctional AgrA and cannot inhibit the IgG binding 
proteins (See Figure 50, lane 7 and section 1.5.6). This is yet another confirmation that 
neither the pSN-P2-agrAH174L or the pSN:agrC832-1261-agrA were not able to fully 
complement AgrA activity. 
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Figure 50: Western blot of SH1000
-
agr IR P3-GFP complementation, without HIgG.  
Western blot analysis comparing the AgrA protein level in the S. aureus strains SH1000agr IR P3-GFP + pSN-P2-
empty, SH1000
-
agr IR P3-GFP + pSN-P2-empty, SH1000
-
agr IR P3-GFP + pSN:agrC832-1261-agrA, SH1000
-
agr IR P3-GFP + pSN-
P2-agrAH174L, SH1000
-
agr IR P3-GFP + pSN-P2-agrA and RN4220. MM = magic marker. The lane number and kDA of 
the magic marker bands are indicated. 
Another western blot was then performed using whole-cell lysate of each strain and in 
presence of HIgG and therefore no contaminating band was detected for any strains (See 
Figure 51). A faint band corresponding to AgrAH174L was detected for SH1000
-
agr IR P3-GFP 
strain with the pSN-P2-empty (See Figure 51, lane 2), a bigger band was detected in 
SH1000agr IR P3-GFP strain with the pSN-P2-empty (See Figure 51, lane 4). In SH1000
-
agr IR P3-
GFP with pSN-P2-agrA, a very strong band was detected (See Figure 51, lane 1) and no protein 
was detectable in the agr operon deletion strain SH1001 agr IR P3-GFP (See Figure 51, lane 3).  
 
Figure 51: Western blot of SH1000
-
agr IR P3-GFP complementation, with HIgG.  
Western blot analysis comparing the AgrA protein level in the S. aureus strains SH1000
-
agr IR P3-GFP + pSN-P2-
agrA, SH1000
-
agr IR P3-GFP + pSN-P2-empty, SH10001agr IR P3-GFP + pSN-P2-empty and SH1000agr IR P3-GFP + pSN-P2-
empty. The lane number are indicated. 
3.7. Conclusion 
The main objective of this section was to set up an in vivo experimental system to study the 
activation of transcription by AgrA. 
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A polyclonal rabbit antibody specific for AgrA was synthesised and purified. It is highly 
specific for AgrA and highly sensitive, opening a number of downstream applications to 
detect AgrA efficiently in whole cell lysates.  
The choice of a suitable S. aureus strain to study AgrA is not an easy task. Many strains 
contain mutations in AgrA or have an altered agr regulon due to mutations in genes involved 
in the regulation of the operon. SH1000 (See Table 8) was our strain of choice as it is rbsU 
cured and contains a functional agr operon. We characterised the SH1000- (See Table 8) 
strain, and have illustrated that it seems to be very close to its parental strain, SH1000, but 
contains a mutation in AgrA that renders the protein non-functional. This strain can be easily 
complemented with a plasmid borne AgrA which makes it an ideal strain for our in vivo set-
up. Furthermore, we have identified a new naturally occurring mutation that leads to 
inactivation of AgrA. Such mutations are frequently observed in the laboratory and clinical 
settings and will be discussed further in the next chapter (See section 4.1) 
The GFP-reporter system described in this chapter was shown to be suitable to measure 
transcription activation by AgrA at the P3 promoter in the SH1000- agr IR P3-GFP strain and the 
results were confirmed by other standard methods. The reporter system has proved to be a 
better system to look at P3 activation by AgrA as it gives a direct read-out and is highly 
quantitative, enabling the detection of subtle differences. It is also more sensitive than the 
traditional methods used such as blood agar plates. 
The SH1000-agr IR P3-GFP strain was successfully complemented with pSN-P2-agrA. The 
complemented strain was able to activated the P3 promoter at a level even higher than the 
SH1000agr IR P3-GFP with pSN-P2-empty strain, displayed an haemolytic activity on blood agar 
plates slightly higher than SH1000agr IR P3-GFP with pSN-P2-empty, was able to inhibit the 
production of the staphylococcal immunoglobulin binding proteins Spa and Sbi and was 
produced at a much higher level than SH1000agr IR P3-GFP with pSN-P2-empty as detected by 
western blotting experiments. In fact, there is a much bigger difference in protein level 
between the complemented strain and the WT SH1000agr IR P3-GFP with pSN-P2-empty strain 
than the one observed with the GFP fluorescence or the blood agar plates. This is due to the 
fact that the protein level does not directly correlate with the activity. AgrA needs to be 
activated by AgrC in order to activate transcription. Therefore, AgrC is the limiting factor in 
this equation and AgrC is produced at WT level, not overexpressed. Thus, most of the AgrA 
protein detected by western blot is probably inactive because it cannot be phosphorylated by 
AgrC because the AgrC/AgrA ratio is skewed.  
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 It was also shown that the use of a P1 driven AgrA is a very weak way to complement for 
AgrA activity as it produces a very weak activation of the P3 promoter, hence low haemolytic 
activity, is barely detectable by western blot and unable to inhibit the production of the 
staphylococcal immunoglobulin binding proteins. Both of the putative P1 promoters (P1A 
further upstream and P1B just upstream of agrA, See Figure 34) have a poor conservation of 
the -35 promoter element which could be somewhat complemented by the fact that they both 
have an extended -10 promoter element. The P1A -10 promoter element has a good 
conservation (5/6) with a change at position -9 which is not too bad in term of activity. The 
P1B -10 promoter element has a poor conservation (4/6) with a change at position -12 which 
often leads to a decreased activity (See Figure 52 and sections 1.1.1 and 1.1.3) (Moyle et al, 
1991). The P1A is the most likely P1 promoter, based on this analysis. Nevertheless, both 
putative P1 promoters are weaker than the P2 and P3 promoter in terms of conservation of the 
-10 and -35 promoter elements which correlates with the observed phenotype. Thus, this 
proves furthermore that the P2 promoter is the “true” AgrA promoter and therefore should be 
used to fully complement AgrA activity. However, we cannot exclude that the massive 
difference observed between the P1 and P2 driven AgrA is partially be due to the SD. The 
pSN:agrC832-1261-agrA plasmid contains the normal SD located in the 3’ end of agrC 
immediately upstream of agrA. There are a few putative SD in that region; hence we did not 
know which one was the one used. Therefore, in the pSN-P2-agrA plasmid we did not use the 
natural AgrA SD but a SD optimised for S. aureus. However, the result showing a weak 
activation of the P1 driven AgrA is consistent with the belief that P1 is responsible for the 
production of a basal low level of AgrA (Novick, 2003). 
 
Figure 52: Conservation of the -35 and -10 of the agr promoters.  
Sequence of the -10 and -35 promoter elements of the putative P1 promoters (P1A and P1B), the P2 and P3 
promoters. -35 refers to the -35 element (5’-TTGACA-3’) and -10 refers to the -10 element (5’-TATAAT-3’). 
Extended -10 refers to the extended -10 element, T at -15 and G at -14. The nucleotides that can vary from the 
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consensus sequence without affecting promoter activity drastically and are thus less conserved are underlined 
in black. The nucleotides that differ from the consensus promoter elements are highlighted in yellow. The 
presence or absence of an extended -10 motif is indicated. 
Overall, this chapter describes how an in vivo system to study transcription activation by 
AgrA was successfully set-up, combining all the tools developed in this section. This system 
will be very useful to help unravelling the mechanism of transcription activation by AgrA. 
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CHAPTER FOUR 
4. Construction, screening and characterisation of a library of single 
alanine mutants in the AgrA LytTR domain 
4.1. Introduction 
Not much is known about the AgrA LytTR domain responsible for the DNA-binding activity 
of AgrA in terms of individual aa contributions. When Sidote et al reported the crystal 
structure of the isolated AgrA LytTR domain in 2008, the knowledge of the field was 
significantly increased (Sidote et al, 2008). The structure is that of the isolated AgrA LytTR 
domain in complex with a pentadecamer DNA duplex containing the 9 bp consensus binding 
sequence for AgrA based on the P2 AgrA binding site. 
The AgrA LytTR domain presents an unusual fold consisting mainly of beta strands. It adopts 
a 10-stranded β-fold which consists of two duplicated 5-stranded β motifs (β1-β5, β6-β10) 
and contains a short two-turn α-helix (See Figure 53).  
 
Figure 53: Secondary structure of the AgrA LytTR domain with amino acid (aa) sequence.  
The 10 β-strands are coloured in cyan and numbered from 1 to 10. The α-helix is coloured in red and labelled 
α1 and the three turns are represented by red boxes in the schematic and highlighted in red in the aa 
sequence. The three residues involved in direct interaction with the DNA are highlighted in magenta. Adapted 
from (Sidote et al, 2008). 
The crystal structure reveals that the AgrA LytTR domain binds to the DNA via three loops 
that insert into two subsequent major grooves and the minor groove separating them. Three 
residues located in these loops make direct contact with the DNA and two of them are 
essential in order for the protein to be able to bind DNA (See Figure 53 and Figure 54, in 
magenta). 
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Figure 54: Crystal structure of the AgrA LytTR domain with the three residues directly interacting with the DNA.  
Ribbon representation of the AgrA LytTR domain-DNA complex crystal structure. The 10 β-strands are coloured 
in cyan, the α-helix and the three turns are coloured in red and the DNA in grey. The three residues making 
direct contact with the DNA are coloured in magenta, displayed as sticks and labelled in black. The N- and C-
terminal ends of the structure are indicated in black. Pymol, PDB 3BS1. 
The first essential residue is a histidine located at position 169 (H169), in the loop between 
β3 and β4 (see Figure 53, in magenta), and inserts in a major groove of the DNA (see Figure 
54, in magenta). The second essential residue is an arginine located at position 233 (R233A), 
in the loop between β10 and the C-terminal end of the protein (See Figure 53, in magenta), 
and inserts in a major groove of the DNA (See Figure 54, in magenta). If H169 or R233 are 
mutated into an alanine, the protein is no longer able to interact with the DNA. Hence H169 
and R233 are essential for the DNA-binding activity of the protein. The third residue making 
direct contact with the DNA is an asparagine located at position 201 (N201), in the loop 
between β6 and β7 (See Figure 53, in magenta) and inserting in a minor groove of the DNA 
(See Figure 54). If this residue is mutated into an alanine, the affinity of protein for the DNA 
is drastically reduced. Therefore N201 is thought to stabilise the interaction between AgrA 
and the DNA backbone.  
Fourteen other residues located on the face of AgrA proximal to the DNA make indirect 
contact with the DNA (See Figure 55, in green). 
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Figure 55: Crystal structure and amino acid (aa) sequence of the AgrA LytTR domain with all the residues 
making contact with the DNA.  
Ribbon representation of the AgrA LytTR domain-DNA complex crystal structure. The 10 β-strands are coloured 
in cyan, the α-helix and the three turns are coloured in red and the DNA in grey. The three residues making 
direct contact with the DNA are coloured in magenta, displayed as sticks and labelled in black. The fourteen 
residues making indirect contact with the DNA are coloured in green and displayed as sticks. The N- and C-
terminal ends of the structure are indicated in black. Pymol, PDB 3BS1. 
 As mentioned in section 1.5.5, upon binding by AgrA, the DNA bends to conform to the 
surface of the protein, creating a bend of approximately 38°. This bend is thought to be 
important for the transcription activation function of AgrA. 
AgrA is predominantly negatively charged with the majority of the positively charged 
residues located along the DNA-binding surface of the protein. 
The structural integrity of the protein is maintained through eight salt bridges interactions 
involving ten different aa residues (See Figure 56 and Table 11). One residue, R218, is 
involved in four different salt bridges interactions. The histidine responsible for the agrA 
minus phenotype of the SH1000- strain, H174, is involved in two salt bridges interactions 
with E163 and E226 (See Figure 40 and section 3.4) (Sidote et al, 2008).  
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Figure 56: Crystal Structure of the AgrA LytTR domain with the salt bridges interactions. 
Ribbon representation of the AgrA LytTR domain. The LytTR domain is coloured in cyan. The ten residues 
involved in salt bridges interactions are displayed as sticks and coloured according to their charge. The 
positively charged residues are coloured in red and the negatively charged residues in blue. The eight salt 
bridges interactions are represented by yellow dotted lines and numbered from 1 to 8. Pymol, PDB 3BS1. 
Adapted from (Sidote et al, 2008). 
 
Table 11: Salt bridges interactions. 
List of the salt bridges interactions maintaining the structural integrity of the AgrA LytTR domain. The table 
contains the name of each of the residues involved (the positive (pos.) partner and the negative (neg.) partner) 
and the two regions stabilised by their interaction. 
Two cysteine residues, C199 and C228 are involved in resistance to oxidative stress. Under 
reducing conditions, AgrA binds to the promoter of the bsaA gene (encoding the glutathione 
peroxidase essential for survival under oxidative stress) thereby repressing it. Under oxidative 
stress, a disulphide bond is created between C199 and C228 leading to the dissociation of 
AgrA from the bsaA promoter. Therefore the bsaA gene is no longer repressed enabling the 
bacteria to adapt its behaviour to the oxidative stress. In any of the two cysteine residues is 
mutated into a serine, the disulphide bond cannot be formed and the bsaA gene gene is 
repressed by AgrA under any conditions. This leads to an increase susceptibility to oxidative 
stress (See section 1.5.5.4). Furthermore, if C228 is mutated into a serine, the mutated 
AgrAC228S lacks haemolytic activity which is indicative of an agrA- phenotype (See section 
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3.1.2). Thus this residue is thought to be essential for the correct folding of the protein. To the 
contrary, if C199 is mutated into a serine, the AgrAC199S mutant displays a hyperactive 
haemolytic activity compared to WT AgrA (Sun et al, 2012b). 
Spontaneous mutations in the agr operon resulting in a non-haemolytic phenotype occur very 
frequently in a laboratory setting but also in clinical isolates. The historical S. aureus 
laboratory strain RN4220 (See Table 8) is a nitrosoguanidine-induced mutant able to accept 
foreign non-staphylococcal DNA and an example of such mutations. RN4220 presents a non-
haemolytic phenotype which is due to a frameshift mutation at the C-terminal end of the 
AgrA LytTR domain. An additional adenine is added to the stretch of seven adenines at the 
C-terminal end of AgrA (aa 236-238, See Figure 57) creating a frameshift resulting in a 
protein with three additional aa. This agrA 8A is defective and creates a delay in RNAIII 
production which in turns leads to failure to translate α and δ haemolysins (Traber & Novick, 
2006). The agrA 8A was also observed in clinical isolated along other naturally occurring 
mutations targeting the same adenine stretch (Traber et al, 2008). This adenine stretch is 
conserved in all published S. aureus genomes except for the strains Mu3 and Mu50. These 
strains contain two additional adenines which results in a non-synonymous mutation 
changing isoleucine 238 into a lysine in agrA 9A (See Figure 57). This AgrA is however fully 
functional (Traber & Novick, 2006). Another spontaneous mutation observed in clinical 
isolates targeting the same adenine stretch presents a much more drastic effect. If an adenine 
is removed, the resulting frameshift lengthens the protein by 21 aa (See Figure 57) and the 
agrA 6A is completely inactive (Traber & Novick, 2006; Traber et al, 2008). Similarly, 
another mutation observed in clinical isolates consists of an agrA shortened by one aa 
residue. Lysine 238 is mutated into a stop codon and the resulting agrA is non-haemolytic 
(Shopsin et al, 2010).The C-terminal end of AgrA therefore seems to be a hotspot for 
mutations conferring an agr- phenotype. 
 
Figure 57: C-terminal agrA variants.  
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C-terminal end of the DNA sequence of the two non-haemolytic variants of agrA (8A and 6A) compared to the 
WT (7A) and the 9A variant. The stretch of As containing the mutations is highlighted in yellow. The amino acid 
are indicated and numbered in red. Adapted from (Traber & Novick, 2006). 
A number of other mutations present in clinical isolates have been reported as agrA is the 
mutational hotspot of the operon, together with the 3’ end of agrC. These mutations consist 
of frameshift insertions/deletions, nonsense mutations and non-synonymous changes 
resulting in a non-haemolytic phenotype. Most of them are located into the AgrA LytTR 
domain (Shopsin et al, 2010). Only the five non-synonymous mutations identified will be 
mentioned here, as they are indicative of aa residues important for the function of the AgrA 
protein. They consist of V140A, V140K, L171F, L186I and R218H. Each of these single aa 
mutations is sufficient to render the protein inactive and therefore suggests that these aa are 
essential for the normal function of the protein. Note that residues L186 and R218 are 
involved in indirect interaction with the DNA (See Figure 55, in green).  
The C-terminal loop of AgrA contains a hydrophobic cleft to which fragment compounds can 
bind leading to inhibition the DNA-binding ability of the protein. This region contains the aa 
residues S231, V232, R233, N234, K236, K237 and I238 (Leonard et al, 2012). This loop is 
important for the DNA-binding activity of the protein as residue R233 is essential for the 
DNA-binding activity of the protein and residues S231, V232 and N234 make indirect 
contact with the DNA (See Figure 55). In addition, mutations in that region result in partially 
deficient or complete lack of activity of the protein (See Figure 57). That region had been 
identified as a putative DNA-binding region because of its hydrophobic nature in the first 
report about the LytTR domain (See section 1.3.2.1) (Nikolskaya & Galperin, 2002). 
Very recently, a small molecule inhibitor able to selectively target AgrA in S. aureus was 
identified. This inhibitor, called savirin, inhibits the activation of the P3 promoter and the 
production of RNAIII by AgrA. It also inhibits the DNA-binding activity of the AgrA LytTR 
domain.  
The docking region for savirin was identified as the region between R218 on β9 and Y229 on 
β10 (See Figure 53 and Figure 58). Residues E217 and Y229 are within interaction distance 
(Sully et al, 2014).  
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Figure 58: Savirin binding site. 
In silico docking of savirin to the AgrA LytTR domain. Savirin is represented by yellow sticks. The residues in the 
close vicinity are annotated and displayed as sticks (Sully et al, 2014).  
The savirin docking region contains C228, involved is disulphide bond and important for 
AgrA folding (See above) and R218 which is involved in indirect interaction with the DNA 
(See Figure 55) and important for the activity of the protein (see above). This region therefore 
seems to be important for the activity of AgrA. 
The most conserved motif found in LytTR domain containing transcription factor is the 
FhRhH[RK][SNQ]hhVN motif (h corresponds to hydrophobic residues, see Figure 59 and 
section 1.3.2.1) (Nikolskaya & Galperin, 2002) spanning from aa residues 196 to 206 and 
corresponding to FFRCHNSFVVN in AgrA (See Figure 60). This motif contains the aa N201 
involved in direct interaction with the DNA (See Figure 53 and Figure 54), the aa R198 and 
S202 making indirect contact with the DNA (See Figure 53 and Figure 54) and C199 
involved in disulphide bond under oxidative stress (see above).  
 
Figure 59: Clustal alignment LytTR domain containing transcription factors (LDCTFs). 
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Multiple sequence alignment of the amino acid (aa) sequence of the LytTR domain of forty-three 
representative LDCTFs. Aa residues with similar properties have similar colour (See legend). Conserved aa are 
represented by a dot. The FhRhH[RK][SNQ]hhVN motif is highlighted in yellow and the S[RK][RK][RKHY] 
motif in orange. 
 
Figure 60: Secondary structure and amino acid sequence of the AgrA LytTR domain with FFRCHNSFVVN motif. 
The 10 β-strands are coloured in cyan and numbered from 1 to 10. The α-helix is coloured in red and labelled 
α1 and the three turns are represented by red boxes in the cartoon and highlighted in red in the aa sequence. 
The FFRCHNSFVVN motif is highlighted in green and the residue N201 making direct contact with the DNA is 
highlighted in magenta in the schematic. Adapted from (Sidote et al, 2008). 
In addition, this motif (FFRCHTSYIVN in the LDCTF VirR from Clostridium perfringens) has 
been shown to be involved in the DNA-binding activity of VirR and to be essential for the 
activity of the protein. Residues R186, H188 and S190 from VirR (corresponding to R198, 
H200 and S202 from AgrA, See Figure 61) have been shown to be essential for the activity of 
the protein and R186 and S190 to be involved in DNA-binding. Residues L179, F184, N194 
and L195 (corresponding to D193, F196, N206 and R207 in AgrA, See Figure 61) are also 
essential for the activity of the VirR protein. Residues E176, F185 and I198 (corresponding to 
S190, F197 and I210 in AgrA, See Figure 61) are important for the activity of the VirR 
protein but are not essential (McGowan et al, 2002). The wide conservation of this motif 
among LDCTFs suggests that the corresponding residues in S. aureus AgrA could assume a 
similar function. 
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Figure 61: Clustal alignment of AgrA with VirR from Clostridum perfringens. 
Amino acid (aa) sequence alignment of the LytTR domain of AgrA and VirR. The conserved aa are indicated by 
a dot. The number corresponding to each aa is indicated above for AgrA and below for VirR. 
Another motif conserved among most LDCTFs, S[RK][RK][RKHY] (See Figure 59) was 
characterised in VirR. The SKHR motif from VirR (aa 216-219) corresponds to the SVRN 
motif in AgrA (aa 231-234, see Figure 61). Each residue of the motif is essential for the 
activity of the VirR protein. Residue M172 (L186 in AgrA, see Figure 61) was also identified 
as being required for the biological activity of VirR. Residues M172, and H218 are involved 
the in the DNA-binding activity of the protein and residues S216, K217 and R219 are 
essential for the DNA-binding activity of VirR (See Figure 61) (McGowan et al, 2003). This 
motif seems to assume a similar function in AgrA. R233A is essential for the DNA-binding 
activity of the protein and S231, V232 and N234 make indirect contact with the DNA (See 
Figure 54 and Figure 55) and all are part of the hydrophobic region important for the DNA-
binding activity of the protein (See above). 
All the residues involved in DNA-binding in VirR have already been identified as being 
involved in DNA-binding in AgrA as well. Therefore the DNA-binding mode could very well 
be conserved among LDCTFs. 
In summary, the knowledge of the AgrA LytTR domain individual aa contributions is limited 
to DNA-binding and structural (salt bridges) roles and nothing is known about potential aa 
involved in transcription activation. 
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4.2. Objectives 
The objective of this section was to try to elucidate the individual contribution of the aa 
residues in AgrA LytTR domain to the transcription activation function of the protein. To this 
aim the specific section involved:  
I. Selection of the aa residues to mutate in the AgrA LytTR domain 
II. Construction of a single alanine mutant library in the AgrA LytTR domain 
III. Scanning of the alanine mutant library in the SH1000-agr IR P3-GFP strain 
IV. In vivo characterisation of a selection of single alanine mutants in the AgrA LytTR 
domain 
V. Synonymous and non-synonymous mutations at selected residues in the AgrA LytTR 
domain 
4.3.  Selection of the amino acid residues to mutate in the AgrA LytTR domain 
The AgrA LytTR contains 101 aa residues, 29 of which have an assigned function (See 
Figure 62). The remaining 70% of the aa of the AgrA LytTR domain have no assigned 
function. In order to try to elucidate the function of the residues with unknown function and 
hoping to unravel aa involved in the transcription activation function of AgrA we decided to 
target all these residues for alanine mutagenesis. A few residues with known function were 
selected as well. One residue essential for binding the DNA (R233),three residues involved in 
salt bridges interactions (H218, K223, H174 [mutated into a leucine, like in the SH1000- 
strain, See section 3.6]), three residues making indirect contact with the DNA (R198, S202, 
R218) and the two cysteine residues involved in disulphide bond formation (changed into 
serine residues). This led to a library of 81 mutants to construct by Site Directed Mutagenesis 
(SDM) (See Figure 62).  
 
Figure 62: List of residues targeted by Site Directed Mutagenesis 
Amino acids (aa) sequence of the AgrA LytTR domain. In the first line, the residues that were targeted for SDM 
that are coloured in red. In the second line, the residues with a known function are coloured according to that 
function (See key).  
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4.4. Construction of a single alanine mutant library in the AgrA LytTR domain 
The alanine library was constructed by Site Directed Mutagenesis (SDM) using the pSN-P2-
agrA plasmid as a template, as described in Section 2.2.8 and in Figure 63 with the primers 
listed in Table 15, Table 16 and Table 17.  
 
Figure 63: SDM library construction.  
Flow-chart describing how the S. aureus single alanine mutant library was constructed. In the pSN-P2-agrA 
plasmid, agrA is under the control of the P2 promoter and the agr intergenic region (IR).  
4.5. Scanning of the alanine mutant library in the SH1000-agr IR P3-GFP strain 
The SH1000- agr IR P3-GFP strain was transformed with each of the 81 mutants and their ability 
to complement for AgrA activity was tested by GFP growth curve using a plate reader (See 
Section 2.1.2 and Section 3.6). As described in Section 3.6, the GFP activity for each mutant 
is calculated according to the growth (GFP-Fluo/OD600 nm) after 8 h of growth and is 
displayed compared to the WT complementation with pSN-P2-agrA set at 100%. Three 
controls were included: SH1000- agr IR P3-GFP + pSN-P2-agrAH174L (H174L), SH1000
- 
agr IR P3-
GFP + pSN-P2-empty (SH
-) and SH1000- agr IR P3-GFP + pSN-P2-agrA (WT).
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Figure 64: Systematic mutational analysis of the AgrA LytTR domain. 
Graph showing GFP expression [as GFP fluorescence units (GFP-Fluo)] as a function of growth (OD600 nm) relative to the SH1000
-
 agr IR P3-GFP + pSN-P2-agrA for each of the 81 
mutant after 8 h of growth in TSB. AgrA mutants displaying more than 60% activity compared to the WT AgrA are shown in white, the AgrA mutants displaying between 20 
and 60% activity compared to the WT AgrA are shown in light grey, the AgrA mutants displaying less than 20% activity compared to the WT AgrA are shown in dark grey 
and the controls (SH1000
-
agr IR P3-GFP + pSN-P2-agrAH174L, SH1000
-
agr IR P3-GFP + pSN-P2-empty and SH1000
-
agr IR P3-GFP + pSN-P2-agrA) are shown in white with black stripes. Data 
obtained from at least three biological replicate.
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Figure 65: Position of the mutants of category 1 on the structure.  
Ribbon representation of the AgrA LytTR domain-DNA complex crystal structure. The AgrA LytTR domain is 
coloured in cyan and the DNA in grey. The fourteen residues that display less than 20% activity compared to 
the WT when mutated to alanine are displayed as sticks, coloured in black and labelled in black. Pymol, PDB 
3BS1. 
 
 
Figure 66: Position of the mutants of category 2 on the structure.  
Ribbon representation of the AgrA LytTR domain-DNA complex crystal structure. The AgrA LytTR domain is 
coloured in cyan and the DNA in grey. The eleven residues that display less between 20 and 60% activity 
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compared to the WT when mutated to alanine are displayed as sticks, coloured in grey and labelled in black. 
Pymol, PDB 3BS1. 
The mutants displayed a wide range of activities and were separated into three activity 
categories. The first activity category contained the fourteen mutants the most drastically 
affected and displaying less than 20% activity compared to the WT (in dark grey in Figure 
64). The second activity category contained the eleven mutants displaying between 20 and 
60% activity compared to the WT (in light grey in Figure 64). The position on the structure of 
the AgrA LytTR domain of the residues belonging to the first and second category is 
illustrated in Figure 65 and Figure 66, respectively. The third activity category contained the 
fifty-five mutants displaying more than 50% activity compared to the WT (in white in Figure 
64). The third category was not investigated further as the attention was focused on the two 
remaining groups. The aim of the screen was to identify putative transcription activation 
defective (TAD) mutants and it seemed unlikely that such mutants would retain more than 
60% activity in vivo. 
 However, a few residues are worth mentioning as they have been discussed above. For 
example, the C199S mutation has been described as hyperactively haemolytic which does not 
seem to be the case here as it displays 90% activity compared to the WT. The two residues 
involved in salt bridges interactions H208 and K223 (See Figure 56) do not appear to be 
essential to maintain the structural integrity of the protein as H2008A and K233A both 
display 82% activity compared to the WT. The C-terminal end residues of AgrA V235,K236, 
K237 and I238 part of the hydrophobic cleft do not seem to be affected by the change to 
alanine as they display 103%, 110%, 100% and 80% activity, respectively. Maybe replacing 
these residues with hydrophilic residues would have a more drastic effect. So even if this 
region has been reported to be a hotspot for mutations inactivating AgrA (See Figure 57), this 
is not reflected in this screen.  
The mutation V140A was observed in clinical isolates and resulted in an agrA- phenotype. 
However, in this screen it displayed 70% activity. 
4.6. In vivo characterisation of a selection of single alanine mutants in the AgrA LytTR 
domain 
The mutants for the first and the second category (See Figure 64) were selected for further 
analysis aiming to identify potential TAD mutants. C228 was excluded as it has a known 
function in oxidation sensing (See section 4.1). It can be mentioned that this residue was 
thought to be essential for the folding of AgrA as the C228S mutation was observed to be 
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non-haemolytic. However, in this screen this mutant displays 47% activity which means it 
would still be partially haemolytic. 
 In order to exclude the possibility that the TAD property is caused by effects on protein 
stability by the mutation in question, we aimed to determine whether the 25 putative TAD 
AgrA mutants were produced at level similar to WT AgrA under the assay conditions. To 
investigate this, the 25 putative TAD mutants were transferred into the plasmid pSN-itet-
agrA (See Table 14), so that expression of AgrA could be induced with anhydrotetracycline 
and thus be independent of the P2 promoter. This was necessary because in pSN-P2-agrA the 
native AgrA-dependent P2 promoter drives agrA transcription and therefore a putative TAD 
mutant would fail to or poorly activate its own transcription (See Figure 67 and section 1.5).  
 
Figure 67: Cartoon of the agr operon feedback loop.  
The agr operon feedback loop is illustrated by black arrows forming a circle. agrD encodes a propeptide that is 
processed and secreted by the transmembrane AgrB with the help of SpsB releasing the finalised AIP. AgrC 
senses the cell density-dependent accumulation of the AIP and autophosphorylates upon binding the AIP. The 
phosphorylated AgrC is then able to activate AgrA via phosphotransfer. The phosphorylated AgrA is then able 
to bind to specific direct repeats at the agr IR and activate transcription at the P2 and P3 promoter. By 
activating the P2 promoter, AgrA creates an autocatalytic circuit as it stimulates its own transcription. For 
more details, see section 1.5.  
pSN-itet-agrA contained the same plasmid backbone (pCN34) as pSN-P2-agrA but with an 
inducible tetracycline promoter in place of the P2 promoter and agr IR (pCN34itet, see Table 
9). Initially we tested if P3 activity in SH1000- agr IR P3-GFP could be restored with pSN-itet-
agrA. As shown in Figure 68, P3 activity was restored to comparable levels in SH1000-agr IR 
P3-GFP containing pSN-itet-agrA, both in the presence and absence of anhydrotetracycline, but, 
as expected, not in SH1000-agr IR P3-GFP containing pSN-itet-agrAH174L even in the presence of 
anhydrotetracycline. It seems that leaky expression of AgrA from pSN-itet-agrA is sufficient 
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to restore full P3 activity in SH1000-agr IR P3-GFP containing pSN-itet-agrA, therefore all 
downstream experiments involving pSN-itet-agrA were conducted in the absence of 
anhydrotetracycline. 
 
Figure 68: GFP growth curve of pSN-itet-agr.  
Graphs showing GFP expression [as GFP fluorescence units (GFP-Fluo)] as a function of growth (OD600 nm) over 
time for SH1000
-
agr IR P3-GFP + pSN-itet-agrA and SH1000
-
agr IR P3-GFP + pSN-itet-agrAH174L strains grown in TSB with 
and without the addition of anhydrotetracycline. The bar chart in the insert represents the GFP expression of 
the same samples (colour coded accordingly) at the 8 h’ time point. Data obtained from at least three 
biological replicates. 
The GFP fluorescence for each mutant was measured as well and compared to the values 
obtained in SN-P2-agrA.The 16 h’ time point was chosen instead of the 8 h’ time point in 
order to get enough protein to be detectable by western blot. No significant differences were 
observed between the two plasmids and the two different time points for most of the mutants 
(See Figure 69).  
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Figure 69: Comparison of the GFP fluorescence of the 24 putative TAD mutants in pSN-P2-agrA and in pSN-
itet-agrA.  
Graph showing GFP expression [as GFP fluorescence units (GFP-Fluo)] as a function of growth (OD600 nm) 
relative to the SH1000
-
 agr IR P3-GFP + pSN-itet-agrA for the mutants in pSN-itet-agrA or relative to the SH1000
-
 agr 
IR P3-GFP + pSN-P2-agrA for the mutants in pSN-P2-agrA for the 24 single alanine mutants displaying less than 
60% WT activity after 8 h (pSN-P2-agrA) or 16 h (pSN-itet-agrA) of growth in TSB. Data obtained from at least 
three biological replicates.  
The variation that was observed for most of the mutants was within the range of the error bars 
except for five mutants which all displayed a higher activity in pSN-P2-agrA : T142A (32.2% 
vs 25.7%), L171A (50.4% vs 32.9%), I172A (39.8% vs 27.4%), L192 (56.4% vs 39%) and 
F222A (56% vs 34.6%). These differences could be due to the feedback loop system of the 
P2 promoter which would mean that none of these five mutants are likely to be TAD mutants 
as they are apparently able to activate their own transcription. Alternatively, these differences 
could be the result of another TF binding at the agr IR to activate transcription at the P2 and 
that is not binding to the itet promoter. 
Nevertheless, the protein expression level of the 24 selected putative TAD mutants was tested 
by western blot after growth for 16 h in TSB (See section 2.3.8 and Figure 70). 
138 
 
 
Figure 70: GFP activity vs AgrA expression for the 24 putative TAD mutants.  
Graph showing GFP expression [as GFP fluorescence units (GFP-Fluo)] as a function of growth (OD600 nm) 
relative to the SH1000
-
 agr IR P3-GFP + pSN-itet-agrA for each of the 24 single alanine mutant displaying less than 
60% WT activity after 16 h of growth in TSB. A section of the Western blot image indicating AgrA protein levels 
in whole cell lysates for each mutant is shown. For the 13 mutants that are detectably expressed, the AgrA 
protein levels in whole cell lysates relative to the WT AgrA levels is shown on the graph. Data were obtained 
from at least three biological replicates. 
Eleven of the twenty-four mutants are not detectably expressed, which suggests that that 
alanine substitution at positions L145, Y153, Y156, F161, F196, R198, N206, I210, N224 
and R233 in the LytTR domain of AgrA could impair the gross structural stability of the 
protein under the assay conditions. Consistent with this view, side-chains of Y156, F161, 
F196, N206, I210 and N224 are either fully or partly buried within the hydrophobic core of 
AgrA (See Figure 71, colored in blue and labelled in red).  
 
Figure 71: AgrA crystal structure with eleven residues not detectably expressed when mutated to alanine. 
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Ribbon representation of the AgrA LytTR domain-DNA complex crystal structure. The AgrA LytTR domain is 
coloured in cyan and the DNA in grey. The eleven residues that are not detectably expressed when mutated to 
alanine are displayed as sticks and coloured in blue. They are labelled in black but the eight residues that are 
buried in the hydrophobic core are labelled in red. Pymol, PDB 3BS1. 
For 4 (L171A, E181A, H200A and Y229A) of the 13 AgrA mutants which are detectably 
expressed, the ability to activate transcription did not correlate with the expression levels 
(both relative to WT AgrA) under the assay conditions. In other words, even though the 
L171A, E181A, H200A and Y229A mutants are expressed to levels at least ≥ 35-50% of that 
of WT AgrA, a relatively reduced level of P3 activity (by ≥60% loss of activity) is seen in 
cells containing these mutants. Thus, the results suggest that aa residues L171, E181, H200 
and Y229 in the LytTR domain could potentially play a significant role in transcription 
activation by AgrA. This conclusion is further substantiated by the fact that L171, E181, 
H200 (100% identity) and Y229 (100% similarity) are fully conserved in AgrA found in all 
staphylococci (See Figure 72). Moreover, three of these residues, L171, E181 and H200 are 
well conserved among LDCTFs as well (See Figure 73).  
 
Figure 72: Multiple Sequence alignment of the amino acid (aa) sequence of the AgrA LytTR domain of 29 
representative Staphylococci strains with the four TAD mutants. 
Aa residues with similar properties have similar colour (See legend). Conserved aa are represented by a dot. 
The four putative transcription activation deficient (TAD) mutants L171, E181, H200 and Y229 are highlighted 
in yellow and labelled.  
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Figure 73: Multiple Sequence alignment of the amino acid (aa) sequence of the LytTR domain of 43 
representative LDCTFs with the four TAD mutants. 
Conserved residues are represented by a dot. The aa residues displaying similar colours have similar properties 
(See legend). The four putative transcription activation deficient (TAD) mutants L171, E181, H200 and Y229 are 
highlighted in yellow and labelled in black.  
4.7. Synonymous and non-synonymous mutations at selected residues in the AgrA 
LytTR domain 
In parallel to the in vivo characterisation in section 4.6, a number of synonymous and non-
synonymous mutations in selected mutants from the first and second category were 
investigated. This mutagenesis was conducted in order to try to determine the aa requirements 
at each of these positions. The eleven residues that were not detectably expressed were 
excluded as well as five residues that seem to be buried in the structure, I159, V204, V220 
and F222 (See Figure 74, in orange). 
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Figure 74: AgrA crystal structure with the four residues excluded. 
Ribbon representation of the AgrA LytTR domain-DNA complex crystal structure. The AgrA LytTR domain is 
coloured in cyan and the DNA in grey. The four residues that were excluded are displayed as sticks, coloured in 
orange and labelled in black. Pymol, PDB 3BS1. 
The mutations were created by SDM as described in section 4.4 and screened as described in 
section 4.5. Nine of the twenty-four TAD mutants were targeted: T142, I143, L171, I172, 
E181, F182, L192, H200 and Y229 (See Figure 75).  
 
Figure 75: Synonymous and non-synonymous mutations. 
Graph showing GFP expression [as GFP fluorescence units (GFP-Fluo)] as a function of growth (OD600 nm) 
relative to the SH1000
-
 agr IR P3-GFP + pSN-P2-agrA for each of the 33 single aa mutants after 8 h of growth in TSB. 
The alanine mutants are colour coded according to their activity category (See Figure 64).The mutants 
displaying less than 20% activity compared to the WT are coloured in black and the ones displaying between 
20% and 60% compared to the WT in grey. The WT and H174L mutants are coloured in white with black 
stripes. The different mutants at each position are shown in the same colour, the alanine mutant without any 
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pattern and the other mutants with a dotted pattern. Data were obtained from at least three biological 
replicates. 
Position 142 does not seem to tolerate any other aa than a threonine. As expected, the 
substitution with a non-polar glycine (7%) was even more disruptive than the alanine 
substitution. But the substitution with a serine, differing from a threonine only by a hydrogen 
group instead of a methyl group, was expected to produce a higher activity than the alanine 
substitution. However, it was not the case and both the alanine and the serine substitution had 
a very similar activity, 22% and 16%, respectively (See Figure 75). This position is poorly 
conserved among LDCTFs (See Figure 76).  
The requirements at position 143 and 172 appear to be very similar. The most disruptive 
substitution is with the negatively charged aspartate (8% and 7%, respectively). A positively 
charged aa, lysine, is much more tolerated giving about 50% activity (47% and 53%, 
respectively), better than with the alanine substitution (29% and 24%, respectively). The 
valine substitution, very similar to the WT isoleucine, gives almost full activity (91%) at 
position 143 and 78% activity at position 172 (See Figure 75). This suggests that a bulky, 
aliphatic and hydrophobic residue is needed at both positions but an isoleucine is required in 
order to get full activity at position 172. However, looking at the conservation of position 143 
among LDCTFs, the only substitutions that are observed are with a leucine and a 
phenylalanine (See Figure 76) suggesting that these are the only accepted substitutions. 
Interestingly, although position 172 is conserved with 100% identity among Staphylococci it 
is poorly conserved among LDCTFs suggesting that this position is important only in the 
context of AgrA (See Figure 76).  
Position 171 does not tolerate small residues like a glycine (13%) nor a positively charged 
arginine (13%) which gives a lower activity than the alanine substitution (35%). However, an 
isoleucine, very similar to the WT leucine gives almost full activity (See Figure 75). This 
substitution can be observed in other LDCTFs as well as valine and threonine substitutions 
(See Figure 76).This suggests that an aliphatic and hydrophobic, preferably bulky residue is 
needed at that position  
Position 192 is fairly similar to position L171 but more tolerant. The small residue glycine 
has about 40% activity, similar to the alanine substitution (43%). With a positively charged 
arginine (82%) or an isoleucine (86%), very similar to the WT leucine, the activity is much 
higher but still lower than the WT (See Figure 75).This suggests that a positively charged or a 
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bulky, aliphatic and hydrophobic residue is tolerated at that position. This position is poorly 
conserved among LDCTFs (See Figure 76).  
Position 181 seems to absolutely require a glutamate. All other substitutions lead to an 
activity of 15% or less, even with a negatively charged aspartate (See Figure 75). This 
position is very well conserved among other LDCTFs (See Figure 76) supporting this view. 
At position 182, an aromatic reside is required for the activity of the protein. Substitutions 
with an arginine (7%) or the bulky leucine (8%) give lower activity than an alanine (18%). 
Substitutions with another aromatic residue, tyrosine gives 87% activity (See Figure 75). This 
position is very well conserved among other LDCTFs (See Figure 76).  
Position 200 does not tolerate any other aa than a histidine. Other polar aa, positively charged 
arginine or negatively charged aspartate or an alanine all give about 13% activity (See Figure 
75). This position is very well conserved among other LDCTFs (See Figure 76) suggesting 
that a histidine is required for full activity.  
Position 229 tolerates some variation. An alanine substitution gives 50% activity, a bit less 
with the smaller glycine, 28%. The bulky, aliphatic and hydrophobic residue isoleucine has a 
high activity (83%). Aromatic residue phenylalanine has almost WT activity (93%, See 
Figure 75). The phenylalanine substitution is observed in other Staphylococci (See Figure 72). 
This position can tolerate another bulky aa but an aromatic residue is needed at that position 
for full activity. This position is poorly conserved among other LDCTFs (See Figure 76) 
 
Figure 76: Multiple Sequence alignment the amino acid (aa) sequence of the LytTR domain of forty-three 
representative LDCTFs with the nine residues mutated highlighted. 
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The conserved residues are represented by a dot. The aa residues displaying similar colours have similar 
properties (See legend). The nine residues T142, I143, L171, I172, E181, F182, L192, H200 and Y229 are 
highlighted in yellow and labelled in black.  
 
4.8. Conclusion 
The aim of this chapter was to clarify the individual aa contribution in the LytTR domain to 
the activity of the AgrA protein. Overall, the aim was reached. Essential and important 
residues in the LytTR domain were identified by means of a systematic alanine screen. The 
screen enabled an unbiased approach to identify potentially important residues in the AgrA 
LytTR domain.  
The residues were categorised according to their activity in the screen and a subset of 
residues were further characterised in vivo. This in vivo approach consisting of a western blot 
analysis enabled the identification of 11 residues potentially essential for the protein to 
assume the correct structural fold. These residues display a very low activity in the screen 
(~4%) and the proteins are not stably detected by western blot. These residues have never 
before been implicated in a structural role in AgrA. However, residues F196 and N206 have 
been reported as being essential for the activity of the VirR protein and are in the FxRxHrS 
motif (See Figure 62) which is involved in DNA-binding in VirR. One could therefore 
hypothesise that these residues are likely involved in the DNA-binding activity of the AgrA 
protein. 
Residue I210 has been reported as being important for the activity of the VirR protein (See 
Figure 62) and it appears to be essential.  
R233A is recognised as being essential for the DNA-binding function of the protein and 
R198 and R218 make indirect contact with the DNA (see section 4.1). R198 is also in the the 
FxRxHrS motif (See Figure 62). As mentioned in section 4.1, the FhRhH[RK][SNQ]hhVN 
motif is the most conserved motif among LDCTFs (See Figure 59) and important for the 
function of the Clostridum perfringens regulator VirR. All the residues of the motif except 
N201 were included in screen (See Figure 77).  
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Figure 77: Activity of the residues in the FFRCHNSFVVN motif.  
Graph showing GFP expression [as GFP fluorescence units (GFP-Fluo)] as a function of growth (OD600 nm) 
relative to the SH1000
-
 agr IR P3-GFP + pSN-P2-agrA for each mutant in the FFRCHNSFVVN motif after 8 h of growth 
in TSB. AgrA mutants displaying more than 60% activity compared to the WT AgrA are shown in white, the 
AgrA mutants displaying between 20 and 60% activity compared to the WT AgrA are shown in light grey, the 
AgrA mutants displaying less than 20% activity compared to the WT AgrA are shown in dark grey and the 
controls (SH1000
-
agr IR P3-GFP + pSN-P2-agrAH174L, SH1000
-
agr IR P3-GFP + pSN-P2-empty and SH1000
-
agr IR P3-GFP + pSN-
P2-agrA) are shown in white with black stripes. Data obtained from at least three biological replicates. 
The result clearly shows that four of the most conserved residues (F196, R198, H200 and 
N206, in dark grey in Figure 77) appear to be essential for the activity of AgrA. Residue 
V204 seems to be important for the function of AgrA as it displays a low activity as well, 
33% (in light grey in Figure 77). These five residues will be further characterised and 
discussed further below. However, residue S202 which is essential in VirR and makes 
indirect contact with the DNA in AgrA does not appear to be essential as it retains 68% 
activity. Another essential residue in VirR is R207 which does not seem to be essential in 
AgrA either as it displays still 66% activity (See Figure 64). Even if not all the residues of the 
motif are important in AgrA, this motif to be globally important for the activity of the AgrA.  
 
The in vivo characterisation of the selected 25 putative TAD mutants resulted in reducing the 
list of potential TAD mutants to only 4 candidates. Because the next step of the 
characterisation of the TAD mutants involves in vitro analysis with the need to purify each 
individual mutant protein it was essential to refine the number of candidates as much as 
possible in order to have a feasible number of candidates. Therefore, our criteria for the 
selection were very stringent. It cannot therefore be excluded that potential TAD mutants 
were missed because of that. However, because of the stringency of our criteria, we can be 
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absolutely sure that none of the 4 TAD mutants are involved in maintaining the structural 
integrity of the protein.  
A number of synonymous and non-synonymous mutations were investigated in order to 
elucidate the aa requirements at each of the targeted positions. These substitutions allowed a 
further characterisation of the 4 TAD mutants. H200 and E181 are very conserved position 
among LDCTFs and no other residue appears to be tolerated at these positions. L171 can be 
substituted with a hydrophobic and aliphatic residue, preferably bulky. Y229 can be 
substituted with a hydrophobic bulky residue, preferably aromatic.  
These 4 TAD mutants will be further characterised in vitro in the next chapter (See chapter 
0).  
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CHAPTER FIVE 
5. Further characterisation of the four putative TAD mutants 
5.1. Introduction 
In the previous chapter (chapter 0) four putative transcription activation deficient (TAD) 
mutants were identified. They were shown to have a reduced activity in vivo compared to the 
WT AgrA protein which was not due to any kind of structural instability. However, further 
characterisation of these mutants is necessary in order to unravel the mechanism responsible 
for their decreased activity. An in vitro approach was selected as we were mainly interested 
in looking at transcription activation. A fully native in vitro system to study transcription in S. 
aureus has been previously successfully developed in the lab (Reynolds & Wigneshweraraj, 
2011) and is readily available. Furthermore, such an in vitro analysis enables the isolation of 
each mechanistic step in order to identify which one is responsible for the observed 
phenotype. We can therefore look at transcription activation directly without having any 
other mechanism taking place at the same time. However, it is important to keep in mind that 
an in vitro setting is artificial and can lead to artefactual effects. This should not be the case 
here as the mutants we have selected have proved to be deficient for transcription activation 
in vivo.  
The use of an in vitro approach implies the purification of all the individual necessary 
components for the reaction in order to recreate the system artificially. Therefore, all the 
proteins components needed to be purified and a suitable DNA template to be designed.  
5.1.1. AgrA  
AgrA had been successfully purified in the lab with an N-terminal 6His tag (See section 3.3 
and 2.3.4.1) (Reynolds & Wigneshweraraj, 2011). However, in order to have a protein as 
native as possible, and to exclude potential detrimental effects of the tag, we decided to adopt 
a tag-less approach. Therefore, the intein mediated purification with an affinity chitin-binding 
tag (IMPACTTM) method was selected. We used the pTYB2 plasmid, containing an N-
terminal intein tag. The method makes use of the inducible self-cleavage activity of protein 
splicing elements called inteins to separate the target protein from the affinity tag. The splice 
junction of the intein is modified in order to allow controllable peptide bond cleavage. The 
cleavage of the intein is activated by thiol reagents such as DTT. The intein tag also contains 
a chitin-binding domain (CBD) that will enable it to bind to chitin. Therefore, the purification 
can be achieved with a column packed with chitin slurry by means of on column cleavage 
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with thiol reagents that will result in the target protein being released from the intein tag (See 
Figure 78). This enables the purification of a native recombinant protein without the use of 
proteases (Chong et al, 1997; Chong et al, 1998).  
 
Figure 78: Principle of the IMPACT
TM
 kit. 
Schematic representation of the mechanism of the Intein Mediated Purification with an Affinity Chitin-binding 
Tag (IMPACT). For more details refer to section 2.3.4.3. Adapted from (Chong et al, 1997). 
5.1.2. Activation of AgrA 
In the cell, AgrA needs to be phosphorylated by AgrC in order to be in the active state. 
Therefore, we needed to find a way to activate AgrA in a similar fashion in order to produce 
active AgrA. Two different approaches were undertaken. The first approach involved 
creating a system as native as possible via the introduction of the natural sensor HK 
responsible for the phosphorylation of AgrA, AgrC. However, AgrC is by definition a 
transmembrane protein therefore most likely poorly soluble. Therefore, in order to maximise 
the chances of successful purification, we decided to attempt using only the cytoplasmic part 
of the AgrC protein, the HK domain, from aa residues 206-430 (AgrC-HK, See Figure 79) to 
phosphorylate AgrA. This approach has already been successfully conducted for a large 
number of HKs and their cognate RRs in Caulobacter crescentus (Skerker et al, 2005).  
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Figure 79: AgrC topology. 
Schematic representation of the domain organisation of the AgrC dimer. The transmembrane sensor domain 
of each monomer (aa 1-200) is coloured in green, the linker (aa 201-221) in black and the Histidine kinase 
domain (aa 222-430) in brown.  
The second approach, widely used for in vitro activation of RRs (See Table 12), involved 
using a small phophodonor, acetyl phosphate, to activate AgrA. Acetyl phosphate is a high 
energy form of phosphate. It has the ability to store more energy than almost any other 
phosphorylated compound, even more than ATP. It has been shown to have the ability to 
donate phosphoryl group to many RRs partners in two-component signalling systems (TCS) 
in vitro thereby activating the RR in the absence of its cognate HK (See Table 12) (Wolfe, 
2005). Acetyl phosphate has been previously successfully used to activate AgrA, in presence 
of MgCl2 (Koenig et al, 2004; Queck et al, 2008; Reyes et al, 2011). The presence of MgCl2 
has been shown to be essential in order for the CheY RR to be phosphorylated by acetyl 
phosphate in vitro (Lukat et al, 1992; McCleary & Stock, 1994) 
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Table 12: Examples of RRs successfully activated by acetyl phosphate.  
The table lists the name of each response regulator (RR), the name of the corresponding histidine kinase (HK), 
the organism(s) they are found in and whether the RR could be activated with acetyl phosphate in vitro. 
Adapted from (Wolfe, 2005). 
Acetyl phosphate is an intermediate in the conversion pathway of acetyl coenzyme A 
(Acetyl-CoA) to acetate. Acetyl-CoA can be converted into acetyl phosphate by the 
phosphotransacetylase (PTA) enzyme whereas acetyl phosphate can be converted into acetyl-
CoA by the PTA. Similarly, the acetyl phosphate can be converted into acetate by the acetate 
kinase (AK) whereas the acetate can be converted into acetyl phosphate by the AK. The 
conversion of acetate into acetyl phosphate by the AK releases a phosphoryl group that can 
be acquired by a RR (See Figure 80) (Wolfe, 2005). 
 
Figure 80: Phosphorylation of a RR by Acetyl phosphate. 
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Schematic of acetyl phosphate in the conversion pathway of acetyl-CoA to acetate and phosphorylation of a 
response regulator (RR) by acetyl phosphate. Acetate is converted into acetyl phosphate (Acetyl~P) by the 
acetate kinase (AK) using ATP and releasing ADP. The same enzyme can convert Acetyl~P into acetate, thereby 
converting ADP in ATP. The conversion of Acetyl~P into acetyl coenzyme A (Acetyl-CoA) by the 
phosphotransacetylase (PTA) uses coenzyme A (CoA) and releases inorganic phosphate (Pi) that can be 
acquired by the RR thereby phosphorylating it (RR~P). The PTA can also convert Acetyl-CoA into Acetyl~P using 
Pi and releasing CoA. Based on (Wolfe, 2005). 
5.1.3. The S. aureus RNA polymerase  
The native S. aureus core RNAp was purified with a method previously optimised in the 
laboratory for S. aureus (Reynolds & Wigneshweraraj, 2011) (See section 2.3.4.2). This 
method consists of an immunoaffinity chromatography using a polyol-responsive antibody in 
order to reduce the need for harsh conditions and preserve core RNAp activity. The cross-
reactive polyol-responsive monoclonal antibody (Mab) 8RB13 can be used to purify core 
RNAp from a number of bacteria (E. coli, Bacillus subtilis, Pseudomonas aeruginosa, etc…) 
that contain the epitope recognised by the Mab. 8RB13 specifically detects an epitope in the 
flap tip helix of the β-flap domain. The epitope, corresponding to aa sequence 5’-
PEEKLLRAIFGEKAS-3’, is conserved in many bacteria, hence the wide recognition 
spectrum of the Mab (Bergendahl et al, 2003). The use of a polyol responsive antibody is 
ideal for large proteins such as the core RNAp as the elution is gentle and only requires a 
polyol containing buffer and salt. This method also minimises the chances of contamination 
with sigma (σ) factors.  
5.1.4. Sigma factor (σ) 
The S. aureus σ factor σA, was cloned in the pET28b
+ vector to create an N-terminal 6His tag 
, expressed and purified by Jonathan Reynolds (Reynolds & Wigneshweraraj, 2011).  
5.1.5. DNA templates 
Three different DNA templates (See Figure 81) were used for the in vitro analysis. One linear 
216 bp DNA template containing the P2 and the P3 promoter, as well as the agr IR was used 
for the EMSAs. For the short RNA synthesis assay, a 96 bp linear probe containing the P3 
promoter only was used. The third template consisted of the same 216 bp fragment inserted in 
the circular plasmid pJRP2+P3 (Reynolds & Wigneshweraraj, 2011) and was used for the in 
vitro transcription assay.  
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Figure 81: DNA templates for in vitro analysis. 
DNA sequence of the promoter templates used for the in vitro analysis. The linear template was used for the 
EMSAs (See section 5.4). The circular template was used for the in vitro transcription assay (See section 5.5.2). 
For this template, the red arrows represent the transcripts originating from the P2 and the P3 promoter, 
respectively. The P3-IR-probe is indicated in pink and was used for the short RNA synthesis assay (See section 
5.5.1). 
5.2. Objectives 
The aim of this chapter was to further characterise the four putative TAD mutants in order to 
determine whether they are indeed bona fide transcription activation deficient mutants. This 
further characterisation consisted mainly of an in vitro analysis. This in vitro analysis was 
then complemented with further in vivo and in silico characterisation. The specific sections 
involved:  
I. Tooling up for the in vitro analysis 
II. Electrophoretic mobility shift assay (EMSA) 
III. In vitro transcription assay 
IV. In vivo analysis: double mutants  
V. In vitro phosphorylation of AgrA 
VI. In silico simulation of the effect of the Y229Amutation (performed by Dr. Robert Weinzierl) 
VII. DNA-bending assay 
5.3. Tooling up for the in vitro analysis 
The first step of the in vitro analysis involved purifying and preparing all the components 
necessary for the in vitro analysis which is here referred to as “tooling up”. 
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5.3.1. Expression and purification of AgrA, AgrAE181A, AgrAL171A, AgrAH200A, 
AgrAY229A and AgrAR233A 
The WT agrA gene and the TAD mutants (agrAL171A, agrAE181A, agrAH200A and agrAY229A) 
were cloned into the pTYB2 plasmid and expressed in the E. coli expression strain ER2566 at 
37°C and induced with IPTG at mid-log phase, see section 2.3.1.4. Another agrA mutant was 
selected, R233A, which is unable to bind DNA (See section 4.1), to use as a negative control 
in the in vitro assays. The five AgrA proteins were lysed and purified using the IMPACTTM 
kit, as in section 2.3.4.3. The purification was performed at 4°C and the cleavage reaction 
was performed at 4°C O/N before the protein was eluted. A sample for the chitin resin was 
taken and the elution fraction was then reloaded (except for AgrAR233A) into the column and 
incubated for another hour before being eluted again. Another sample from the chitin resin 
was taken and the elution fraction was concentrated to about 1/12 of the initial elution 
volume and dialysed O/N at 4°C in a low glycerol (20%) storage buffer.  
 
5.3.1.1. Purification AgrA  
 
Figure 82: WT AgrA purification. 
Image of a 12.5% (w/v) SDS-PAGE gel showing the IMPACT
TM
 purification of AgrA. M = Marker, T0 = before 
induction, O/N = after induction and expression O/N, S = Soluble fraction, IS = Insoluble fraction, FT = Flow-
through, W = Wash, E = Elution, C = Chitin resin, EC = Concentrated elution. The lane numbers and molecular 
weight of the marker bands in kDa are indicated. 
The purification was successful and the native untagged AgrA was successfully eluted from 
the column (Figure 82, lane 9) with minimal contamination. After the first elution, there was 
still some untagged protein stuck in the chitin slurry (Figure 82, lane 10). The second elution 
(Figure 82, lane 11) did not appear to contain more untagged protein than the first one but the 
chitin resin appeared to contain less protein (Figure 82, lane 12). After dialysis, the 
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concentration of protein obtained was approximatly 10-20 µM, which was enough for in vitro 
analysis. 
5.3.1.2. Purification AgrAL171A  
 
Figure 83: AgrAL171A purification. 
Image of a 12.5% (w/v) SDS-PAGE gel showing the IMPACT
TM
 purification of AgrAL171A. M = Marker, T0 = before 
induction, O/N = after induction and expression O/N, S = Soluble fraction, IS = Insoluble fraction, FT = Flow-
through, W = Wash, E = Elution, C = Chitin resin, E C = Concentrated elution. The lane numbers and molecular 
weight of the marker bands in kDa are indicated. 
The purification was successful and the native untagged AgrAL171A was successfully eluted 
from the column (Figure 83, lane 9, 11) with minimal contamination. However, after 
concentration of the elution fraction, a faint contaminating band, probably corresponding to 
the cleaved intein tag was observed (Figure 83, lane 13). After dialysis, the concentration of 
protein obtained was between 10-20 µM. 
5.3.1.3. Purification AgrAE181A 
 
Figure 84: AgrAE181A purification. 
155 
 
Image of a 12.5% (w/v) SDS-PAGE gel showing the IMPACT
TM
 purification of AgrAE181A. M = Marker, T0 = before 
induction, O/N = after induction and expression O/N, S = Soluble fraction, IS = Insoluble fraction, FT = Flow-
through, W =Wash, E =Elution, C = Chitin resin, EC = Concentrated elution. The lane numbers and molecular 
weight of the marker bands in kDa are indicated. 
The purification was successful and the native untagged AgrAE181A was successfully eluted 
from the column but the band was quite faint (Figure 84, lane 9, 11) with minimal 
contamination. However, after concentration of the elution fraction, a faint contaminating 
band, probably corresponding to the cleaved intein tag was observed (Figure 84, lane 13). 
After dialysis, the concentration of protein obtained was ~5 µM. 
5.3.1.4. Purification AgrAH200A  
 
Figure 85: AgrAH200A purification. 
Image of a 12.5% (w/v) SDS-PAGE gel showing the IMPACT
TM
 purification of AgrAH200A. M = Marker, T0 = before 
induction, O/N = after induction and expression O/N, S = Soluble fraction, I S = Insoluble fraction, FT = Flow-
through, W = Wash, E = Elution, C = Chitin resin, EC = Concentrated elution. The lane numbers and molecular 
weight of the marker bands in kDa are indicated. 
The purification was successful and the native untagged AgrAH200A was successfully eluted 
from the column (Figure 85, lane 9, 11) with minimal contamination. However, after 
concentration of the elution fraction, a faint contaminating band, probably corresponding to 
the cleaved intein tag was observed (Figure 85, lane 13). After dialysis, the concentration of 
protein obtained was between 10-20 µM. 
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5.3.1.5. Purification AgrAR233A 
 
Figure 86: AgrAR233A purification. 
Image of a 12.5% (w/v) SDS-PAGE gel showing the IMPACT
TM
 purification of AgrAR233A. M = Marker, T0 = before 
induction, O/N = after induction and expression O/N, S = Soluble fraction, IS = Insoluble fraction, FT = Flow-
through, W = Wash, E = Elution, C = Chitin resin, EC = Concentrated elution. The lane numbers and molecular 
weight of the marker bands in kDa are indicated. 
The purification was successful and the native untagged AgrAR233A was successfully eluted 
from the column (Figure 86, lane 9, 11) with minimal contamination. However, after 
concentration of the elution fraction, a few faint contaminating bands, probably 
corresponding to the cleaved intein tag were observed (Figure 86, lane 13). After dialysis, the 
concentration of protein obtained was between 10-20 µM. 
5.3.2. Expression and purification of AgrC-HK 
The histidine kinase domain of AgrC (AgrC-HK, aa 206-430) was cloned into the pET28b+ 
vector to encode an N-terminal 6His tag, expressed in the E. coli expression strain BL21 at 
37°C and induced with IPTG at mid-log phase, see section 2.3.1.3. The [6His]-AgrC-HK was 
purified with magnetic nickel beads following the methodology in section 2.3.4.1.  
 
Figure 87: AgrC-HK purification.  
157 
 
Image of a 12.5% (w/v) SDS-PAGE gel showing the magne-His purification of [6His]-AgrC-HK. M = Marker, T0 = 
before induction, O/N = after induction and expression O/N, L = Lysate FT = Flow-through, W = Wash, E = 
Elution. The lane numbers and molecular weight of the marker bands in kDa are indicated. 
The elution fraction (See Figure 87, lane 9) contained soluble [6His]-AgrC-HK and was 
dialysed O/N in a storage buffer with low glycerol (10%). After dialysis, the concentration of 
protein obtained was ~10 µM. 
5.3.3. Expression and purification of the S. aureus RNA polymerase (RNAp) 
The Mab 8RB13 was used to purify S. aureus SH1000 core RNAp extracted from 
exponentially growing cells (See section 2.3.2). The core RNAp was purified by cell lysis 
and extraction using Polymin P and ammonium sulphate precipitation steps, as in section 
2.3.4.2. The extracted fraction was then purified by immunoaffinity chromatography using a 
column pre-packed with 8RB13 Mab resin.  
 
Figure 88: RNAp purification.  
Image of a 10% (w/v) SDS-PAGE gel showing the immunoaffinity chromatography of S. aureus core RNAp. M = 
Marker, FT = Flow-through, W = Wash, EC = Concentrated elution. The lane numbers and molecular weight of 
the marker bands in kDa are indicated. 
The S. aureus RNAp was successfully purified to a high purity level (Figure 88, lanes 6-14). 
The elution fractions were pooled together, concentrated (Figure 88, lanes 15) and dialysed 
O/N in storage buffer.  
5.4. Electrophoretic mobility shift assay (EMSA) 
In the crystal structure of the AgrA LytTR domain-DNA complex,the 4 putative TAD 
mutants, aa residues L171, E181, H200 and Y229 are located proximal to the DNA (See 
Figure 89). 
158 
 
 
Figure 89: Crystal structure of the AgrA LytTR domain with the 4 TAD mutants. 
Ribbon representation of the AgrA LytTR domain-DNA complex crystal structure (the LytTR domain and DNA 
are coloured in cyan and grey, respectively). The 4 transcription activation deficient (TAD) mutants are 
coloured in red and labelled in black. Pymol, PDB 3BS1. 
We initially wanted to determine, using purified proteins, if alanine substitutions at L171, 
E181, H200 and Y229 impaired the DNA-binding activity of the mutant AgrA protein, and 
thereby contributed to the observed TAD phenotype. To test the DNA-binding activity of the 
L171A, E181A, H200A and Y229A AgrA mutants, we conducted electrophoretic mobility 
shift based protein-DNA-binding assays (EMSAs) with a 214 bp long DNA probe containing 
the intergenic region of the agr operon (See Figure 81) and with the purified AgrA mutants. 
Since AgrA requires phosphorylation by AgrC for specific binding to DNA, in vitro 
phosphorylation of AgrA was achieved using the small phosphodonor acetyl phosphate and 
with AgrC-HK in presence of ATP (See section 5.1.2). The acetyl phosphate activation 
involved the pre-incubation of AgrA in the presence of acetyl phosphate and MgCl2 for 1h at 
37°C (See section 2.4.2). For the activation with AgrC-HK, purified AgrC-HK was incubated 
for 10 min at RT with AgrA in the presence of dATP (See section 2.4.3). The AgrAR233A 
mutant served as the negative control in the protein-DNA-binding assays.  
5.4.1. EMSA with acetyl phosphate activation 
 
Figure 90: EMSA with acetyl phosphate activation.  
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Autoradiograph image of a 4-20% (w/v) native polyacrylamide gel comparing the ability of the 4 TAD mutants 
AgrAL171A (lanes 3,4), AgrAE181A (lanes 5, 6), AgrAH200A (lanes 7, 8), AgrAY229A (lanes 9, 10) with that of WT AgrA 
(lane 1, 2) to bind to a DNA probe representing the intergenic region of the agr operon in absence (lane 1, 3, 5, 
7, 9, 11) and presence (lane 2, 4, 6, 8, 10, 12) of acetyl phosphate. Lanes 11 and 12 contain the DNA-binding 
AgrAR233A mutant, which is used here as a negative control. The percentage of DNA bound by AgrA (%C) in each 
reaction is given at the bottom of the gel and was calculated from three independent experiments. 
As shown in Figure 90, and as expected, phosphorylation with acetyl phosphate markedly 
increased the binding of WT AgrA to the DNA probe (Figure 90 lanes 1 and 2) and the 
AgrAR233A mutant did not detectably bind to the DNA probe in the presence of acetyl 
phosphate compared to WT AgrA (Figure 90 lanes 11 and 12), thus showing the specific 
binding of AgrA to the DNA probe in the presence of acetyl phosphate. Of the four putative 
TAD mutants, only AgrAY229A bound to the DNA probe to a level comparable to the WT 
AgrA (49% vs 62%, respectively), whilst AgrAL171A, AgrAE181A and AgrAH200A bound to the 
DNA probe with different degrees of reduced efficiency compared to WT AgrA (Figure 90, 
lanes 3-8). Overall, the results indicate that an alanine substitution at aa residue Y229 in the 
LytTR domain of AgrA, whilst only moderately affecting DNA-binding, significantly impairs 
the ability of AgrA to activate transcription. Further, since the AgrAY229A mutant only binds 
DNA in a phosphorylation-dependent manner, we can exclude the possibility that the TAD 
property of this mutant is due to defects associated with phosphorylation. 
5.4.2. EMSA with AgrC-HK activation 
 
Figure 91: EMSA with AgrC-HK activation.  
Autoradiograph image of a 4-20% (w/v) native polyacrylamide gel comparing the ability of the 4 TAD mutants 
AgrAL171A (lanes 3,4), AgrAE181A (lanes 5, 6), AgrAH200A (lanes 7, 8), AgrAY229A (lanes 9, 10) with that of WT AgrA 
(lane 1, 2) to bind to a DNA probe representing the intergenic region of the agr operon in absence (lane 1, 3, 5, 
7, 9, 11) and presence (lane 2, 4, 6, 8, 10, 12) of AgrC-HK. Lanes 11 and 12 contain the DNA-binding AgrAR233A 
mutant, which is used here as a negative control. The percentage of DNA bound by AgrA (%C) in each reaction 
is given at the bottom of the gel and was calculated from three independent experiments. 
Overall, the results obtained for the activation with AgrC-HK (See Figure 91) are mostly 
consistent with those obtained with acetyl phosphate activation (See Figure 90). However, 
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there is a major difference. With the AgrC-HK activation, the unactivated AgrA samples are 
able to bind to the DNA probe efficiently (Figure 91, lanes 1, 3, 5, 9) which is not the case 
with the acetyl phosphate activation (Figure 90, lanes 1, 3, 5, 9). This is probably due to the 
difference in treatment of the unactivated samples between the two methods. In the case of 
the acetyl phosphate, the unactivated sample consists of AgrA pre-incubated with MgCl2 for 
1h at 37°C without acetyl phosphate. The AgrA protein is highly unstable in vitro and the 
treatment at 37°C for 1h most likely destabilizes the protein. However, the activation state 
renders the protein more stable. Therefore, the ability of the protein to bind DNA also 
depends on its ability to be activated by phosphorylation. This explains why there is no DNA-
binding activity observed for the unactivated samples with the acetyl phosphate activation. 
In the case of the activation with AgrC-HK, the unactivated samples are incubated for 10 min 
at RT in the absence of AgrC. Because this step is much shorter and at a lower temperature, it 
does not destabilise the protein hence why the untreated samples retain their ability to bind 
DNA.  
Taken together, the results of the two different EMSAs allow drawing a number of 
observations. One of the TAD mutants, AgrAH200A, is clearly unable to bind DNA under any 
conditions (Figure 90 and Figure 91, lanes 7 and 8), explaining the very low activity observed 
in vivo. In addition, it behaves exactly like the negative control AgrAR233A. Residue R233 is 
essential in order for AgrA to be able to bind DNA and therefore it appears that H200 could 
also be an essential residue for the DNA-binding activity of AgrA. This is also supported by 
the fact that H200 is proximal to the DNA in the crystal structure of the AgrA LytTR domain 
(See Figure 89). 
AgrAE181A binds to DNA with a reduced efficiency (>50%) compared to the WT in any 
conditions (Figure 90 and Figure 91, lanes 5 and 6). Therefore, the reduced activity of this 
mutant in vivo can be attributed to a defect in DNA-binding. This suggests that this residue is 
involved in the DNA-binding activity of the AgrA protein, as the position of this residue on 
the structure suggested (See Figure 89).  
AgrAL171A appears to have a more complicated behavior. When activated with acetyl 
phosphate, it binds to DNA with a reduced efficiency compared to the WT (~40%, See Figure 
90, lanes 3 and 4). However, when unactivated or activated with AgrC-HK (See Figure 91, 
lanes 3 and 4, its DNA-binding ability is much higher, 74% and 79% of the WT, respectively. 
Therefore, it appears that the decreased ability of AgrAL171A to bind DNA when activated 
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with acetyl phosphate could be due to a defect in the ability to be activated by 
phosphorylation.  
AgrAY229A binds to DNA with a slightly reduced efficiency compared to the WT (Figure 90 
and Figure 91, lanes 9 and 10) but that is not enough to explain the decreased activity 
observed in vivo. AgrAY229A is therefore still a putativeTAD mutant.  
5.5. In vitro transcription assay 
To ascertain that AgrAY229A is a bona fide TAD mutant, we tested the ability of the 
AgrAY229A to activate transcription from the agr operon P3 promoter in vitro. The AgrAL171A 
mutant was also included in the in vitro transcription assays as it displayed the best DNA-
binding activity (~50% WT activity; Figure 90 and Figure 91, compare lanes 3 and 4) 
compared to AgrAE181A and AgrAH200A mutants.  
5.5.1. Short RNA synthesis assay with AgrC-HK activation 
As the in vitro activation of AgrA by the HK domain of its cognate two component partner 
AgrC has never been used for in vitro transcription before, the WT AgrA was first tested 
along with the relevant controls (See section 2.4.4). As shown in Figure 92, the results 
revealed that this method of activation was flawed in respect to in vitro transcription. An 
increase of 4-fold in transcription is observed under activation conditions (AgrA, AgrC-HK 
and ATP; Figure 92, lane 5) suggesting that AgrA is activated and activates transcription 
more than when unactivated (Figure 92, lane 4). However, an equivalent 4-fold increase in 
transcription is observed in presence of AgrC-HK and dATP but without AgrA (Figure 92, 
lane 3). This result has no biological relevance and must be due to an artefact of the in vitro 
system. AgrC is a transmembrane protein, therefore it is highly unlikely that it would ever 
come in contact with the DNA, let alone be involved in transcription activation. Moreover, 
this would render AgrA useless as it acts as the intermediate between AgrC and the DNA. 
We therefore moved on to using acetyl phosphate activation only, as it has been successfully 
used to activate transcription in vitro previously.  
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Figure 92: Short RNA synthesis assay with AgrC-HK activation. 
Autoradiograph image of a 20% (w/v) urea-denaturing-PAGE gel showing the synthesis of the short RNA 
product GpAU from the P3 promoter at 25°C, (indicated by a black bar, underlined nucleotide in 
32
P-labelled. 
Reactions are conducted in the absence of AgrA, AgrC-HK and dATP (lane 1), in the absence of AgrC-HK and 
dATP but in presence of AgrA (lane 2), in the presence of AgrC-HK and dATP but without AgrA (lane 3) , in the 
absence of AgrC-HK but with AgrA and dATP (lane 4), in the presence of AgrC-HK, AgrA and dATP (lane 5). The 
amount of short RNA product synthesised is expressed as fold increase in short RNA from P3 (xF) relative to 
the basal level of P3 transcription without any activation (lane 1) with data from three independent 
experiments. 
5.5.2. Full-length in vitro transcription assay with acetyl phosphate activation 
In order to allow the monitoring of transcription initiation in presence of AgrA, we decided to 
use full length in vitro transcription assay instead of short RNA synthesis assay (See section 
2.4.5). Moreover, the effect of AgrA activation of transcription is clearer with this type of 
assays and this was therefore a better way to test whether AgrAY229A is deficient for 
transcription activation.  
As shown in Figure 93, phosphorylated AgrAY229A failed to activate transcription from the P3 
promoter to a level comparable to that seen in reactions containing WT AgrA (Figure 93, 
compare lanes 2 and 3 with lanes 6 and 7). AgrAY229A is therefore a true TAD mutant. 
In contrast, phosphorylated AgrAL171A activated transcription from the P3 promoter to a level 
almost comparable to that of WT AgrA (Figure 93, compare lanes 2 and 3 with lanes 4 and 
5), even though this mutant binds DNA approximately 50-60% less efficiently than the 
AgrAY229A mutant or WT AgrA when activated with acetyl phosphate (See Figure 90). This 
observation supports the theory that AgrAL171A is not truly deficient in DNA-binding but 
more likely deficient for phosphorylation (See section 5.4.2). Therefore one could imagine a 
model where AgrAL171A binds DNA less efficiently because of its phosphorylation defect, but 
will be able to activate transcription almost as well as the WT when it does bind. Therefore, if 
the system is saturated and there is an excess of AgrA, there might be enough AgrAL171A able 
to bind to DNA and activate transcription so the amount of transcript produced with 
AgrAL171A will be very similar to that produced with the WT. This is apparently the case here.  
As expected, the DNA-binding defective mutant AgrAR233A is unable to activate 
transcription at the P3 promoter (See Figure 93, lanes 8 and 9).  
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Figure 93: Full-length transcription assay with acetyl phosphate activation. 
Autoradiograph image of a 10% (v/v) denaturing urea gel showing the synthesis of the P3 transcript by WT 
AgrA (lane 2, 3), AgrAL171A (lane 4, 5), AgrAY229A (lane 6, 7) and AgrAR233A (lane 8, 9) in the absence (lane 2, 4, 6, 
8) and presence (lane 3, 5, 7, 9) of acetyl phosphate. The fold decrease in transcription (xF) compared to the P3 
transcript in the presence of activated AgrA (lane 3) in each reaction is given at the bottom of the gel with data 
obtained from three independent experiments. 
5.6. In vivo analysis: double mutants 
In order to attempt to clarify the role of residues L171 and Y229, a series of double mutants 
were constructed and tested in vivo (as in sections 4.4 and 4.5). The double mutants 
AgrAL171A/Y229A, AgrAL171A/Y229F, AgrAL171I/Y229A and AgrAL171I/Y229F were tested alongside 
the relevant single mutants (as in sections 4.7 and 4.5, See Figure 94)  
 
Figure 94: Substitutions and double mutants at positions 171 and 229. 
Graph showing GFP expression [as GFP fluorescence units (GFP-Fluo)] as a function of growth (OD600 nm) 
relative to the SH1000
-
 agr IR P3-GFP + pSN-P2-agrA strain for each of the mutants in SH1000
-
 agr IR P3-GFP after 8 h of 
growth in TSB. The tested mutants are coloured in grey, the alanine mutants without any pattern and the 
other mutants with a dotted pattern. The controls, WT and H174L are coloured in white with black stripes. 
Data were obtained from at least three biological replicates. 
The mutants AgrAL171I and AgrAY229F have been tested previously (See section 4.7) but gave 
a slightly higher activity in this screen, as they are both equivalent to the WT in terms of 
activity. As discussed previously, substitution of L171 with an hydrophobic, aliphatic and 
bulky isoleucine does not affect the ability of AgrA to activate transcription. Similarly, 
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substitution of Y229 by the aromatic phenylalanine, differing from a tyrosine only by a 
hydroxyl group, did not significantly affect the ability of the AgrAY229I to activate 
transcription (See Figure 94).  
The double mutant AgrAL171A/Y229A has a very low activity (14%), similar to that of the 
negative control AgrAH174L. This illustrates that the two mutations have a cumulative effect 
which suggests that these two residues have different functions, as is expected from our 
analysis so far (See Figure 94).  
The double mutant AgrAL171A/Y229F displays 48% activity, which is higher than the single 
mutant AgrAL171A which displays 35% activity. This suggests that the Y229F mutation has a 
beneficial effect as it can partially complement for the L171A mutation. If Y229 is indeed 
important for transcription activation it might be possible that AgrAY229F is able to activate 
transcription better than the WT AgrA and therefore complement for the defect in 
transcription activation caused by the L171A mutation (See Figure 94).  
The double mutant AgrAL171I/Y229A displays 83% activity. This is much higher than the 
activity of the AgrAY229A mutant (48%). This suggests that the L171I mutation, similar to the 
Y229F mutation, has a beneficial effect. The presence of this secondary mutation almost 
doubles the transcriptional activity of the AgrAY229A. If L171A is indeed deficient for 
phosphorylation as suspected, L171F could be a hyper-phosphorylation mutant or a 
constitutively active AgrA. Such mechanism could possibly complement the transcription 
activation detrimental effect caused by the Y229A mutation (See Figure 94). 
The double mutant AgrAL171I/Y229F displays 112% activity. This is higher than the WT range 
of activity. This illustrates that, as expect from the result obtained with the other mutants, the 
L171I and Y229F mutations are both beneficial and have a cumulative effect, as observed 
with the double mutant AgrAL171A/Y229A (See Figure 94). 
5.6.1. In vitro phosphorylation of AgrA 
After section 5.6, we strongly suspected that residue L171 is somehow involved in the ability 
of AgrA to phosphorylate. In order to test that, we decided to develop an assay to look at the 
ability of AgrA to phosphorylate in order to be able to compare the level of phosphorylation 
of AgrAL171A with the WT AgrA. As discussed in section 5.1.2, we developed two different 
methods to activate AgrA with acetyl phosphate and with AgrC-HK. The activation via 
phosphorylation with AgrC-HK proved to be problematic in the context of in vitro 
transcription but enabled the successful activation of AgrA for the EMSA (See section 5.4.2). 
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5.6.2. Acetyl Phosphate phosphorylation of AgrA 
In order to be able to visualise AgrA activated with acetyl phosphate we used radiolabelled 
acetyl phosphate (Quon et al, 1996). This method was first tested with the WT AgrA. 
Potassium acetate (KOAc) was incubated in presence of the acetate kinase and γ32P-ATP in 
order to create γ32P-acetyl phosphate. The negative control reaction involved KOAc 
incubated in presence of γ32P-ATP but without the acetate kinase which should result in no 
γ
32P-acetyl phosphate being synthesised. The γ32P-acetyl phosphate or negative reaction was 
then incubated for 1h at 37°C in presence of AgrA (See section 2.4.7), similar to the 
activation performed in sections 5.4.1 and 5.5.2. The results, shown in Figure 95, were 
disappointing. There was only a low level of phosphorylation of AgrA by γ32P-acetyl 
phosphate (Figure 95, lane 2) which was barely detectable. This might be due to the fact that 
a low concentration of AgrA was used (1.5 µM final) and can probably be improved with a 
higher concentration of protein. However, the main problem was that AgrA was able to self-
phosphorylate in presence of γ32P-ATP. This did not really make sense therefore we decided 
not to use this method to test the ability of AgrAL171A to be phosphorylated.  
 
Figure 95: Phosphorylation of AgrA with γ
32P-acetyl phosphate. 
Autoradiograph of a 4.5% (w/v) native-PAGE gel showing the ability of AgrA to self-phosphorylate in presence 
of γ
32P-ATP and KOAc (lane 1) or γ32P-acetyl phosphate (lane 2). The migratory positions of the acetate kinase 
and of AgrA are indicated with arrows. 
5.6.3. AgrC-HK phosphorylation of AgrA 
We then tried to use the ability of AgrC-HK to phosphorylate AgrA in presence of γ32P-ATP 
to visualise the phosphorylated AgrA. The method was first tested with the WT AgrA. Two 
separate reactions were incubated for 1h at 30°C. The first reaction contained AgrC-HK, 
γ
32P-ATP and MgCl2. The second reaction contained AgrA and MgCl2. The two reactions 
were then mixed and incubated for 1h at 30°C (See section 2.4.8). As shown in Figure 96, 
AgrC-HK was able to autophosphorylate in presence of γ32P-ATP (Figure 96, lane 1) and 
transfer phosphate to AgrA (Figure 96, lane 2). A Coomassie stain confirmed that the faint 
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band observed above AgrC-HK was indeed AgrA (Figure 96, lane 2 and 3). Moreover, the 
band observed for AgrC-HK in presence of AgrA was fainter than the one obtained with 
AgrC-HK alone (Figure 96, lane 1 and 2) as expected if AgrC-HK is able to phosphorylate 
AgrA.  
 
 
Figure 96: Phosphorylation of AgrA with AgrC-HK. 
Lane 1 and 2 are autoradiograph of a 10% SDS-PAGE gel. Lane 1 contains the AgrC histidine kinase domain 
(AgrC-HK) and lane 2 AgrC-HK and AgrA. Lane 3 is a Coomassie staining of lane 2. The migratory positions of 
AgrA and AgrC-HK are indicated with arrows. 
This result was promising but the ability of AgrAL171A to be phosphorylated by AgrC-HK 
could unfortunately not be tested as there was not enough time left at this point. 
5.6.4. Position of L171A in the context of the predicted structure of the full-length 
AgrA 
As the time restrictions did not allow us to investigate a potential role for residue L171 in 
phosphorylation via a phosphorylation assay, we decided to take a closer look at its position 
in the structure relative to the CheY-like phosphorylation domain. However, as the crystal 
structure available for AgrA does not include the CheY-like domain, we resolved to use a 
structure prediction software. The Protein Homology/AnalogY Recognition Engine 2 (Phyre 
2) (Kelley & Sternberg, 2009) was used to obtain the predicted structure. The predicted full-
length structure of AgrA obtained was modelled on the crystal structure of the full-length 
LDCTF ComE from Streptococcus peumoniae (PDB 4CBV) (Boudes et al, 2014) with 100% 
confidence and a coverage of 98% (234/238 residues). This predicted structure was used to 
analyse the position of residue L171 relative to the CheY-like domain and the residues 
potentially important for the phosphorylation of AgrA (See Figure 97).  
The precise site of phosphorylation in AgrA is not known but can be predicted based on the 
information available on CheY from Salmonella typhimurium and E.coli as AgrA contains a 
CheY-like phosphorylation domain. Five residues in CheY have been identified as important 
for phosphorylation: D12, D13, D57, T87, Y106 and K109. The corresponding residues in 
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AgrA are D8, D9, D59, T88, F107 and K110. D57, D59 in AgrA is the phosphorylation site 
(See Figure 97). Refer to section 1.5.5.1 for details. 
 
 
Figure 97: Phyre 2 predicted full-length structure of AgrA.  
Ribbon representation of the predicted crystal structure of the full-length AgrA. The CheY-like domain is 
depicted in green and the LytTR domain in blue. The 6 residues potentially involved in phosphorylation, D8, 
D9, D59, T88, F107 and K110 are coloured in red and labelled in black. The L171 residue is coloured in magenta 
and labelled in black. The two β-sheets of the LytTR domain that are the closest to the CheY-like domain are 
labelled in black β4 and β5. 
The predicted structure of AgrA revealed that, while L171A is not located close to the cluster 
of residues important for activation in CheY (See Figure 97, residues coloured in red), it is 
located in close proximity to the CheY-like domain. The β4-sheet is the region of the LytTR 
domain that is the closest to the CheY-like domain and the β5-sheet containing L171 is next 
in line. Therefore, if L171 is somehow involved in maintaining the spatial localization of β4 
and β5, its mutation to alanine might allow these two β-sheets to move away from the rest of 
the LytTR domain. This movement could induce a steric clash with the CheY-like domain 
and prevent it from adopting an active conformation. 
5.7. In silico simulation of the effect of the Y229A mutation (performed by Dr. 
Robert Weinzierl) 
To further interrogate the interactions made by aa residue Y229 in AgrA a collaboration with 
Dr. Robert Weinzierl, in the Department of Life Sciences at Imperial College was 
established. Dr Weinzierl carried out a series of fully atomistic accelerated molecular 
dynamics (aMD) stimulations. aMD is a powerful technique to explore the conformational 
space available to macromolecules (Markwick & McCammon, 2011) and is thus a 
particularly effective method for investigating structural changes induced by mutations. 
168 
 
Simulation of the WT AgrA LytTR domain revealed that the core of the structure is very 
stable and deviates only within the expected range (root-mean square deviation < 2.4 Å) from 
the original crystal structure during 100 nanosec of aMD simulation. In contrast, simulation 
of AgrA LytTR domain containing the in silico Y229-A substitution under identical 
conditions shows a substantial destabilization of the carboxyl-terminal domain (See Figure 98 
and Figure 99). 
 
Figure 98: Molecular dynamics analysis of AgrA LytTR domain with the Y229A mutation. 
Snapshots of the aMD simulation of Y229-A at different time points. The polypeptide chain of the AgrA LytTR 
domain is shown as a grey ribbon. The side chains of aa of interest are represented as van der Waals spheres 
(C199 yellow, H200 blue, I219 orange and the Y229-A in silico substitution in purple). At the beginning of the 
simulation (t = 0 ns), Y229-A is in close contact (as Y229 would be in the WT structure) with C199 and H200. 
This association dissociates during the course of the simulation, resulting in the carboxyl-terminal three β-
sheets to dissociate from the remainder of the LytTR domain (t = 36). At a later stage Y229-A and I219 
dissociate from each other (t = 84). 
 
In the WT structure Y229 makes close contact with C199, H200 and I219 based on a dense 
network of van der Waals-contacts, hydrogen-bonding and hydrophobic interactions. These 
contacts are severely disrupted in Y229-A, resulting in the rapid dissociation of the three C-
terminal β-strands from the main β-sheet transversing the LytTR domain (See Figure 98 and 
Figure 99, 36 ns). At a later stage of the simulation it becomes also evident that Y229-A 
further destabilises the two carboxyl-terminal β-strands and causes a reversible unfolding of 
this sub-structure due to the absence of interaction between I219 and Y229 (See Figure 98 
and Figure 99, 84 ns). Taking into account the structural relevance of the interaction between 
I219 and Y229, it appeared initially puzzling that the AgrAI219A substitution displayed no 
discernible defect in activating transcription from the P3 promoter (See Figure 64 and section 
4.5). 
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Figure 99: Molecular dynamics analysis of AgrA LytTR domain with the Y229A or I219A mutations. 
Quantitation of the aMD results shown in Figure 98: The center-of-mass distances between I219 and Y229-A 
(left panel) and I219-A (right panel) are plotted against aMD simulation time for the WT (wt) structure (black), 
Y229-A (red) and I219-A (blue). The distance between I219 and Y229-A increases substantially at one stage of 
the simulation (from 55 ns onwards), but appears to reform in the final stages of the simulation. In contrast, 
the WT and I219-A simulations maintain a high degree of stability of this interaction. The distance between 
C199 and I219 serves as a measure of the dissociation of the three carboxyl-terminal β-sheets. 
 
Simulations of the in silico I219-A substitution revealed, however, that in this situation Y229 
forms an alternative interaction network involving the adjacent residues E217 and R218. It is 
therefore evident, from both theoretical as well as experimental observations, that I219 plays 
a structurally redundant role (which also explains the evolutionary variability in this position 
(See Figure 72)). Overall the aMD simulations show that an alanine substitution at Y229 is 
predicted to have a substantial impact on the carboxyl-terminal part of the LytTR domain of 
AgrA. The mutation causes a ‘localised’ structural destabilisation that may prevent AgrA 
from adopting a conformation required for transcription activation.  
5.8. DNA bending assay 
A previous study by Reyes et al reported that AgrA induced bending of DNA is the main 
driving force for activation of transcription at the P2 and P3 promoters (Reyes et al, 2011). 
However, based on the results above (See Figure 94, Figure 98 and Figure 99), it is unlikely 
that Y299 is involved in the DNA bending activity of AgrA. Therefore, to directly rule out 
this possibility, we carried out the DNA bending assay previously used by Reyes et al to 
compare the DNA bending activity of the AgrAY229A mutant with that of the WT AgrA in the 
presence of acetyl phosphate. This assay uses the pAM1847 plasmid containing the AgrA 
tandem binding site upstream of the P2 promoter region cloned between the SacI and BglI 
sites (See Figure 100). Digestion of the plasmid with EcoRI, HindIII, BstNI, EcoRV, NheI, 
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and BamHI results in DNA fragments of identical length and composition in which only the 
position of the AgrA binding site is permuted with respect to the 5’ terminus of the fragments 
(See Figure 100 and section 2.4.6).  
 
Figure 100: Schematic of the DNA bending vector pAM1847.  
Schematic (based on Reyes et al) of the DNA bending vector pAM1847 containing the AgrA P2 tandem binding 
site (represented by a black rectangle) cloned into the SacI-BglII site. The EcoRI-SacI fragment on the 5’ side of 
the AgrA P2 binding site is identical to the BglII-BamHI fragment on the 3’ side of the AgrA P2 binding site. 
Hence, digestion of the recombinant vector with any of the six restriction enzymes EcoRI (E), HindIII (H), BstNI 
(N), EcoRV (V), NheI (N) or BamHI (B) produces DNA fragments of identical length but with a different position 
of the AgrA P2 binding site with respect to the 5’ and 3’ end of the fragment. 
Therefore, AgrA-mediated DNA bending can be monitored by non-denaturing 
polyacrylamide electrophoretic analysis of the AgrA-DNA complexes, as the mobility of 
these will be strongly dependent on the position of the bend in the DNA molecule as a result 
of AgrA binding. As shown in Figure 101, no detectable differences were seen in the pattern 
of the mobility of the WT and mutant AgrA-DNA complexes, thus indicating that AgrAY229A 
and WT AgrA bend the DNA equally well and that conserved aa Y229 in the LytTR domain 
of AgrA is not a major determinant of the DNA bending activity of AgrA.  
 
Figure 101: DNA bending assay AgrA and AgrAY229A.  
The autoradiograph image of a 4.5% (v/v) non-denaturing polyacrylamide gel shows the mobilities of phosphorylated 
AgrAY229A and WT AgrA-DNA complexes bound to each of the DNA fragments generated upon digestion of pAM1847 with 
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EcoRI (E), HindIII (H), BstNI (N), EcoRV (V), NheI (N) or BamHI (B). Lanes 1-6 and 13-18 contain no protein. Data from at least 
two independent experiments. 
5.9. Conclusion 
In this section, AgrA was successfully purified using a tag-less method and a new method to 
phosphorylate AgrA using AgrC-HK was developed. Although this mode of activation 
proved to be unsuccessful in the case of in vitro transcription, it was successfully used to 
visualise the level of phosphorylation of AgrA by AgrC-HK in presence of γ32P-ATP. 
But mostly, our analysis has provided several novel insights into AgrA function in S. aureus 
and other LytTR containing transcription factors:  
Alanine substitutions at aa residues E181 or H200 significantly impair the DNA-binding 
activity of AgrA. Alternatively, alanine substitutions at these aa residues could also indirectly 
affect the ability of mutant AgrA to become phosphorylated, however, this is unlikely for 
H200 given its proximity to DNA in the context of the structure of the AgrA LytTR domain-
DNA complex and the fact that even when activated via AgrC it cannot bind DNA at all (See 
Figure 89). However, E181A binds to DNA a little bit better when activated with AgrC. 
Therefore it could, like L171A, be deficient for activation via phosphorylation. Nevertheless, 
even when activated with AgrC it still binds DNA 60% less efficiently than the WT and thus 
is most likely deficient for DNA-binding as well.  
The most conserved sequence motif within the LytTR domain is FhRhHRS (where ‘h’ 
indicates a hydrophobic aa (See section 1.3.2.1) (Nikolskaya & Galperin, 2002). In AgrA the 
FhRhHRS corresponds to FFRCHNS (residues 196-202). In the crystal structure of the AgrA 
LytTR domain-DNA complex only aa residues R198, N201 and S202 were shown to be 
involved in interaction with the DNA and alanine substitution at N201 reduced the ability of 
the AgrA LytTR domain to bind DNA (Sidote et al, 2008). These observations clearly imply 
a role for aa residue H200 within the highly conserved FFRCHNS motif in the binding of 
AgrA to DNA, and, based on the proximity of H200 to the DNA in the AgrA LytTR domain-
DNA complex, base specific contacts between H200 and the DNA cannot be excluded. In 
further support of this view, alanine substitution of H188 (equivalent residue of H200 in 
AgrA) in the LytTR domain of Clostridium perfringens RR-TF VirR, which regulates 
virulence and toxin gene expression, confers a loss of activity phenotype and residues R186 
and S190 in the FhRhHRS motif of VirR has been shown to be involved in DNA-binding 
(McGowan et al, 2002) (See section 4.1).To summarize, we have identified two novel 
residues important for the DNA-binding activity of AgrA, E181 and H200. The mutation of 
H200 into alanine completely abolishes the ability of AgrA to bind DNA, similar to the effect 
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of the R233A mutation. Therefore H200 appears to be essential for the DNA-binding activity 
of AgrA.  
The phenylalanine substitution at aa residues L171 in AgrA has been previously reported to 
confer the non-haemolytic phenotype (indicative of agr operon dysfunction) in a nosocomial 
methicillin-resistant S. aureus isolate (Shopsin et al, 2008) (See section 4.1). Intriguingly, our 
results reveal that even though the AgrAL171A mutant displays a reduced (by ~50%) DNA-
binding activity compared to WT AgrA when activated with acetyl phosphate and slightly 
reduced (80%) when activated with AgrC, its ability to activate transcription is only 
moderately affected (~20% reduction compared to WT AgrA). Thus, it is possible that an 
aromatic side chain at position L171 in the LytTR domain is more deleterious for AgrA 
activity than the presence of alanine. We have hypothesised that the defect in DNA-binding 
observed for the L171A mutant is due to a defect in phosphorylation. Therefore, if this is the 
case, maybe the L171F mutation completely abolishes the ability of AgrA to be activated 
resulting in non-haemolytic phenotype.  
Double mutant studies have revealed that the L171I mutation has a beneficial effect as it can 
partially complement the Y229A mutation. Therefore this mutation probably confers a higher 
phosphorylation or renders AgrA constitutively active. All these arguments go towards a role 
for position L171 in activation by phosphorylation. We have shown, using a model of the 
AgrA full-length structure, that residue L171 is not located close to the determinants of 
phosphorylation in the AgrA CheY-like domain. However, we have shown that it is located 
in the second β-sheet the closest to the LytTR domain and have therefore concluded that a 
disruption of a putative contact between L171A and the β3-sheet could result in more 
freedom of movement for the β4-sheet containing L171 and the β5-sheet and a steric clash 
with the CheY-like domain. Interestingly, the β5-sheet contains the E181 residue which also 
appears to show a defect in phosphorylation.  
Alternatively, L171 could be important in order for AgrA to assume the active conformation. 
The activation by phosphorylation results in changes in the CheY-like domain but the LytTR 
domain must be slightly modified as well as its ability to bind DNA is increased when active. 
Therefore, it is possible that residue L171 is an important determinant for reaching the active 
conformation and that when mutated to alanine AgrA cannot be fully active. Similarly, the 
L171I mutation could facilitate the transition to the active state or further stabilise it and the 
E181 residue could also be involved. 
Importantly, the results identify the highly conserved aa residue Y229 in the LytTR domain 
of AgrA as a major determinant for transcription activation by AgrA. When mutated into an 
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alanine, a drop of 70% for transcription activation in vitro is observed but this residue is not 
involved in the DNA bending activity of AgrA. Interestingly, in the structure of the AgrA 
LytTR domain DNA-complex, Y229 is adjacent to aa residues critical for AgrA folding 
(C228) and DNA interaction (R218), thus indicating that Y229 is part of a functional hotspot 
in AgrA (See section 4.1). Consistent with this notion, a recent study reported that a novel 
antibacterial compound, called savarin, binds to the LytTR domain of AgrA in a region 
proximal to aa residues C228, R218 and Y229 and thereby abrogates AgrA function (Sully et 
al, 2014) (See section 4.1). The proximity of both AgrA binding sites to the P2 and P3 core 
promoter elements (See Figure 102) suggests that transcription activation at both promoters 
could involve direct protein-protein interaction involving aa residue Y229 in AgrA and the 
RNAp and thus could occur via a simple ‘recruitment’ mechanism, whereby AgrA could 
facilitate the binding of the RNAp to the promoter to yield a transcriptionally-proficient 
promoter complex or via a class I or class II mechanism (See section 1.2.2.1 and 1.2.2.2). 
Moreover, double mutants studies have shown that the Y229F mutation has a beneficial 
effect as it can partially complement the L171A mutation. Therefore if Y229 is involved in 
recruiting or contacting the RNAp maybe the Y229F mutant can recruit the RNAp better or 
have a more stable interaction resulting in more transcription. These theories will be further 
developed in the next chapter (See chapter 0). 
A previous study by Reyes et al reported that transcription from P2 and P3 agr operon 
promoters is differentially regulated, with the former (P2) dependent on AgrA and SarA and 
the later (P3) dependent only on AgrA for maximum promoter activity (Reyes et al, 2011) 
and the SarA binding site overlaps with the AgrA footprint at the P2 promoter (See Figure 
102). Therefore, it is possible that Y229 in AgrA is a determinant for interaction with SarA 
for the activation and that the SH1000-agr IR P3-GFP reporter strain used in this study indirectly 
indicates P2 activity (which drives its own transcription – see section 1.5). However, this is 
unlikely because AgrAY229A mutant displays the same level of activity in the context of pSN-
P2-agrA and pSN-itet-agrA in SH1000-agr IR P3-GFP strain and because the Y229A is deficient 
for transcription activation in vitro compared to the WT in the absence of SarA.  
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Figure 102: AgrA binding sites and footprint at the P2 and P3 promoter. 
The nucleotide sequence of the S. aureus agr operon intergenic region with the different regions of relevance 
indicated. -35 refers to the -35 element (5’-TTGACA-3’) and -10 refers to the -10 element (5’-TATAAT-3’). The 
published -10 and -35 promoter elements are highlighted in yellow and the SarA palindromic repeats boxed in 
black. Adapted from (Koenig et al, 2004). 
The aMD analysis reveals that an alanine substitution at Y229 could cause a ‘localised’ 
structural destabilisation that may prevent AgrA from adopting a conformation required for 
making interactions with the RNAp and/or other co-activators for transcription activation 
from the P2 and P3 promoters. However, as with SarA, the defect in transcription activation 
observed for Y229A compared to the WT is unlikely to be due to an inability to interact with 
another factor binding to the agr IR as the defect is also seen in vitro when no other factors 
are presents. In fact, the only external factor that is present in the in vitro system is the RNAp 
therefore the most likely explanation for the Y229A defect in transcription is the lack of an 
interaction with the RNAp that takes place with the WT AgrA.  
The main results obtained in this chapter will be further discussed and developed in the next 
chapter, chapter 0. 
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CHAPTER SIX 
6. Final conclusions and overview 
6.1. Introduction 
The LytTR domain is an unusual DNA-binding domain that is present in ~3% of all RRs. 
Unlike other DNA-binding domains, the LytTR domain consists mainly of β-sheets (See 
Figure 26) and binds to the DNA via 3 loops that connect these β-sheets. Interestingly, LytTR 
domain-containing transcription factors (LDCTFs) are disproportionally associated with the 
regulation of virulence genes (Nikolskaya & Galperin, 2002) (See section1.3.2.1).  
The best characterised LDCTF is AgrA from the important human pathogen Staphylococcus 
aureus (S. aureus) and the only one for which the DNA-binding mechanism has been 
demonstrated. AgrA is a key regulator of virulence gene expression in S. aureus and is 
responsible for the downregulation of cell surface-associated virulence factors and the 
upregulation of secreted virulence factors that takes place in a growth phase and cell density-
dependent manner thanks to a two component quorum sensing system (TCS). The tight 
regulation of virulence factors operated by the agr operon allows S. aureus to switch its 
behaviour from a colonisation state to a more invasive state once a certain threshold of 
population has been reached and contributes to the success of S. aureus as a pathogen and its 
ability to adapt rapidly to changing environments (Novick & Geisinger, 2008). 
The agr operon consists of two transcriptional units: RNAII and RNAIII encoded by two 
divergent promoters: P2 and P3, respectively (See Figure 103 and section 1.5). 
RNAII consists of the quorum sensing system, genes agrB, D, C and A. AgrD is the 
precursor of the autoinducing peptide (AIP) which is processed and secreted by the 
transmembrane endopeptidase AgrB with the help of another peptidase, SpsB releasing the 
finalised AIP. AgrC and AgrA are members of a TCS in which AgrC is the transmembrane 
receptor histidine kinase which senses the growth phase and cell density-dependent 
accumulation of the AIP. Upon binding the AIP, AgrC autophosphorylates and is then able to 
activate the DNA-binding RR AgrA via phosphotransfer. The activated AgrA is then able to 
bind to specific sequences within the agr intergenic region (IR) and activate transcription at 
the P2 and P3 promoters. Like many other RRs, AgrA therefore stimulates its transcription in 
a feed-back loop mechanism.  
RNAIII is the effector RNA molecule of the agr operon and is responsible for the regulation 
of over 200 genes (Novick & Geisinger, 2008).  
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Figure 103: Schematic representation of the organisation of the agr operon and the auto-catalytic circuit.  
AgrD encodes a propeptide that is processed and secreted by the transmembrane AgrB with the help of SpsB 
releasing the finalised AIP. AgrC senses the cell density-dependent accumulation of the AIP and 
autophosphorylates upon binding the AIP. The phosphorylated AgrC is then able to activate AgrA via 
phosphotransfer. The phosphorylated AgrA is then able to bind to specific direct repeats at the agr IR and 
activate transcription at the P2 and P3 promoter. The P3 promoter encodes RNAIII, the pleiotropic effector 
RNA of the operon. RNAIII is responsible for the upregulation of secreted virulence factors and the 
downregulation of cell surface-associated virulence factors. By activating the P2 promoter, AgrA creates an 
autocatalytic circuit as it stimulates its own transcription.  
The P2 and P3 promoters present a non-optimal spacer length of 18 and 20 nt, respectively 
and AgrA was shown to induce a significant bend in the promoter DNA upon binding (See 
Figure 104) (Sidote et al, 2008). The artificial shortening of the P3 spacer in vivo was shown 
to significantly increase its activity and in vitro to result in a level of transcription equivalent 
as when activated by AgrA (Morfeldt et al, 1995; Reynolds & Wigneshweraraj, 2011). 
Together, these findings have led to the theory that the bend in the DNA induced by AgrA is 
responsible for its ability to activate transcription by a typical remodelling of the promoter 
type of activation (See Figure 7) 
 
Figure 104: AgrA binding sites and footprint at the P2 and P3 promoters DNA sequence of the agr IR.  
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The nucleotide sequence of the S. aureus agr operon intergenic region with the different regions of relevance 
indicated. -35 refers to the -35 element (5’-TTGACA-3’) and -10 refers to the -10 element (5’-TATAAT-3’). The 
published -10 and -35 promoter elements are highlighted in yellow. The nucleotide length of the spacer 
between the -10 and -35 promoter elements is indicated for the P2 and the P3 promoter. The end and start of 
the AgrA footprint and the centre of the AgA direct repeats at the P3 promoter are indicated in red. Adapted 
from (Koenig et al, 2004). 
The agr operon has been extensively characterised since its discovery nearly 30 years ago 
and a number of TFs acting to regulate its expression have been identified. Nevertheless, the 
exact mechanism of transcription activation by AgrA remains elusive. 
6.2. Summary of findings 
The objective of this study was to try to clarify the mechanism of transcription activation by 
LCDTFs at their target promoter using AgrA as a model. The first step involved the 
characterisation of the SH1000- strain, previously identified as a possible agrA- strain due to 
a spontaneous mutation. This strain was shown to be agrA deficient due to the mutation 
H174L in the AgrA LytTR domain. The SH1000- strain was successfully complemented 
using a plasmid-borne AgrA, pSN-P2-agrA therefore demonstrating that the H174L mutation 
was causing the agrA- phenotype. Residue H174 was shown to be involved in two salt 
bridges interactions with residues E163 and E226 in the crystal structure of the AgrA LytTR 
domain (Sidote et al, 2008). These salt bridges stabilise the interactions between the β-sheets 
β4 and β3 (H174-E163) and between the β-sheets β4 and β10 (H174 and E226). As illustrated 
in Figure 105, these two salt bridges interactions are the only ones taking place on this face of 
the protein, the only ones linking the β-sheet β10 to the rest of the protein and the only ones 
connecting the β-sheets β4 and β3. Therefore, this observation and the fact that the AgrAH174L 
was barely detectable by Western blot using a polyclonal antibody again AgrA led us to 
conclude that these salt bridges interactions are essential in order for AgrA to adopt the 
correct structural fold and that residue H174 is thus essential for AgrA function. This 
information is novel as this residue has never been identified as being essential for AgrA 
function before. The fact that this mutation was the result of a spontaneous mutation indicates 
that this position is sometime targeted by bacteria in order to inactivate the agr response. 
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Figure 105: Salt bridges interactions in the AgrA LytTR domain with H174, E163 and E226 in red. 
Sequence in amino acid (aa) of the AgrA LytTR domain and ribbon representation of the AgrA LytTR domain-
DNA complex (the LytTR domain and the DNA are coloured in cyan and grey, respectively). H174, E163 and 
E226 are coloured in red. They are labelled in black and the salt bridges interactions are represented by a black 
dotted line on the structure. The other 7 residues involved in salt bridges interactions: R195, E141, D193, 
D157, H208, K223 and D176 are coloured in green. The N- and C-terminal ends of the protein are labelled in 
black on the structure. The different β-sheets and the α-helix are labelled and numbered in the sequence. 
Pymol, PDB 3BS1. 
In order to try to understand the mechanism of transcription action by AgrA by elucidating 
the individual contributions of the aa in the AgrA LytTR domain to transcription activation, a 
systematic mutational analysis of the AgrA LytTR domain was performed. A library of 81 
single aa mutants (78 single alanine) in pSN-P2-agrA targeting 80% of the residues of that 
domain was therefore constructed by site directed mutagenesis.  
A P3-GFP reporter system that had been previously developed in the lab (James et al, 2013) 
was transduced into the SH1000- strain creating the SH1000-agr IR P3-GFP. The SH1000
-
agr IR P3-
GFP was transformed with each of the library mutant plasmid and the whole library was tested 
by growth curves using a multiwall plate reader measuring GFP fluorescence units (GFP-
Fluo) and OD600 nm. This system enabled the quantification of the ability of each library 
mutant AgrA to activate transcription at the P3 promoter by measuring the GFP-Fluo emitted 
by the SH1000-agr IR P3-GFP strain complemented with each mutant plasmid and comparing it to 
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the WT AgrA complementation level (See Figure 64). The screening of the library resulted in 
a wide range of transcriptional activities and demonstrated that this method is highly sensitive 
and quantitative and enables to discriminate between subtle differences in activity. We have 
therefore developed an efficient and simple method to quantify AgrA transcriptional activity 
at the P3 promoter in vivo. 
The screen enabled the identification of 25 putative transcription activation defective (TAD) 
mutants that displayed a reduced ability to activate the P3 promoter by at least 40% compared 
to WT AgrA. The structural stability of these mutants was then tested by western blot in 
order to exclude the mutants whose decrease in activity resulted from structural instability.  
11 of the putative TAD mutants were not detectably expressed (similar to H174L level) and 
were therefore concluded to be structurally impaired. These residues are probably important 
in order to maintain the structural fold of the protein. This is a new finding as none of these 
residues have been identified as important for the activity of the AgrA protein before. 
However, 2 of these residues: R198 and R218 have been shown to make contact with the 
DNA. Interestingly, the essential DNA-binding residue R233 was also barely detectable 
suggesting that this residue is also involved in maintaining the structural fold of the AgrA 
protein.  
For 9 of the remaining putative TAD mutants, the decrease in transcriptional activity 
appeared to correlate with an impaired stability. These mutants were therefore excluded as 
well.  
After this stringent selection, 4 putative TAD mutants remained: L171A, E181A, H200A and 
Y229A. They were purified alongside the DNA-binding defective control mutant R233A 
using a tag-less method and characterised in vitro by EMSA. The EMSAs revealed that all 
mutants but Y229A had a reduced DNA-binding ability compared to the WT. E181A was 
severely impaired in its DNA-binding ability with a 90% reduction compared to the WT with 
acetyl phosphate activation. The H200A was completely unable to bind DNA, as the R233A 
mutant. We have therefore identified two residues involved in DNA-binding in AgrA: E181 
that is important and H200 that is essential for the DNA-binding activity of AgrA. Therefore 
both of these residues are most likely involved in the interaction between AgrA and the DNA. 
Synonymous mutations performed at both these positions revealed that no other aa is 
tolerated at these positions and that these residues at very conserved among LDCTFs which 
highlights their importance.  
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The LytTR domain binds to DNA though three loops that insert into three subsequent 
grooves in the DNA (two minor and one major). Two residues, located on two of these loops, 
H169 and R233 have been shown to be essential in order for the protein to be able to bind to 
DNA. However, the residue located on the third loop inserting in the minor groove, N201, 
was shown to make direct contact with the DNA and to be important in order for AgrA to 
bind DNA, but not essential. H200 is located in this third loop, immediately before N201 and 
appears to be essential. Therefore, it is conceivable that H200 is the main residue responsible 
for the interaction between the AgrA LytTR domain and the DNA in the third loop, the third 
“finger” essential to correctly position the LytTR domain onto the DNA (See Figure 106).  
 
Figure 106: Crystal structure of the AgrA LytTR domain with H200 and the three residues directly interacting 
with the DNA.  
Ribbon representation of the AgrA LytTR domain-DNA complex crystal structure. The LytTR domain is coloured 
in cyan and the DNA in grey. H200 is coloured in red and labelled in the black. The three residues making 
direct contact with the DNA are coloured in magenta, displayed as sticks and labelled in black. The N- and C-
terminal ends of the structure are indicated in black. Pymol, PDB 3BS1. 
The FhRh[RK][SNG]hhVN motif (See Figure 107) was identified as the most conserved 
motif among LDCTFs (Nikolskaya & Galperin, 2002) and as involved in DNA-binding in 
VirR (McGowan et al, 2002) is also very important in S. aureus and involved in DNA-
binding. The essential DNA-binding residue identified, H200 is part of that motif and two 
residues that were shown to make contact with the DNA, R198 and R218 as well. The N206 
residue was identified as resulting in structural instability in the screen (See Figure 107). 
Therefore, judging by the high degree of conservation of this motif among LDCTFs (See 
Figure 59), it highly probable that the involvement of this motif in DNA-binding is conserved 
among LDCTFs. This would implicate that H200 could also be essential for the DNA-
binding activity of other LDCTFs. 
181 
 
 
Figure 107: Residues in the FhRh[RK][SNG]hhVN motif identified in the screen. 
The residues displaying 4% activity or less in the screen and therefore thought to be important in S. aureus are 
coloured in red. Their percentage of activity in pSN-P2-agrA is indicated in red as well.  
The last remaining TAD mutant, Y229A was used in an in vitro transcription assay to assess 
whether it was able to activate transcription at the P3 promoter. The L171A mutant was 
tested as well as it had displayed the best DNA-binding activity after Y229A and was 
suspected to be deficient for activation via phosphorylation. 
The Y229A mutant was unable to activate transcription at the P3 promoter to a level 
equivalent to the WT AgrA. It was able to activate transcription in vitro to ~30% of the WT 
activity which correlates with the in vivo observed activation that was 40-50% of that of the 
WT. Y299A is therefore the only true TAD mutant that was identified by our screen. 
Interestingly, another mutation at that position, Y229F, appears to have the opposite effect 
and to have a higher ability to activate transcription than the WT AgrA. When combined with 
the L171A mutation, the Y229F mutant can compensate for this mutation and the level of 
transcription activation is higher than in the single L171A mutant. Importantly, this result 
identifies the highly conserved Y229A residue in the AgrA LytTR domain as a key 
determinant for maximal transcription activation by AgrA. 
Surprisingly, the L171A was able to activate transcription in vitro to about 80% of the WT 
ability (See Figure 93). This corresponds to the 20% drop in the ability to bind DNA observed 
when the L171A mutant was activated with AgrC and further strengthens the case for L171A 
being deficient for phosphorylation. The L171A mutant displayed a reduced ability to bind 
DNA when activated by acetyl phosphate that appeared to be due to a deficient activation. 
Therefore we hypothesised that this position might be important for activation via 
phosphorylation in the LytTR domain. Upon phosphorylation, a RR undergoes structural 
changes and adopts the active state. These structural changes are mainly localised in the 
receiver domain of the RR (Lee et al, 2001) but must affect the DNA-binding domain as well 
as the ability of the RR to bind DNA is dependent on its activation. Therefore it is 
conceivable that position L171 is important in order for AgrA to reach the active state and 
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that its mutation to alanine prevents AgrA from being fully active. Therefore the DNA-ability 
of the L171A is reduced as it is not fully active.  
The L171I mutant appears to be more transcriptionally active than the WT AgrA as it can 
partially compensate for the Y229A mutation in a double mutant. Therefore having an 
isoleucine at position L171 appears to be more advantageous than a leucine. Following the 
theory that position L171 is important in order to reach the active conformation, the L171I 
mutant could be hyper-phosphorylated or a constitutively active mutant. However, these 
theories are purely speculative now and further work needs to be done in order to confirm or 
infirm them. 
Having identified a true TAD mutant we decided to try to understand the nature of the 
inability of the Y229A mutant to activate transcription to WT level 
An in silico analysis of that mutant was performed by Robert Weinzierl using molecular 
dynamics demonstrated the importance of that residue to connect the C-terminal part of the 
protein to the rest. It predicted that the Y229A mutation creates a local structural 
destabilisation which probably explains the reduced protein stability observed compared to 
the WT AgrA by western blot.  
The ability of AgrA to activate transcription at the P3 and P2 promoter is thought to be the 
result of its ability to bend DNA. We therefore tested the ability of the Y229A mutant to bend 
DNA at the P2 promoter using an in vitro DNA bending assay and showed that the Y229A 
while unable to properly activate transcription at the P3 promoter retained its DNA bending 
ability (See Figure 101). This result brings to question the current belief that the transcription 
activation function of AgrA is solely due to its ability to bend the promoter DNA. Therefore, 
we propose a new model for transcription activation via AgrA that takes into account our new 
findings. As the AgrA footprint at the P2 and P3 promoter overlap the -35 promoter element, 
an interaction between AgrA and the RNAp is conceivable. Therefore activation by AgrA 
would implicate remodelling of the promoter by DNA bending (See section 1.2.1) and direct 
interaction via Class II-like mechanisms. In this case, AgrA could potentially interact with 
σ4, α-CTD or α-NTD (See section 1.2.2.2). Moreover, we have observed that the Y229F 
mutant has a higher ability to activate transcription than the WT AgrA. Therefore, If Y229A 
does indeed interact with the RNAp, the Y229F probably has a better ability to interact than 
the WT AgrA. 
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The crystal structure of the AgrA-LytTR domain/DNA complex indicates that the N-terminal 
part of the LytTR domain is directed towards the -35 promoter element (Sidote et al, 2008) 
(See Figure 108).  
 
Figure 108: Crystal structure of the AgrA LytTR domain in complex with its DNA-binding sequence and the P2 
promoter. 
Ribbon representation of the AgrA LytTR domain-DNA complex (the LytTR domain and the DNA are coloured in 
cyan and grey, respectively) and DNA sequence of the P2 promoter. Y229A is highlighted in red and labelled. 
The consensus AgrA binding sequence is annotated on the corresponding base in the DNA on the structure and 
the direction of the -35 promoter element is indicated with an arrow. The sequence of the P2 promoter with 
the AgrA binding sites (the blue arrows) is displayed under the structure. The binding site corresponding to the 
structure binding site is coloured in red. -35 refers to the -35 element (5’-TTGACA-3’, in yellow) and -10 refers 
to the -10 element (5’-TATAAT-3’, in yellow). The +1 site is highlighted in green and the spacer length between 
the -10 and the -35 promoter elements is indicated in black. Pymol, PDB 3BS1. 
As Y229A is located in the C-terminal part of the protein, it seems unlikely that this residue 
would be involved in an interaction with σ4. Therefore the best candidate to interact with 
AgrA would be the α-CTD subunit. The AgrA footprint at the P3 promoter extends from 
position -23 to position -70 and the centre of the direct repeats is at -55.5 (See Figure 104). 
Therefore, the α-CTD subunit could only bind after position -70. It has been demonstrated 
that activation via interaction with the α-CTD subunit can happen until position -90 as the 
linker joining it to the α-NTD subunit is very flexible (Gaston et al, 1990; Lee et al, 2012; 
Ushida & Aiba, 1990). Therefore, our model of activation by AgrA is represented in Figure 
109. 
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Figure 109: Model of transcription by AgrA.  
AgrA bends the DNA upon binding and Y229A interacts with the α-C-terminal domain (α-CTD) by a Class II 
mechanism. AgrA could therefore also interact with the α-N-terminal domain (α-NTD) and region 4 of the σ 
factor (σ4). 
AgrA makes a contact with the RNAp α-CTD subunit via residue Y229A. Such interaction 
could take place before the AgrA dimer binds the promoter DNA and therefore act as a pre-
recruitment mechanism (See Figure 12) or it could stabilise the interaction between the RNAp 
and the promoter DNA (See Figure 9). In this model, residues located in the N-terminal part 
of the AgrA LytTR domain could possible interact with σ4 or the α-NTD subunit. In addition, 
the δ subunit of the S. aureus RNAp was recently shown to be involved somehow in 
promoter recognition as it appears to direct the RNAp towards strongly expressed promoters. 
Therefore the δ subunit could also be considered as a candidate region for interaction.  
We have evidence to support that AgrA does indeed interact with region 4 of σ. Preliminary 
results of a bacterial adenylate cyclase two-hybrid (BACTH) screen have identified a weak 
interaction between the AgrA LytTR domain and σ4 (See Figure 111). The BACTH system 
enables the detection of the interaction of two proteins of interest fused to the complementary 
fragments of the adenylate cyclase from Bordetella pertussis T25 and T18 in vivo in an E. 
coli strain where the adenylate cyclase gene has been deleted, BTH101. When the two 
domains T25 and T18 are fused to two interacting proteins, the T25 and T18 fragments can 
interact and the adenylate cyclase is functional and can produced cyclic AMP (cAMP). The 
cAMP produced interacts with the catabolite activator protein (CAP) and forms a cAMP/CAP 
complex that can activate the transcription of many E. coli genes. In this case, the complex 
will activate transcription of the lac operon involved in lactose catabolism and containing the 
lacZ gene encoding the β-galactosidase enzyme (See Figure 110). The amount of β-
galactosidase enzyme produced is proportional to the ability of both of the target protein to 
interact with each other and can be quantified in Miller Units. When the two domains T25 
and T18 are physically separated by two non-interacting proteins, there is no production of 
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cAMP, no activation of the transcription of lacZ and therefore no β-galactosidase production 
(Karimova et al, 1998). 
 
Figure 110: Schematic of the principle of the BACTH system.  
A) The T25 and the T18 complementary fragments of the adenylate cyclase from Bordetella pertussis are 
physically linked which results in a functional adenylate cyclase, cAMP production and activation of the lacZ 
reporter gene. B) The T25 and the T18 complementary fragments are not physically linked, the adenylate 
cyclase is non-functional and there is not cAMP produced hence no transcription activation. C) AgrA and σ4 are 
fused to the T25 and the T18 complementary fragments of the adenylate cyclase and if they interact, the 
physical link between T25 and T18 will be restored, the adenylate cyclase will be functional, cAMP will be 
produced and the lacZ reporter gene activated. Adapted from (Karimova et al, 1998). 
In this case, we tested the ability of several subunits of the RNAp (α-CTD, α-NTD, β-flap, β-
flap-tip and σ4) to interact with the AgrA LytTR domain and the AgrA CheY-like domain. A 
weak interaction was detected between σ4 and the AgrA LytTR domain but not the AgrA 
CheY-like domain. None of the other subunits seemed to interact.  
 
Figure 111: BACTH interaction between the AgrA-LytTR domain and σ4.  
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The interaction between the AgrA-LytTR domain and σ4 is over 10-fold above the negative control. The CheY-
like domain does not interact with σ4 as it displays the same level of activity as the negative control. The 
interaction is measured in Miller Units.  
The interaction between the AgrA LytTR domain and σ4 was weak and difficult to detect. 
This might be because this system does not involve DNA and AgrA is not activated. The 
interaction between AgrA and the RNAp is probably mediated by the presence of the 
promoter DNA and requires AgrA to be active. Thus, the fact that we did not detect an 
interaction between AgrA and the other subunits we tested, mainly α-CTD, does not mean 
that they do not interact. We therefore conclude that the BACTH is not a suitable system to 
investigate the putative interaction between the AgrA LytTR domain and the RNAp. 
Nevertheless, this system identified that the AgrA LytTR domain does interact with another 
RNAp subunit than the α-CTD. 
To summarise, our putative model of activation by AgrA involves the bending of the 
promoter DNA in order to reduce the spacer length between the -10 and -35 promoter, direct 
contact with the α-CTD of the RNAp via residue Y229 in the AgrA LytTR domain, 
interaction of unknown residue(s) probably in the N-terminal part of the AgrA LytTR domain 
with σ region 4 and putatively a third interaction of unknown residue(s) probably in the N-
terminal part of the AgrA LytTR domain could take place with the α-NTD subunit. Examples 
of TFs that bind directly to the RNAp and bend the DNA include: CAP, MerR and Fis.  
The CAP TF from E. coli binds to its target promoters (>100) in presence of the allosteric 
effector cyclic AMP and enhances the ability of the RNAp to initiate transcription from these 
promoters. The binding of CAP to the promoter DNA induces a ~ 80° bend in the DNA. CAP 
is also involved in direct interaction with the RNAp. There are Class I promoters where CAP 
interacts with the α-CTD subunit and this interaction facilitates the binding of the RNAp to 
the promoter DNA and thereby stimulates transcription. At Class II promoters, CAP interacts 
with the α-CTD subunit and recruits the RNAp to the promoter. The interaction of CAP with 
the α-NTD subunit and σ4 facilitate the isomerisation from closed complex (RPc) to open 
complex (RPo) thereby activating transcription (Belyaeva et al, 1996; Lawson et al, 2004). 
MerR is a metal ion responsive TF in E. coli and activates transcription as a result of binding 
to mercuric (Hg) ion. MerR binds to its target promoters and recruits the RNAp by interaction 
with σ4. However a ~33° bend in the promoter DNA is induced upon MerR binding which 
results in the -10 and -35 being misaligned in regards to the σ factor. The binding of Hg to 
MerR results in an allosteric underwinding of the DNA which realigns the -10 and -35 
promoter element so that the σ factor can contact them (Ansari et al, 1992; Hobman, 2007).  
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FIS (Factor for Inversion Stimulation) is a global regulator of gene expression in E. coli. Fis 
induces a 40-90° bend in the promoter DNA upon binding. The DNA bending induced by 
FIS is not sufficient for transcription activation on its own. FIS activates transcription via an 
interaction with the α-CTD subunit (Bokal et al, 1997; Finkel & Johnson, 1993; Gille et al, 
1991; Thompson & Landy, 1988). 
The principal limitation of this study is the fact that we might have missed other important 
residues for transcription activation. At first we excluded residues involved in salt bridges 
interactions and DNA-binding, then in the screen we excluded the mutants that were 
structurally impaired, had reduced stability or a reduced ability to bind to DNA. We cannot 
exclude the fact that some of the residues we excluded are involved in transcription activation 
as one residue can be involved in different functions. For example, we exclude residues R218 
and R198 because they appeared to be structurally impaired but these residues are involved in 
contacting the DNA. However, the stringency of the criteria we used was necessary in order 
to be certain that the drop in activity we were observing was due to a defect in transcription 
activation. 
In this study, we have successfully identified a key residue for transcription activation in the 
AgrA LytTR domain, Y229, which is not deficient for DNA bending and thus challenges the 
current model that AgrA activates transcription by its DNA bending activity. We have also 
identified two new residues in the AgrA LytTR domain that are involved in contacting the 
DNA, E181 and H200 and discovered that H200 is essential for the DNA-binding activity of 
AgrA.  
6.3. Future directions 
In order to try to illustrate the interaction between the RNAp, we will use a co-immuno-
precipitation approach to identify proteins interacting with AgrA. This approach implicates 
the use of protein A beads, and the polyclonal antibody against AgrA. Protein A specifically 
binds to the Fc chain of antibodies. First the protein A beads will be coated with polyclonal 
AgrA antibody then incubated with S. aureus whole cell lysate in order for the antibody to 
bind to AgrA. A wash step will remove un-specifically bound and excess protein. Then the 
protein A beads coated with the AgrA/anti-AgrA antibody complex will be incubated in S. 
aureus whole cell lysate again in order for putative proteins interacting with AgrA to bind to 
AgrA. The complexes will be released from the beads after a washing step by incubation with 
Laemmly buffer. The samples will then be analysed by SDS-PAGE electrophoresis to 
determine the nature of the proteins bound to AgrA (Firestone & Winguth, 1990). 
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Alternatively, b-benzoyl-p-phenylalanine (Bpa) crosslinking could be used to try to illustrate 
binding of the RNAp to AgrA. Bpa is a photoreactive artificial aa that can be introduced in a 
protein at a specific site during translation. The chosen insertion sites need to be replaced 
with TAG stop codons. The incorporation of Bpa takes place in a strain carrying a Bpa-
specific suppressor tRNA and aminoacyl-tRNA synthetase (available in the lab) that will 
incorporate the Bpa aa in place of the TAG stop codon. Then the protein containing the 
artificial Bpa can be purified and used in a crosslinking experiment. Bpa can crosslink to 
aliphatic side chains of aa when exposed to long-wave UV light (Dorman & Prestwich, 1994; 
Forne et al, 2012; Liu & Schultz, 2010). Therefore, we could incorporate the Bpa aa close to 
residue Y229A in the AgrA LytTR domain and perform a crosslinking experiment with AgrA 
in presence of the RNAp and see if they interact. 
A third method could be used to confirm that AgrA activation involves contact with the α-
CTD subunit of the RNAp using a reconstituted RNAp with a truncated α subunit lacking the 
CTD (aa 235-329) (Igarashi et al, 1991; Igarashi & Ishihama, 1991). This mutant RNAp 
could be used in an in vitro transcription assay, as described in section 5.5, to test whether the 
ability of WT AgrA mutant to activate transcription at the P3 promoter is dependent on the 
presence of the α-CTD. The AgrAY229A could also be tested alongside the WT AgrA and if 
the Y229A is truly involved in interaction with the α-CTD that activates transcription, they 
should display a similar level of transcription activation.  
Fourthly, it would be interesting to investigate the putative role of the δ subunit in 
transcription activation by AgrA at the P3 promoter. An rpoE (δ) transposon mutant is 
available in the Nebraska transposon library (NARSA) and was used to determine that δ is 
involved in promoter recognition in S. aureus (Weiss et al, 2014). We could acquire this 
strain and transduce the mutation to our SH1000-agr IR P3-GFP strain. Then we would be able to 
test the ability of pSN-P2-agrA to activate transcription in the absence of the δ subunit and 
the whole mutant library could be screened in this background.  
Finally, we will purify the Y229F mutant that displayed a higher ability to activate 
transcription than the WT AgrA and test it in an in vitro transcription assay to confirm the 
result observed in vivo. 
To investigate whether the AgrAL171A mutant is truly phosphorylation deficient, a 
phosphorylation assay with the HK domain of AgrC, AgrC-HK will be performed, as in 
section 2.4.8 and 5.6.3. The ability of AgrAL171A to be activated by AgrC-HK will be 
compared to that of the WT AgrA. 
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Alternatively, the effect of the L171A could be test in an AgrA constitutively active mutant 
using the SH1000-agr IR P3-GFP strain. Several constitutively active CheY mutants have been 
described (Da Re et al, 2002) but one, the double mutant CheY D13K Y106W has been 
shown to adopt a conformation similar to that of the activated CheY (Dyer et al, 2004). The 
corresponding AgrA double mutant (D9K F107W) could be constructed by site directed 
mutagenesis (SDM) as described in section 4.4. To check that CheY mutants are truly 
constitutively active, they are usually tested in presence of the D57A mutation (the 
phosphorylation site in CheY corresponding to D59 in AgrA) that cannot be phosphorylated 
in vitro. Therefore we could use this method to test whether the D9K F107W mutations result 
in a constitutively active AgrA by adding the D59A mutation by SDM and testing the ability 
of the mutant to activate transcription at the P3 promoter in the SH1000-agr IR P3-GFP strain. 
Once we have confirmed whether the AgrAD9K F107W is constitutively active, we will be able 
to test the effect of adding the L171A mutation to the AgrAD9K F107W mutant using the 
SH1000-agr IR P3-GFP strain.  
Alternatively, a simpler method would be to test whether the AgrAD9K F107W mutant is able to 
activate the agr response in serum to test whether it is constitutively active AgrA mutant. The 
agr response is blocked in serum because the autoinducing peptide, AIP, cannot reach AgrC. 
This blockage can be reversed using a constitutively active AgrC and therefore should also be 
reverted using a constitutively active AgrA (James et al, 2013). Therefore we could test the 
ability of the AgrAD9K F107W mutant to activate transcription at the P3 promoter in presence of 
serum using the SH1000-agr IR P3-GFP strain. 
Finally, we could assess whether the AgrAL171I mutant is constitutively active using the exact 
same methods as for the AgrAD13KY106W mutant.  
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APPENDICES 
7. Appendix I 
7.1. Vector maps 
7.1.1. pGEM-T Easy – used for cloning into pTYB2 and pCN34itet 
 
Figure 112: Vector map of the pGEM-T Easy vector from Promega. 
7.1.2. pCN34 – used to clone P2-RBS-AgrA-TT and P1-AgrA-TT 
 
Figure 113: Vector map of the pCN34 vector. Adapted from (Charpentier et al, 2004).  
7.1.3. pCN44 – used as PCR template for the TT 
 
Figure 114: Vector map of the pCN44 vector. Adapted from (Charpentier et al, 2004). 
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7.1.4. pCN34itet – used to clone RBS-AgrA-TT 
 
Figure 115: Vector map of the pCN34itet. (Corrigan et al, 2011). 
7.1.5. pTYB2 – used to clone AgrA  
 
Figure 116: Vector map pTYB2 from New England Biolabs. 
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7.1.6. pET28b+ -used to clone AgrC-HK 
 
Figure 117: Vector map for pET28b
+
 from Novagen. 
7.2. Protein ladders 
 
Figure 118: Protein Ladders. 
PageRuler was used for SDS-PAGE gels and MagicMark for Western blot. 
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8. Appendix II 
8.1. Oligonucleotides and vectors constructed 
8.1.1. Oligonucleotides for cloning and in vitro analysis 
 
Table 13: List of oligonucleotides used for cloning, EMSA and short RNA synthesis assay in this study. 
Primers AgrA pCN34itet F and R were used to subclone the AgrA mutants from pSN-P2-agrA to pSN-itet-agrA. 
Primers AgrA pTYB2 F and R were used to subclone the AgrA mutants from pSN-P2-agrA to pSN agrA. 
8.1.2. Vectors constructed 
 
Table 14: List of vectors constructed in this study. 
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8.1.3. SDM pSN-P2-agrA primers 
 
Table 15: SDM primer Table 1.  
Primers for pSN-P2-agrA SDM, D137A-E181A. 
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Table 16: SDM primer Table 2.  
Primers for pSN-P2-agrA SDM, E181D-H227A. 
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Table 17: SDM primer Table 3.  
Primers for pSN-P2-agrA SDM, C228S-I238A. 
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Bacteria predominantly rely on two-component signal
transduction systems (TCS) to sense and adapt gene ex-
pression patterns to constantly changing environments.
The typical bacterial TCS comprises signal input and re-
sponse output components, typically represented by a his-
tidine kinase (HK) and a response regulator (RR), re-
spectively. In response to a signal, the HK becomes phos-
phorylated and subsequently transphosphorylates its cog-
nate RR, thereby activating the RR to elicit the output
response. Most RRs contain two domains: a conserved
amino-terminal regulatory domain and a variable carboxyl-
terminal effector domain. The majority of RRs are tran-
scription factors (hereafter referred to as RR-TF) with
their carboxyl-terminal domain containing aDNA-binding
motif, which allows recognition of tandem or inverted re-
peating DNA elements located upstream of promoters of
genes and determinants for interaction with the RNA poly-
merase for modulating the transcriptional response. The
carboxyl-terminal domain of the majority of RR-TFs con-
tains DNA-binding motifs that belong to extensively char-
acterized structural families and include the winged-helix
motif of the OmpR/PhoB family, helix-turn-helix motif
of the NtrC family and four-helix-helix-turn-helix of the
NarL/FixJ family (1,2). In contrast, a small number of RR-
TFs, mostly in  -proteobacteria and firmicutes, have an un-
usual and relatively poorly characterized carboxyl-terminal
domain, called the LytTR domain, which predominantly
comprises  strands (3,4). Intriguingly, LytTR domain con-
taining RR-TFs are disproportionately involved in the reg-
ulation of virulence gene expression. Hence, the role of
LytTR domain containing RR-TFs has been widely stud-
ied in many bacterial pathogens (5–7). The molecular in-
teractions between the LytTR domain and DNA have been
recently elucidated from the crystal structure of the DNA-
bound complex of the LytTR domain of Staphylococcus
aureus accessory gene regulator A (AgrA), which is a cell-
density (quorum) responsive global virulence-associated
RR-TF (4,8).
The quorum-dependent regulation of AgrA activity in S.
aureus is well understood (Figure 1 A): the binding of the
quorum signal (the autoinducing peptide, a peptide thio-
lactone, product of the agrD gene; (8)) to the HK AgrC
results in the autophosphorylation of AgrC. Phosphoryla-
tion of AgrA by AgrC ‘activates’ AgrA thus allowing AgrA
to bind to specific sites in the intergenic region of the agr
operon and activate transcription from divergent promot-
ers, P2 and P3. The P2 transcript contains the agrBDCA
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Figure 1. Establishing an experimental system to assess AgrA activity in Staphylococcus aureus. (A) Schematic representation of the agr operon organiza-
tion and regulation in S. aureus. Secreted virulence factors (SVF) and cell-surface-associated virulence factors (CSAVF). The nucleotide sequence of the S.
aureus agr operon intergenic region with the different regions of relevance to this study indicated. (B) Ribbon representation of the AgrA LytTR domain–
DNA complex crystal structure (the LytTR domain and DNA are colored in green and gray, respectively). H174, E163 and E226 are highlighted in red and
the salt bridge interactions indicated by dotted lines. (C) Western blot indicating AgrA protein level in whole cell lysate of S. aureus SH1000− + pSN-P2-
agrA (lane 1), SH1000− + pSN-P2-empty (lane 2), SH1001 + pSN-P2-empty (lane 3) and SH1000 + pSN-P2-empty (lane 4) strains grown overnight in TSB.
(D) Graph showing GFP expression [as GFP fluorescence units (GFP-FU)] as a function of growth (OD600) over time for S. aureus SH1000−agr IR P3-GFP
+ pSN-P2-agrA (green), SH1000−agr IR P3-GFP + pSN-P2-empty (red), SH1000−agr IR P3-GFP + pSN-P2-agrAH174L (purple) and SH1000 agr IR P3-GFP +
pSN-P2-empty (blue) strains grown in TSB. The bar chart in the insert represents the GFP expression of the same samples (color coded accordingly) at
the 8 h time point. (E) Sheep blood agar hemolysis assay with SH1000−agr IR P3-GFP + pSN-P2-agrA (panel 1), SH1000−agr IR P3-GFP + pSN-P2-agrAH174L
(panel 2), SH1000−agr IR P3-GFP + pSN-P2-empty (panel 3) and SH1000agr IR P3-GFP + pSN-P2-empty (panel 4). Data for (C-E) were obtained from at least
three biological replicates and for (C) and (E) representative results are shown.
genes; the P3 transcript (RNAIII) is the pleiotropic effec-
tor molecule of the agr response (8). RNAIII is directly
responsible for post-transcriptional regulation of multiple
virulence factors such as - and -hemolysin (which is en-
coded within the RNAIII transcript) (8,9). AgrA also di-
rectly activates transcription of genes psm, psm and psm-
mec that encode phenol-soluble modulins (PSMs) (which
play a key role in immune evasion by S. aureus owing to
their leukocidal activity) (10). Furthermore, the LytTR do-
main of AgrA also serves as a redox sensor and controls the
expression of the bsaA gene that encodes the glutathione
peroxidase, which allows bacterial cells to cope with oxida-
tive stress (11). In this scenario, oxidative stress results in
the formation of an intramolecular disulfide bond between
aa C199 and C228 in the LytTR domain, which causes the
dissociation of AgrA from its cognate DNA sequence lo-
cated immediately downstream of the bsaA promoter and
thereby leading to the derepression of bsaA transcription.
AgrA binds as a dimer to two direct repeats located in the
intergenic region of the agr operon immediately upstream
of the P2 and P3 promoters, with the center of the pro-
moter proximal direct repeats located approximately at po-
sition -60 with respect to the transcription start sites at +1
for P2 and P3 (Figure 1A) (12). The agr operon intergenic
region also contains binding sites for several other global
TFs, notably SarA, which binds as a dimer to sites located
between the direct repeats bound byAgrA (Figure 1A) (13).
It seems that SarA andAgrA co-activate transcription from
the P2 promoter (14,15). Therefore, based on the proximity
of both AgrA-binding sites to the P2 and P3 promoters, re-
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spectively, it is possible that transcription activation at P2
and P3 involves protein–protein interaction between AgrA,
SarA and the RNA polymerase (RNAp). Further, the -35
and -10 consensus promoter elements of all known AgrA-
activated promoters in S. aureus have a suboptimal spacer
length. For instance, the -35 and -10 consensus promoter
elements of the P2 and P3 promoters of the agr operon are
separated by 18 and 20 nucleotides, respectively, instead of
the optimal 17 nucleotides long spacer region found at most
promoters. Previous studies have suggested that transcrip-
tion activation by AgrA involves a DNA-bending step (14).
Such a mechanism could compensate for the suboptimal
spacer length at the P2 and P3 promoters. Consistent with
this view, shortening of the P2 and P3 promoter spacer re-
gion to the optimal 17 nucleotides length leads to increased
AgrA-independent transcription from both promoters (16).
To date, only amino acid (aa) residues required for bind-
ing of LytTR domain containing TFs to DNA have been
identified (4,5), but the aa residues in the LytTR domain
involved in transcription activation are not known. In this
study, we strategically targeted 74 of 101 aa residues in the
LytTR domain (aa residues 137–238) of S. aureusAgrA for
substitution with alanine and studied their contribution to
transcription activation at the agr operon in vivo and in vitro.
Our results, which represent the first comprehensive mu-
tational analysis of an LytTR domain containing TF, are
discussed in the context of structure–function relationships
and biology of the S. aureus AgrA.
????????? ??? ???????
Bacterial strains, plasmids and DNA manipulation
The bacterial strains and plasmids used in this study are
listed in Supplementary Table S1 and sequences of primers
used for DNA manipulation and cloning are listed in Sup-
plementary Table S2. Escherichia coli and S. aureus were
grown in Luria broth (LB) and tryptic soy broth (TSB),
respectively. Where appropriate, antibiotics were added to
the growth media at the following concentrations: ampi-
cillin, 100 g/ml (E. coli); kanamycin, 90 g/ml (S. au-
reus), 50 g/ml (E. coli) and chloramphenicol, 7.5 g/ml
(S. aureus). Anhydrotetracycline was added at a concen-
tration of 200 ng/ml where appropriate. Escherichia coli
XL1-blue, DC10B and BL21 (DE3) cells were transformed
with plasmid DNA using the standard heat-shock transfor-
mation protocol. Staphylococcus aureus RN4220, SH1000,
SH1000− and SH1001 cells were transformed by electropo-
ration with a Gene Pulser (Bio-Rad) with settings: 2.5 kV,
0.25 FD, 100  in a 1 mm cuvette. Following this, cells
were recovered in brain-heart infusion (BHI) supplemented
with 0.5 M sucrose for 1 h before being plated onto the ap-
propriate selection plates. Transduction into target strains
of S. aureus was carried out with 11 following published
protocols (17). All restriction enzymes and DNAmodifica-
tion enzymes were purchased from New England BioLabs.
Plasmids and genomic DNA were extracted with the Qia-
gen plasmid miniprep kit and theWizard bacterial genomic
DNA kit (Promega), respectively, according to the manu-
facturers’ instructions. The SH1000−agr IR P3-GFP strain was
constructed exactly as previously described by phage trans-
duction of the reporter construct from SH1000agr IR P3-GFP
(18). Plasmid pSN-P2-agrA was constructed by PCR am-
plifying the P2 promoter region from the pCL55agr IR P2-GFP
(18) plasmid containing a region at the 3′ end homologous
to the 5′ end of the agrA gene of S. aureus SH1000 strain
and containing the RBS using primers P2-RBS F and P2-
RBS R. The agrA gene was amplified from the chromo-
some ofS. aureus SH1000 using primers P2-AgrAF andP2-
AgrA R. The transcription terminator was amplified from
the pCN44 (19) plasmid containing a region at the 5′ end
homologous to the 3′ end of agrA using primers P2-TT F
and P2-TT R. The three fragments were fused together by
PCRusing primers P2-RBSF, P2-RBSRandP2-TTR.The
1226 bp long BamHI and KpnI digested PCR fragment was
then ligated into the BamHI and KpnI sites of pCN34 (19)
plasmid. Plasmid pSN-itet-agrA was constructed by PCR
amplification of the agrA gene and terminator region from
the pSN-P2-agrA plasmid using primers AgrA pCN34itet F
containing the RBS and AgrA pCN34itet R. The 1059 bp
long fragment was digested with KpnI and EcoRI and was
then ligated into theKpnI and EcoRI sites of the pCN34itet
plasmid (20). Plasmid pSN-agrA was constructed by PCR
amplifying agrA from the chromosome of S. aureus SH1000
using primers AgrA pTYB2 F and AgrA pTYB2 F and lig-
ating the 731 bp long NdeI and SmaI digested PCR frag-
ment into the NdeI and SmaI sites of pTYB2.
Purification of proteins
Staphylococcus aureus core RNAp and A (from pJR28-
[6His]rpoD) were prepared exactly as previously described
by Reynolds & Wigneshweraraj (16). Recombinant AgrA
was purified as follows: Escherichia coli strain ER2566 con-
taining pSN-agrA was grown at 37◦C. At OD600 nm ∼0.6,
the cells were temperature shifted to 16◦C for 30 min, and
the expression of AgrA was induced with 0.25 mM IPTG.
The cells were harvested after 17 h at 16◦C. AgrA was pu-
rified using the IMPACTTM kit (New England Biolabs) ac-
cording to the manufacturer’s instructions. Briefly, the cells
were lysed in a buffer containing 20 mM Tris-HCl (pH9), 1
MNaCl and 1 mMEDTA (column buffer) and centrifuged
to remove cellular debris. The supernatant was then loaded
on a 10 ml gravity flow column (Bio-Rad) packed with 2
ml Chitin Resin (New England Biolabs). The column was
washed with 20 bed volumes of column buffer and the pro-
tein was cleaved from the intein tag after incubation for 16
h at 4◦C in three bed volumes of cleavage buffer [column
buffer + 200 mM DTT]. The protein was concentrated us-
ingAmiconUltracel-10K (Millipore) and dialysed in a stor-
age buffer [10 mM Tris-HCl (pH8), 50 mM NaCl, 0.1 mM
EDTA, 1 mM DTT and 20% (vol/vol) glycerol].
Bacterial growth and GFP expression assays
These were conducted exactly as described previously (18).
Briefly, simultaneous growth (OD600 nm) and GFP fluores-
cence measurements (with excitation and emission filters of
485 and 520 nm, respectively) were performed in 96-well
black microtiter plates with clear bottoms (Corning) in a
POLARstarOmegamultiwell plate reader (BMGLabtech).
At least three biological replicates (each defined as a single
colony) were performed for each growth curve.
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Blood agar hemolysis assay
Bacteria were grown for 16 h in TSB culture, then 20 l
aliquots were plated onto Columbia Agar containing 5%
sheep’s blood and left to grow for 16 h at 37◦C and then 24
h at 4◦C prior to image capture of the plates.
Western blotting for AgrA
Western blotting was performed using polyclonal anti-
bodies against AgrA (raised in rabbits against recombi-
nant AgrA by Eurogentec (used at 1:250 dilution) and
anti-rabbit-horseradish peroxidase-conjugated antibodies
(Dako; used at 1:3000 dilution) as primary and secondary
antibodies, respectively, following standard laboratory pro-
tocols and as described by James et al. (18).
Electrophoretic gel mobility shift assays (EMSA)
Phosphorylation ofAgrAwas carried out by pre-incubating
3MAgrAwith 50mMacetyl phosphate and 5mMMgCl2
for 1 h at 37◦C. Ten microliter binding reactions were set up
in a reaction buffer [10 mMHEPES (pH 7.6), 50 mMKCl,
1 mM EDTA, 2 mMDTT, 0.5% (v/v) TritonX-100 and 5%
(v/v) glycerol] using 1 M final concentration of phospho-
rylated AgrA and 10 nM of a 214 bp long  -32P-labeled
DNA fragment representing the agr operon intergenic re-
gion including the P2 and P3 core promoter sequences up
to position +11 of the P2 promoter and +15 of the P3 pro-
moter. The DNA probe for the EMSA was prepared by
PCR amplification of the agr operon intergenic region from
the S. aureus SH1000 chromosome using primers P2-IR-P3
F and P2-IR-P3 R. The phosphorylated AgrA was incu-
bated in reaction buffer for 10 min at 37◦C before adding
the DNA probe. The reactions were incubated at 37◦C for
another 10 min and stopped with native gel loading dye [re-
action buffer + 50% (v/v) glycerol and 0.05% (w/v) bro-
mophenol blue] and resolved on a 4–20% (w/v) gradient
native polyacrylamide gel. The dried gel was visualized and
quantified using a GE Typhoon FLA 2000 PhosphorIm-
ager and the Image Quant TL software, respectively.
In vitro transcription assays
The binding reactions for the in vitro transcription assays
were conducted as described above; however, pJRP2+P3 was
used as promoter template in transcription buffer [40 mM
Tris–acetate (pH7.9), 100mMNaCl, 20mMMgCl2 and 0.2
mM DTT]. The in vitro transcription assay was conducted
as described by Reynolds & Wigneshweraraj (16). Briefly,
50 nM S. aureus core RNAp and 200 nM S. aureus A, 1
MAgrA (phosphorylated as described above) and 10 nM
pJRP2+P3 were incubated at 37◦C for 5 min separately and
then mixed and incubated for another 5 min. RNA syn-
thesis was initiated by adding an elongation mix contain-
ing 0.5 mM ATP, CTP and GTP; 0.25 mM UTP; 0.75 Ci
of -32P UTP and the reaction was incubated for a further
10 min at 37◦C. The reactions were stopped with stop dye
[3% (w/v) xylene cyanol, 3% (w/vl) bromophenol blue and
20 mM EDTA in deionized formamide)] and resolved on
a 10% (w/v) urea-denaturing polyacrylamide gel. The dried
gel was visualized and quantified using aGETyphoon FLA
2000 PhosphorImager and the Image Quant TL software,
respectively.
DNA-bending assays
The DNA-bending assays were conducted exactly as de-
scribed by Reyes et al. (14). Plasmid pAM1847 was digested
with EcoRI,HindIII, BstNI, EcoRV,NheI and BamHI. The
fragments were purified using the Qiagen PCR purifica-
tion kit and individually labeled with  -32P ATP. Seven
nanograms of the labeled fragments were then incubated
with 1 M of phosphorylated AgrA in a reaction buffer
with 0.3 g of sonicated calf thymus at room temperature
for 20 min. The reactions were stopped with native loading
dye and resolved on a 4.5% (w/v) native polyacrylamide gel.
The dried gel was visualized and quantified using a GE Ty-
phoon FLA 2000 PhosphorImager and the Image Quant
TL software, respectively.
Molecular dynamics (MD) simulations
The protonation states of residues present in the LytTR
DNA-binding domain in PDB4G4K (4) were computed us-
ing H++ (21). The resulting atomic coordinates were em-
bedded in a TIP3P (22) cubic water box extending for a
minimum of 15 A˚ beyond the protein structure. The assem-
bly was charge-neutralized, adjusted to 150 mM NaCl and
parameterized with the AMBER99SB (23) force field. Sim-
ulations were run on Nvidia GPUs certified to carry out
accurately reproducible calculations using the AMBER 12
package (24). The parameterized structures were energet-
ically minimized by rapid descent and repeated annealing
minimization before equilibration at 300oKelvin and one at-
mosphere of pressure (NPT ensemble). For all MD simula-
tions, the bond length between hydrogen and heavy atoms
was fixed using the SHAKE algorithm (25). The time-step
was 2 femtoseconds and the Particle Mesh Ewald (26) cut-
off distance was set to 8 A˚. The simulation engine was
pmemd.cuda, a CUDA-accelerated MD production engine
based on a hybrid single-/double precision (SPFP) algo-
rithm. Conventional MD simulations were initially carried
out for 50 ns to obtain representative values for the total
potential and dihedral energy values for adjustment in the
subsequent dual-boost accelerated MD (aMD) production
runs. For boosting the dihedral potential, an energy contri-
bution of 3.5 kcal/mol/residue per degree of freedom was
assumed. A boost factor () of 0.2 was used for adjustment
of the dihedral and potential energy in all aMD simulations
(the complete data sets are available from one of the authors
[ROJW] upon request). All aMD simulations lasted 100 ns,
but are likely due to the acceleration to represent protein
motions occurring in the tens to hundreds of microseconds
range in real time (27). Trajectories were processed, visu-
alized and analyzed using the Visual Molecular Dynamics
(VMD) suite (28).
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Establishing an experimental system to asses AgrA activity
in S. aureus
Mutant S. aureus strain SH1000− displays an agr-defective
phenotype and previous work by Tsompanidou et al.
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showed that wild-type level of agr activity can be restored in
SH1000− in the presence of plasmid-borne AgrA (29). We
obtained the nucleotide sequence of agrA from SH1000−
and identified that it contains a leucine substitution at a
conserved histidine at aa position 174 (H174) in the LytTR
domain (Supplementary Figure S1). In the crystal structure
of the AgrA LytTR domain, aa H174 forms a salt bridge
with aa E163 and E226, which contributes to stabilizing the
interface between three  sheets in the LytTR domain (Fig-
ure 1B) (4). Therefore, it is likely that a leucine substitution
at aa H174L compromises the overall structural integrity
of AgrA, rendering it unavailable for transcription activa-
tion. As expected, AgrA protein was detectable in whole-
cell lysates of agr-positive SH1000 (the isogenic parent of
SH1000−), but was hardly detectable in whole-cell extracts
of SH1000− on western blots using polyclonal anti-AgrA
antibodies (Figure 1C). Since the nucleotide sequence up-
stream of agrA including intergenic region and the P2 and
P3 promoter seqences were intact in SH1000−, these re-
sults are consistent with the view that the H174L mutation
destablizes the structural integrity of AgrA in SH1000− and
thereby makes it unavailable to activate transcription from
P2 and P3 promoters of the agr operon. To ascertain that
this is indeed the case, we placed a transcriptional fusion of
P3 to GFP at the geh locus on the SH1000− chromosome
(creating SH1000−agr IR P3-GFP) and measured GFP fluores-
cence (indicating transcription from the P3 promoter) as a
function of cell growth in the presence of plasmid-borne
wild-type AgrA (pSN-P2-agrA) (Supplementary Table S1).
In pSN-P2-agrA, the transcription of agrA is driven from its
native promoter P2 and is dependent on functional AgrA.
In other words, the transcription of agrA from pSN-P2-
agrAwill be autocatalytic as it is the case at the P2 promoter
at the native agr locus. As shown in Figure 1D and as ex-
pected, P3 activity was not detected in SH1000−agr IR P3-GFP
containing pSN-P2-empty or pSN-P2-agrAH174L. However,
P3 activity was restored in SH1000−agr IR P3-GFP containing
the pSN-P2-agrA. Further, since agr dysfunction is asso-
ciated with reduced -hemolytic activity, we used a blood
agar plate hemolysis assay to confirm that -hemolytic ac-
tivity is restored in SH1000−agr IR P3-GFP containing pSN-
P2-agrA, but not in the SH1000−agr IR P3-GFP containing
pSN-P2-agrAH174L or pSN-P2-empty (Figure 1E). We note
a large difference seen in AgrA levels between in the agr-
positive SH1000agr IR P3-GFP cells (Figure 1C, lane 4) and
the complemented agrA-defective SH1000−agr IR P3-GFP +
pSN-P2-agrA cells (Figure 1C, lane 1). This is as ex-
pected since there are at least 25–30 additional copies
(which equates to the copy number of pSN-P2-agrA)
of agrA in SH1000−agr IR P3-GFP + pSN-P2-agrA than in
SH1000agr IR P3-GFP, which will only contain one copy of
agrA. However, rate-limiting factor for AgrA activation
is AgrC, which will be present at wild-type levels in the
SH1000−agr IR P3-GFP + pSN-P2-agrA cells, it is unlikely that
excess AgrA in SH1000−agr IR P3-GFP + pSN-P2-agrA cells
will have any detectable biological impact on AgrA func-
tion as it is evident in results shown in Figure 1D and
E. In summary, the results unambigiously establish that
SH1000−agr IR P3-GFP in combination with plasmid-derived
AgrA (from pSN-P2-agrA) can be used as a reporter strain
to accurately measure AgrA activity in S. aureus.
Alanine-scanning mutagenesis analysis of AgrA identifies
four amino acid residues potentially important for transcrip-
tion activation in the LytTR domain
To indentify aa residues in the LytTR domain involved in
transcription activation, we generated a mutant library of
AgrA by alanine-scanning mutagenesis of the LytTR do-
main using pSN-P2-agrA as the template. Based on the crys-
tal structure of the AgrA LytTR domain–DNA complex
(4), we only targeted residues for alanine substitution that
were neither implicated in DNA binding, nor known to be
important for maintaining the structrual fold of the LytTR
domain. We also constructed the previously described
DNA-binding defective mutant AgrAR233A to use as a neg-
ative control. SH1000−agr IR P3-GFP cells were transformed
with the library comprising a total of 74 AgrA mutants in
pSN-P2-agrA andmutant AgrA activity was determined by
measuring GFP fluorescence as a function of cell density
(OD600 nm) after 8 h of growth in rich media. As expected,
GFP activity was bareley detected in SH1000−agr IR P3-GFP
containing pSN-P2-agrAR233A and pSN-P2-agrAH174L in
comparison to SH1000−agr IR P3-GFP containing pSN-P2-
agrA (Figure 2 A). Based on the spread of the activities of
the mutant AgrA library in SH1000−agr IR P3-GFP, the AgrA
mutants were categorized into two activity groups: <60%
(21 mutants) and >60% (51 mutants) activity relative to
wild-type AgrA (Figure 2A). Mutants in the first group,
which hereafter are referred to as putative transcription-
activation-defective (TAD) mutants, were selected for fur-
ther analysis.
To establish that the TAD property is not caused by the
alanine substitution adversely affecting the stability of the
mutant AgrA protein under the assay conditions (after 8
h of growth in rich media), we transferred the 21 putative
TAD mutations into plasmid pSN-itet-agrA, so that ex-
pression of AgrA can be induced with anhydrous tetracy-
cline and thus independent of the P2 promoter (see above).
In other words, unlike with pSN-P2-agrA, transcription
of agrA from pSN-itet-agrA will not be autocatalytic and
therefore will be independent of AgrA. This approach will
avoid complications in the interpretation of the results aris-
ing from a putative TAD mutant failing to or poorly acti-
vating its own transcription. Initially, we tested if P3 activ-
ity in SH1000−agr IR P3-GFP can be restored with pSN-itet-
agrA in the presence of anhydrotetracycline. As shown in
Figure 2B, P3 activity was restored to comparable levels
in SH1000−agr IR P3-GFP containing pSN-itet-agrA, both in
the presence and absence of anhydrotetracycline, but, as
expected, not in SH1000−agr IR P3-GFP containing pSN-itet-
agrA H174L even in the presence of anhydrotetracycline. It
seems that leaky expression of AgrA from pSN-itet-agrA is
sufficient to restore full P3 activity in SH1000−agr IR P3-GFP
containing pSN-itet-agrA, therefore all downstream exper-
iments involving pSN-itet-agrA were conducted in the ab-
sence of anhydrotetracycline. We next monitored, by West-
ern blotting using anti-AgrA antibodies, the accumulation
of AgrA in SH1000−agr IR P3-GFP + pSN-itet-agrA (in the ab-
sence of anhydrotetracycline) over time to determine a time
point at which saturation in AgrA levels has occurred. As
shown in Supplementary Figure S2, AgrA levels begun to
saturate approximately after 6 h of growth in rich media.
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Figure 2. Systematic mutational analysis of Staphylococcus aureus AgrA LytTR domain. (A) Graph showing GFP expression [as GFP fluorescence units
(GFP-FU)] as a function of growth (OD600) relative to the SH1000−agr IR P3-GFP + pSN-P2-agrA (WT) for each single alanine mutant after 8 h of growth
in TSB. AgrA mutants displaying more than 60% activity compared to the wild-type AgrA are shown in white, the AgrA mutants displaying less than
60% activity compared to the wild-type AgrA are shown in grey and the controls (SH1000−agr IR P3-GFP + pSN-P2-agrAH174L, SH1000−agr IR P3-GFP +
pSN-P2-empty, SH1000−agr IR P3-GFP + pSN-P2-agrA and SH1000−agr IR P3-GFP + pSN-P2-agrAR233A) are shown in black. (B) Graphs showing GFP
expression [as GFP fluorescence units (GFP-FU)] as a function of growth (OD600) over time for SH1000−agr IR P3-GFP + pSN-itet-agrA (green lines) and
SH1000−agr IR P3-GFP + pSN-itet-agrAH174L (red lines) strains grown in TSB with and without anhydrotetracycline. The bar chart in the insert represents
the GFP expression of the same samples (color coded accordingly) at the 8 h time point. (C) Graph showing GFP expression [as GFP fluorescence units
(GFP-FU)] as a function of growth (OD600) relative to the SH1000−agr IR P3-GFP + pSN-itet-agrA (WT) for each of the 21 single alanine mutant displaying
less than 60%wild-type activity after 8 h of growth in TSB.A section of the western blot image indicatingAgrA detected in whole cell lysates for eachmutant
is shown under the graph. For the 13 mutants that are detectably expressed, the quantification of the intensity of the band corresponding to AgrA mutants
relative to the intensity of the band corresponding to the wild-type AgrA level is shown on the graph. Data for (A–C) were obtained from at least three
biological replicates. (D) As in Figure 1B with the six of the eight aa residues (Y156, F161, F196, N206, I210 and N224), which when changed to alanine
appear to impair the gross structural stability of AgrA indicated in red. (E) Multiple sequence alignment of the AgrA LytTR domain of representative
staphylococci strains. Conserved residues are represented by a dot. The aa residues displaying similar colors have similar properties. The putative TAD
mutants are highlighted in yellow.
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Therefore, we used the 8 h post-inoculation time point to
compare the amount of AgrA in the cell and GFP fluo-
rescence (indicative of P3 activity) in SH1000−agr IR P3-GFP
cells producing the TAD mutants from pSN-itet-agrA with
SH1000−agr IR P3-GFP + pSN-itet-agrA expressing wild-type
AgrA. As shown in Figure 2C, 8 of the 21 mutants are not
detectably expressed, which suggests that alanine substitu-
tion at positions L145, Y153, Y156, F161, F196,N206, I210
and N224 in the LytTR domain of AgrA could impair the
gross structural stability of AgrA under the assay condi-
tions. Consistent with this view, side-chains of Y156, F161,
F196, N206, I210 and N224 are either fully or partly buried
within the hydrophobic core of AgrA (Figure 2D). The re-
maining 13 AgrA mutants are detectably expressed at vary-
ing levels compared to wild-type AgrA under the assay con-
ditions. Notably, even though L171A, E181A, H200A and
Y229A mutants are expressed to levels at least ≥ 35–50%
of that of wild-type AgrA, a relatively reduced level of P3
activity (by ≥60% reduction in activity relative to wild-type
AgrA) is seen in cells containing thesemutants. Thus, the re-
sults suggest that aa residues L171, E181, H200 andY229 in
the LytTR domain could potentially play a significant role
in transcription activation by AgrA. This conclusion is fur-
ther substantiated by the 100% identity of L171, E181 and
H200 among agrA alleles in representative staphylococcal
species; Y229 is also highly conserved, being replaced by the
similar phenylalanine in 5 of the 29 sequences (Figure 2E).
Conserved amino acid Y229 in the LytTR domain of AgrA is
not required for DNA binding or bending but for transcription
activation
In the crystal structure of the AgrA LytTR domain-DNA
complex, aa residues L171, E181, H200 and Y229 are lo-
cated proximal to theDNA (Figure 3A).We initially wanted
to determine, using purified proteins, if alanine substitu-
tion at L171, E181, H200 and Y229 impairs the DNA
binding activity of the mutant AgrA protein, and thereby
contributes to the observed TAD phenotype. To test the
DNA-binding activity of the L171A, E181A, H200A and
Y229A AgrA mutants, we conducted electrophoretic mo-
bility shift based protein-DNA-binding assays with a 214
bp long DNA probe containing the intergenic region of the
agr operon andwith the purifiedAgrAmutants. SinceAgrA
requires phosphorylation by AgrC for specific binding to
DNA (see above), in vitro phosphorylation of AgrA was
achieved using the small phosphodonor acetyl phosphate.
The AgrAR233A mutant served as the negative control in
the protein-DNA-binding assays. As shown in Figure 3B,
and as expected, phosphorylation with acetyl phosphate
markedly increased the binding of wild-type AgrA to the
DNAprobe (compare lanes 1 and 2) andAgrAR233A mutant
did not detectably bind to the DNA probe in the presence
of acetyl phosphate compared to wild-type AgrA (com-
pare lanes 11 and 12), thus indicating the specific binding
of AgrA to the DNA probe in the presence of acetyl phos-
phate. Of the four putative TADmutants, AgrAY229A bound
to the DNA probe to a level comparable to the wild-type
AgrA, whilst AgrAL171A, AgrAE181A and AgrAH200A bound
to the DNA probe with different degrees of reduced effi-
ciency compared towild-typeAgrA (Figure 3B, lanes 3–10).
Overall, the results indicate that an alanine substitution at
aa residue Y229 in the LytTR domain of AgrA, whilst only
moderately affecting DNA-binding, significantly impairs
the ability of AgrA to activate transcription. Further, since
the AgrAY229A mutant binds DNA in a phosphorylation-
dependent manner, we can exclude the possibility that, un-
der the assay conditions, the TAD property of this mutant
is due to defects associated with phosphorylation.
To ascertain that AgrAY229A is a bona fide TAD mu-
tant, we tested the ability of the AgrAY229A to activate tran-
scription from the agr operon P3 promoter in vitro. The
AgrAL171A mutant was also included in the in vitro tran-
scription assays as it displayed the best DNA binding ac-
tivity (∼50% wild-type activity; Figure 3B, compare lanes 2
and 4) compared to AgrAE181A and AgrAH200A mutants. As
shown in Figure 3C, phosphorylated AgrAY229A failed to
activate transcription from the P3 promoter to a level com-
parable to that seen in reactions containing wild-type AgrA
(compare lanes 2 and 3 with lanes 6 and 7). In contrast,
phosphorylatedAgrAL171A activated transcription from the
P3 promoter to a level almost comparable to that of wild-
type AgrA (compare lanes 2 and 3 with lanes 4 and 5), even
though this mutant binds DNA approximately 50–60% less
efficiently than the AgrAY229A mutant or wild-type AgrA.
Tyrosine is a polar, hydrophobic and aromatic aa residue.
To investigate the role of the tyrosine residue at position
Y229 we made the AgrAY229F, AgrAY229I and AgrAY229G
mutants and compared their ability to activate transcrip-
tion from the P3 promoter in vivo. As shown in Figure 3D,
substitution of Y229 by the non-polar, hydrophobic and
aromatic aa phenylalanine did not significantly affect the
ability of the AgrAY229F mutant to activate transcription.
Similarly, substitution of Y229 by the non-polar, hydropho-
bic, and non-aromatic aa isoleucine, which contains a bulky
side chain as tyrosine did not significantly affect the abil-
ity of the AgrAY229I to activate transcription. In contrast,
substitution of Y229 by the small non-polar, hydropho-
bic, non-aromatic aa glycine significantly impaired the abil-
ity of AgrAY229G mutant to activate transcription, as seen
with AgrAY229A. Overall, the results suggest that the bulky
hydrophobic side chain of tyrosine at position 229 in the
LytTR domain in AgrA is required for maximal activation
of transcription.
To further interrogate the interactionsmade by aa residue
Y229 in AgrA, we carried out a series of fully atom-
istic accelerated molecular dynamics (aMD) stimulations.
aMD is a powerful technique to explore the conforma-
tional space available to macromolecules (30) and is thus
a particularly effective method for investigating structural
changes induced by mutations. Simulation of the wild-type
AgrA LytTR domain revealed that the core of the struc-
ture is very stable and deviates only within the expected
range (root-mean square deviation < 2.4 A˚) from the orig-
inal crystal structure during 100 ns of aMD simulation.
In contrast, simulation of AgrA LytTR domain contain-
ing the in silico Y229-A substitution under identical con-
ditions shows a substantial destabilization of the carboxyl-
terminal domain (Figure 4; Supplementary movie 1). In the
wild-type structure Y229 makes close contact with C199,
H200 and I219 based on a dense network of van der Waals
contacts, hydrogen-bonding and hydrophobic interactions.
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Figure 3. Conserved amino acid Y229 in the LytTR domain of AgrA is not required for DNA binding or bending but for transcription activation. (A) As
in Figure 1B with the residues, which when substituted with alanine confer the putative TAD phenotype indicated in red. (B) Autoradiograph image of a
4–20% (w/v) native polyacrylamide gel comparing the ability of the four TAD mutants AgrAL171A (lanes 3, 4), AgrAE181A (lanes 5, 6), AgrAH200A (lanes
7, 8), AgrAY229A (lanes 9, 10) with that of wild-type AgrA (lanes 1, 2) to bind to a DNA probe representing the intergenic region of the agr operon (as
shown in Figure 1A) in absence (lanes 1, 3, 5, 7, 9, 11) and presence (lanes 2, 4, 6, 8, 10, 12) of acetyl phosphate. Lanes 11 and 12 contain the DNA-binding
mutant AgrAR233A, which is used here as a negative control. The percentage of DNA bound by AgrA (%C) in each reaction is given at the bottom of the
gel. (C) Autoradiograph image of a 10% (v/v) denaturing urea gel showing the synthesis of the P3 transcript by wild-type AgrA (lanes 2, 3), AgrAL171A
(lanes 4, 5), AgrAY229A (lanes 6, 7) and AgrAR233A (lanes 8, 9) in the absence (lanes 2, 4, 6, 8) and presence (lanes 3, 5, 7, 9) of acetyl phosphate. The
fold decrease in transcription (xF) compared to the P3 transcript in the presence of activated AgrA (lane 3) in each reaction is given at the bottom of the
gel. (D) Graph showing GFP expression [as GFP fluorescence units (GFP-FU)] as a function of growth (OD600) relative to the SH1000−agr IR P3-GFP +
pSN-P2-agrA strain (WT) for SH1000−agr IR P3-GFP containing pSN-P2-agrAY229A, pSN-P2-agrAY229F, pSN-P2-agrAY229I and pSN-P2-agrAY229G after
8 h of growth in TSB. For (B) and (C) at least two independent experiments were done to obtain the %C and xF values, respectively. The data obtained
were all within 5–10% of the values shown. Data for (D) were obtained from at least three biological replicates.
??????
????????
??????????????????
?????????????
??????????????????????????????
?
??
????????????
?
Nucleic Acids Research, 2014, Vol. 42, No. 20 12533
Figure 4. Molecular dynamics analysis of AgrA LytTR domain. (A) Snapshots of the aMD simulation of Y229-A at different time points. The polypeptide
chain of the AgrA LytTR domain is shown as a grey ribbon. The side chains of the aas of interest are represented as van der Waals spheres (C199 yellow,
H200 blue, I219 orange and the Y229-A in silico substitution in purple). At the beginning of the simulation (t = 0 ns), Y229-A is in close contact (as Y229
would be in the wild-type structure) with C199 andH200. This association dissociates during the course of the simulation, resulting in the carboxyl-terminal
three -sheets dissociating from the remainder of the LytTR domain (t = 36). At a later stage, Y229-A and I219 dissociate from each other (t = 84). (B)
Quantitation of the aMD results shown in (A): The center-of-mass distances between I219 and Y229-A (left panel) and I219-A (right panel) are plotted
against aMD simulation time for the wild-type (wt) structure (black), Y229-A (red) and I219-A (blue). The distance between I219 and Y229-A increases
substantially at one stage of the simulation (from 55 ns onwards), but appears to reform in the final stages of the simulation. In contrast, the wild-type and
I219-A simulations maintain a high degree of stability of this interaction. The distance between C199 and I219 serves as a measure of the dissociation of
the three carboxyl-terminal -sheets.
These contacts are severely disrupted in Y229-A, result-
ing in the rapid dissociation of the three C-terminal -
strands from the main -sheet transversing the LytTR do-
main. At a later stage of the simulation, it also becomes
evident that Y229-A further destabilizes the two carboxyl-
terminal  strands and causes a reversible unfolding of this
sub-structure due to the absence of interaction between
I219 and Y229. Taking into account the structural rele-
vance of the interaction between I219 and Y229, it ap-
peared initially puzzling that the I219A substitution dis-
played no discernible defect in activating transcription from
the P3 promoter (Figure 2A). Simulations of the in silico
I219-A substitution revealed, however, that in this situation
Y229 forms an alternative interaction network involving the
adjacent residues E217 and R218 (Figure 4; Supplemen-
tary movie 2). It is therefore evident, from both theoreti-
cal as well as experimental observations, that I219 plays a
structurally redundant role (which also explains the evolu-
tionary variability in this position (Supplementary Figure
S1)). Overall the aMD simulations show that an alanine
substitution at Y229 is predicted to have a substantial im-
pact on the carboxyl-terminal part of the LytTR domain of
AgrA. The mutation causes a ‘localized’ structural destabi-
lization that may prevent AgrA from adopting a conforma-
tion required for transcription activation, while still retain-
ing DNA-binding activity.
A previous study by Reyes et al. reported that AgrA in-
duced bending of DNA is the main driving force for ac-
tivation of transcription from the P2 and P3 promoters
(14). However, based on the results above (Figures 3D and
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4), it is unlikely that Y229 is involved in the DNA bend-
ing activity of AgrA. Therefore, to directly rule out this
possibility, we carried out the DNA bending assay previ-
ously used by Reyes et al. to compare the DNA bending
activity of AgrAY229A mutant with that of wild-type AgrA
in the presence of acetyl phosphate. This assay uses the
pAM1847 plasmid containing the AgrA tandem binding
site upstream of the P2 promoter region cloned between
the SacI and BglI sites (schematic in Figure 5). Digestion
of the plasmid with EcoRI, HindIII, BstNI, EcoRV, NheI
and BamHI results in DNA fragments of identical length
and composition in which only the position of the AgrA
binding sites is permuted with respect to the 5′ terminus
of the fragments (schematic in Figure 5). Therefore, AgrA-
mediated DNA bending can be monitored by nondenatur-
ing polyacrylamide electrophoretic analysis of the AgrA–
DNA complexes, as the mobility of these will be strongly
dependent on the position of the bend in theDNAmolecule
as a result of AgrA binding. As shown in Figure 5, no de-
tectable differences were seen in the pattern of the mobil-
ities of the wild-type and mutant AgrA–DNA complexes,
thus indicating that AgrAY229A and wild-type AgrA bend
the DNA equally well and that conserved aa Y229 in the
LytTR domain of AgrA is not a major determinant of the
DNA bending activity of AgrA.
??????????
Our analysis has provided several novel insights into AgrA
function inS. aureus and other LytTR containing transcrip-
tion factors:
The agr operon indirectly controls the expression of
hemolysins in S. aureus via RNAIII and directly via AgrA
(8). Lack of hemolytic activity is typical of strains with dys-
functional agr operon. A dysfunctional agr operon is con-
sidered to provide an adaptive advantage for survival in
the infected host but counter-adaptive outside infected host
tissues (31). Under laboratory growth conditions, sponta-
neous mutations in the agr operon genes can occur, which
can confer a nonhemolytic phenotype and this has also been
observed for the widely used laboratory strain SH1000, with
the nonhemolytic variant designated SH1000− (29). Our re-
sults reveal that the molecular basis for the agr operon dys-
function in SH1000− is a point mutation at a conserved aa
residue (H174) in AgrA, which disrupts salt–bridge interac-
tions that stabilizes the interaction between three  sheets in
the LytTR domain of AgrA. Further, a phenylalanine sub-
stitution at aa residues L171 in AgrA has been previously
reported to confer the nonhemolytic phenotype (indicative
of agr operon dysfunction) in a nosocomial methicillin-
resistant S. aureus isolate (31). Intriguingly, our results re-
veal that even though AgrAL171A mutation displays a re-
duced (by ∼50%) DNA binding activity compared to wild-
type AgrA, its ability to activate transcription is only mod-
erately affected (∼20% reduction compared to wild-type
AgrA). Thus, it is possible that an aromatic side chain at
position 171 in the LytTR domain is more deleterious for
AgrA activity than the presence of alanine.
The results reveal that alanine substitutions at aa residues
L171, E181 or H200 significantly impair the DNA-binding
activity of AgrA. It is possible that alanine substitutions
at these aa residues indirectly affect the ability of mu-
tant AgrA to become phosphorylated, however, this is un-
likely given their proximity to DNA in the context of the
structure of the AgrA LytTR domain–DNA complex (Fig-
ure 3A). The most conserved sequence motif within the
LytTR domain is FhRhHRS (where ‘h’ indicates a hy-
drophobic aa) (3). In AgrA, the FhRhHRS corresponds to
FFRCHNS (residues 196–202). In the crystal structure of
the AgrA LytTR domain–DNA complex only aa residues
R198, N201 and S202 were shown to be involved in interac-
tion with DNA and alanine substitutions at N201 reduced
the ability of the AgrA LytTR domain to bind DNA (4).
These observations clearly imply a role for aa residue H200
within the highly conserved FFRCHNS motif in the bind-
ing of AgrA to DNA, and, based on the proximity of H200
to DNA in the AgrA LytTR domain–DNA complex, base-
specific contacts between H200 and DNA cannot be ex-
cluded. In further support of this view, alanine substitution
of H188 (equivalent residue of H200 in AgrA) in the LytTR
domain ofClostridium perfringensRR-TFVirR, which reg-
ulates virulence and toxin gene expression, confers a loss
of activity phenotype and residues R186 and S190 in the
FhRhHRS motif of VirR has been shown to be involved in
DNA-binding (5).
Importantly, the results identify the highly conserved aa
residue Y229 in the LytTR domain of AgrA as a key de-
terminant for maximal transcription activation by AgrA
and the AgrAY229A mutant still retains some level of ac-
tivity (40–50% in vivo and 30% in vitro compared to wild-
type AgrA) to activate transcription. In the structure of the
AgrA LytTR domain–DNA complex, Y229 is adjacent to
an aa residue critical for AgrA folding (C228) and DNA
interaction (R218), thus indicating that Y229 is part of a
multifunctional region in AgrA. Consistent with this no-
tion, a recent study reported that a novel antibacterial com-
pound, called savarin, binds to the LytTR domain of AgrA
in a region proximal to aa residues C228, R218 and Y229
and thereby abrogates AgrA function (32). The proximity
of both AgrA-binding sites to the P2 and P3 core promoter
elements (Figure 1A) suggests that transcription activation
at both promoters could involve direct protein–protein in-
teraction between the region containing Y229 in AgrA and
the RNAp and thus could occur via a simple ‘recruitment’
mechanism, whereby AgrA could facilitate the binding of
RNAp to the promoter to yield a transcriptionally profi-
cient promoter complex. Furthermore, a previous study by
Reyes et al. reported that transcription from P2 and P3 agr
operon promoters is differentially regulated, with the for-
mer (P2) dependent on AgrA and SarA and the later de-
pendent only onAgrA formaximumpromoter activity (14).
Therefore, it is possible that the region containing Y229 in
AgrA is involved in interaction with SarA for the activa-
tion and that the SH1000−agr IR P3-GFP reporter strain used
in this study indirectly indicates P2 activity (which drives
its own transcriptio, see Materials andMethods). However,
this is unlikely becauseAgrAY229A mutant displays the same
level of activity in the context of pSN-P2-agrA and pSN-
itet-agrA in SH1000−agr IR P3-GFP strain. The aMD analysis
reveals that an alanine substitution at Y229 could cause a
‘localized’ structural destabilization that may prevent AgrA
from adopting a conformation required for efficient tran-
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Figure 5. A schematic (based on Reyes et al. (14)) of the DNA bending vector pAM1847 containing the AgrA P2 tandem binding site (represented by
a black rectangle) cloned into the SacI-BglII site. The EcoRI-SacI fragment on the 5′ side of the AgrA P2 binding site is identical to the BglII-BamHI
fragment on the 3′ side of the AgrA P2 binding site. Hence, digestion of the recombinant vector with any of the six restriction enzymes EcoRI (E),HindIII
(H), BstNI (N), EcoRV (V), NheI (N) or BamHI (B) produces DNA fragments of identical length but with a different position of the AgrA P2 binding
site with respect to the 5′ and 3′ end of the fragment. The autoradiograph image of a 4.5% (v/v) nondenaturing polyacrylamide gel shows the mobilities
of phosphorylated AgrAY229A and wild-type AgrA-DNA complexes bound to each of the DNA fragments generated upon digestion of pAM1847 with
EcoRI (E), HindIII (H), BstNI (N), EcoRV (V), NheI (N) or BamHI (B). Lanes 1–6 and 13–18 contain no protein. Data from at least two independent
experiments.
scription activation. This observation further substantiates
the multifaceted role of Y229 in transcription activation
and maintaining local structural integrity of AgrA. Future
work will focus on molecular details of such potential in-
teractions in order to further delineate the mechanism by
which AgrA activates transcription.
????????????? ????
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